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ABSTRACT 
This work reported is divided into two parts: the first part deals with quinoxaline 
derivatives and includes the preparation and characterisation of novel linear tricyclic 
quinones 1,4-diazanthracen-9,10-diones, (54) and (55). The reaction of diaza-
naphthoquinones and 1-acetyl-1,3-butadiene are used to produce these quinones 
through the Diels-Alder reaction. 
In addition hexaazapentacyclic 5,6,7,12,13, 14-hexaazapentacene was prepared by the 
reaction ofbis(2-chloroquinoxalin-3-yl)sulfide with thioxamide and the reaction of the 
sulfide with amines was investigated. Two different approaches to 6,13-dibutyl-
5,6,7,12,13,14-hexaazapentacene are given. Derivatives of the pentacyclic, 6-thia-
5,7,12,13,14-pentaazapentacene and the unsubstituted 6,13 -dihydro compound are 
described. 
The novel N-(2,5-dimethoxy-6-nitrophenyl)guanidine is used to obtain 3-amino-5,6-
dimethoxy-1 ,2,4-benzotriazine-1-oxide and 4,7 -dimethoxy-1 ,2,3 -benzotriazole is 
shown to be second product. 
Second part of the work is concerned with the development of a preparative route to 
2,6-diphenylpyridines substituted with different groups on the phenyl nuclei. Several 
approaches were attempted. Finally, success was achieved and a series of compounds 
having basic chains of different length on the phenyl groups was prepared. One chain 
in each case had a terminal primary amine. The binding constants of the primary amines 
and their N-acetyl derivatives with DNA were determined using fluorescence 
spectroscopy. 
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CHAPTER: 1 
1.1 INTRODUCTION 
1.1.1 Quinoxaline and related compounds. 
The approved numbering for the quinoxaline ring system, also known as 1, 4-diaza 
naphthalene, is shown in structure (1). 
(1) 
The vast majority of quinoxalines are of synthetic origin and with very few exceptions 
the synthetic method used is to condense an ortho-disubstituted benzene with a two-
carbon synthon. Thus condensation of o-phenylene diamines with a-dicarbonyl 
compounds results in quinoxaline (2) (Scheme 1). 
Scheme 1 
Formation of the bicyclic system generally takes place very smoothly in good yields at 
a temperature below 100°C and compounds are readily isolated as crystalline solids. 1 
1 
By suitable choice of the 1,2-dicarbonyl component, alkyl and aryl substituted 
quinoxalines and quinoxalinones have been prepared. Some have shown biological 
activity. 2 
Quinoxaline itself and many of its simple derivatives do not readily undergo 
substitution on carbon when treated with electrophilic reagents. However, the parent 
base is resistant to nitration with fuming nitric acid and concentrated sulfuric acid at 
100°C, but under forcing condition (concentrated nitric acid and oleum) it has been 
converted into 5,6-dinitroquinoxaline as the major product.3 
The benzene ring of quinoxalin-2-ones is susceptible to electrophilic substitution and 
nitration and halogenation occur smoothly in the 7 -position when the reactions are 
carried out in acetic acid solution.4 Quinoxaline 2,3-dione (3) is readily converted into 
2,3-dichloroquinoxaline (4) on treatment with phosphoryl chloride,5 or with a mixture 
of phosphoryl chloride and phosphorus pentachloride6 (Scheme 2). 
H 
~NX°---... ~NX/-CI ~NO ~NCI 
H 
(3) (4) 
Scheme 2 
Many 2-chloro-3-substituted quinoxalines have been prepared from 2,3-dichloro 
quinoxaline (4) by partial displacement of chlorine7 and (4) has been converted into a 
number of polycyclic compounds. 
2 
1.1.2 Oxidation of quinoxaline. 
Quinoxaline di-N-oxides with useful antibacterial and growth promoting properties 
have been synthesized by oxidation of corresponding quinoxalines. 
The most convenient reagent for causing N-oxidation is 30% aqueous hydrogen 
peroxide in acetic acid. One equivalent of peracetic acid in acetic acid gives the I-oxide 
but with an excess of peracetic acid, quinoxaline 1,4-dioxide (5) is formed. s 
-o 
I (XI tt~ ~ +~ 
N 
I 
Q 
(5) 
5-Substituted quinoxalines generally give I-oxides which can not be oxidized further 
into 1,4-dioxides. However, 5-methoxyquinoxaline is an exception in this respect, 
because it is readily converted into the I,4-dioxide.9 Substituents in the 6-position have 
an unexpected effect. Thus, quinoxalines with electron-donating groups e.g., Me or 
MeO in this position readily form di-N-oxides, but when electron withdrawing groups 
e.g., N02 and eN are present, quinoxaline-2,3-diones (7) are the major products of 
oxidationS (Scheme 3). 
N 
I ) 
N NC 
(6) (7) 
Scheme 3 
3 
Quinoxaline I,4-dioxides are active against a wide range of bacteria and they have been 
added to animal feeds both as bactericides and growth promoting agents.lO 
The oxidation of quinoxaline at the 5,8-positions produces quinoxaline 5,8-diones (9). 
The parent compound is obtained by silver oxide oxidation of 5,8-dihydroxy 
quinoxaline (8)11 (Scheme 4). 
OH o 
N 
I )---. 
N 
N 
I ) 
N 
OH o 
(8) (9) 
Scheme 4 
It is also found that oxidation of I-aminoquinoxaline-2-ones (10) with lead tetraacetate 
gives benzo-I,2,4-triazines12 (11) as shown in Scheme 5. 
(XI NXR ------.. ~ N 0 
I 
NH2 
(10) (11 ) 
Scheme 5 
4 
1.1.3 Linear tricyclic quinones. 
Compounds derived from benzene and its homologues by the replacement of two 
atoms of hydrogen with oxygen are known as Quinones. Natural Quinones are found 
most commonly in higher plants, fungi and bacteria; the simplest carbocyclic Quinones 
are 1,2-benzoquinone (12) and 1,4-benzoquinone (13). 
o o 
o 
(12) (13) 
Next in the series of carbocyclic Quinones are naphthoquinones (14) and anthra-
Quinones (15). Compounds containing the quinone nucleus play an important role in 
numerous biological processes due to their participation in reduction-oxidation 
changes. 13 
o o 
o o 
(14) (15) 
5 
Many investigators have now reported a large number ofbenzo-, naphtho- and anthra-
quinone derivatives which are appropriately substituted to facilitate quinone methide 
formation subsequent to an initial reduction to the hydroquinone. I~ The intermediate 
quinone met hide is then viewed as the cytotoxic species in that it reacts with a 
biologically important nucleophile to form covalently bound adducts. An outline of 
this is given in Scheme 6. 
0 OH OH 
R R 
+ 2H 
• 
-HX 
• 
2e R A R 
HLO 0 ~non:metlllde 
OH 
R 
OH 
Nu = DNA, protein, carbohydrate. 
X=CL OH 
Scheme 6 
Some heterocyclic quinones have chemotherapeutic value as antitumour, antibacterial 
and antifungal agents. IS The largest group of natural quinones and the most important 
(biologically) is the anthraquinones. 
6 
The three unsubstituted anthraquinones are 1,2-, 1,4- and the 9,1 O-isomers, (16), 
(17) and (18), respectively. 
o o o 
o o 
(16) (17) (18) 
The parent 9,10-anthraquinone (18) is a substance of great technical importance as an 
intermediate for the manufacture of anthraquinone dyes and drugs. 
Naturally occurring quinones which structurally consist of an anthracene-9, 10-dione 
chromophore include some important antitumour agents such as doxorubicin and the 
anthracycline antibiotics. The synthetic anthracene-9, 10-diones such as mitoxantrone 
(19) and ametantrone (20) are potent antitumour agents. 16 
OR 0 
OH 0 
(19) (20) 
7 
1.1.4 Preparation of quinones. 
Heterocyclic quinones are usually prepared by using one of the following methods :_ 
1) Oxidation of heteroaromatic compounds 
2) Cyclisation reactions. 
An example of an oxidation process is the conversion of 5,8-dihydroxyquinoline (21) 
into the p-quinone (22) by using nitric acid as the oxidant (Scheme 7). 
OR o 
OR o 
(21) (22) 
Scheme 7 
This reagent can also produce o-qumones from the corresponding dimethoxy 
compounds. 17 A possible disadvantage of using a strong acidic oxidising agent is the 
formation of bypro ducts such as nitro derivatives. 18 
Fremy's salt (potassium nitrosodisulphonate) is a widely used oxidising agent in this 
field, particularly for those aromatic rings which have hydroxy or amino groups, and 
the oxidation is normally carried out in an aqueous medium. 19 
CAN (cerium(IV) ammonium nitrate) is another cheap and multi-electron oxidant, 
which has been used extensively for the fast and convenient preparation of quinones 
from dihydroxy- and dimethoxy-quinones. 2o 
8 
5,8-Dimethoxyquinoxaline (23) was oxidatively demethylated with CAN in aqueous 
acetonitrile to afford the corresponding quinoxalin-5,8-dione (9) (Scheme 8). 
OCR3 0 
• I 
N
J 
N 
OCR3 0 
(23) (9) 
Scheme 8 
Mechanism 
Ce (IV) e. Ce (III) e. Ce (II) 
Stable Unstable Quite stable 
+ Ce(ill) 
o 
HO OCH3 
~ ;t- + Ce(I1) 
-H 
o 
Scheme 9 
9 
1.1.5 Cyclisation by addition reaction. 
Renault and co-workers21 have obtained the 5,10-pyrazino[2,3-g]quinoxaline (26) by 
the condensation of 2,3,5,6-tetraaminobenzoquinone (24) with 1,4-dibromo 
butanedione (25) (Scheme 10). 
0 0 
NH: 0XR R N N R H2N ~X I I NXR 
H2N R N NH2 0 R 
0 0 
(24) (25) (26) 
Where R=CH2Br 
Scheme 10 
In the present work, the Diels-Alder reaction is a useful method for the preparation of 
linear tricyclic quinones. The Diels-Alder reaction is a very useful reaction in organic 
synthesis. 22 It involves the cycloaddition of an alkene (dienophile) to a conjugated 
diene. The term cycloaddition refers to the fact that the cyclic compound is produced 
by an addition between two non-cyclic partners23 (Scheme 11). 
RI RI 
H R3 
+X .. 
H It 
R2 
Scheme 11 
10 
In the process two 1t bonds, one in the dienophile and one from the diene are converted 
to two sigma bonds. A four carbon fragment, the diene, reacts with a two carbon 
fragment, the dienophile. Therefore, the Diels-Alder reaction is termed a [4+2] cyclo-
addition process.24 
1.1.6 Fused polycyclic system. 
Many reactions which utilise nitrogen, oxygen and sulfur nucleophiles have been 
carried out on 2,3-dichloroquinoxaline (4) and its benzo substituted derivatives. 
When 2,3-dichloroquinoxaline and thiourea are allowed to react in ethanol, 1,4-dithia-
1 ,4-dihydrophenazino[2,3-b ]quinoxaline (27) is obtained in excellent yield 25 
(Scheme 12). 
(4) (27) 
Scheme 12 
11 
Recently, Parrick and co-workers reported26 that treatment of 2 3-dichloro-5 8-, , 
dimethoxy quinoxaline (28) with an equimolar quantity of thiourea in Dr..1F gave two 
products (Scheme 13). 
OCH3 
N XC_I __ ~__ •• 
N CI 
(28) 
Reagents: (i) H2NCSNH2 
(ii) DMF 
Scheme 13 
N:(S):N I ~ ~ ~ ~ I N N 
CI CI 
(29) 
+ 
NXS:r:
N 
I" ~ ~ ~ I 
N S N 
(30) 
The bis (2-chloro-5,8-dimethoxyquinoxalin-3-yl)sulfide (29) was an intermediate in the 
formation of 1,4,8, 11-tetramethoxy-6, 13 -dihydro-5,7,12,14-tetraaza -6, 13 -dithia penta-
cene (30) and bis (2-chloro-5,8-dimethoxyquinoxalin-3-yl)sulfide (29) was thought to 
be formed from isothiouronium salt (31) (Scheme 14). 
12 
(31) 
I 
(30) III( H2NCSNH2 (29) + H2NCN 
Scheme 14 
However 2,3-dichloroquinoxaline (4) has been converted into a number ofpolycyc1ic 
derivatives by reaction with o-disubstituted benzenes (32). Thus reaction of (4) with 
o-phenylene diamines (32) and 2,3-diaminoquinoxaline (34) gave the tetraaza-
naphthalene (33) (Scheme 15), 27 and fluorubin (35) respectively (Scheme 16). 
(XNXa ~ I /-
N a 
(4) (32) (33) 
Scheme 15 
13 
(4) (34) 
Scheme 16 
Fluorubin is a reddish-yellow pigment with an orange red fluorescence. It has been 
suggested that derivatives of fluorubin are suitable substances for signalling in sea 
rescue work. 28 
1.1. 7 3-Amino-l,2,4-benzotriazine. 
Benzotriazine dioxide can be considered as an azaquinoxaline derivative. The dioxides 
have shown significant selective toxicity towards hypoxic cells in solid tumours. 29 
The most active compound of the series was found to be 3 -amino-l ,2, 4-benzotriazine-
l,4-dioxide (36), SR4233, and this now represents the lead compound in a new class 
ofbioreductively activated anticancer drugs. SR 4233 is in clinical trials. 30 
o 
I 
OC~~N I + ... ) ~ NANH 
I 2 
o 
SR 4233 (36) 
14 
A number of derivatives of 1,2,4-benzotriazine and of its 1,4-dioxides have been 
reported 31 and tested for anticancer activity. The biological activity is dependent on 
the substituent. 
o 
I 
CX~~N ~ I +~ N R 
I 
o 
Where R = NH2 (SR 4233) 
CH3 (SR 4713) 
CH2CH20CH3 (SR 4941) 
CH2CH3 (SR 4895) 
SR 4941 has almost identicallipophilicity to SR 4233 but is 10 times more soluble in 
aqueous media, and has excellent hypoxic selectivity.31 
The mode of action of SR 4233 may be due to DNA damage caused by a radical 
intermediate. 3-Amino-l,2,4-benzotriazine-dioxide and analogues are reduced to 
radicals which then abstract a hydrogen atom from the sugar of DNA. 32 However the 
first stable reduced metabolites of SR 4233 are the two electron and four electron 
reduction products SR 4317 (37) and SR 4330 (38) respectively (Scheme 18) in a 
hypoxic cell. 33 
o 0 
I I N ex~~ + ex~~ + ex ~N I '~+2e, +2~ I ~ .+2e, +2~ I I ~ +A -~O ~ A -H20 ~ ~ N ~ N ~ N ~ 
I 
o 
SR 4233 (36) SR 4317 (37) SR 4330 (38) 
Scheme 18 
15 
SR 4317 (37) is reported to be not measurably toxic to hypoxic cells at levels 
significantly greater than those at which SR 4233 (36) is toxic. 34 It was suggested that 
the damaging species existed at the one electron reduction level. Furthur studies 
showed that the one electron reduction product of SR 4233 is an oxidising radical that 
causes single and double strand breaks in the DNA molecule.35 
The natural life time of this radical was sufficiently long that it could diffuse over 
significant distances within hypoxic cells and thus cause oxidative damage of cellular 
targets. Therefore, it has been suggested that the one electron reduction product (39) 
is the active species. 35 
o 
I 
~1j{~N ~N~NH I 2 
OH 
(39) 
The most convenient preparation of 3-aminobenzo-1,2,4-triazine-1-oxide was 
reported by Arndt in 1913.36 and involves the cyc1isation of o-nitrophenylguanidines 
(Scheme 19). 
-:P' I Base a
N02 
~ NH-C==NH 
I 
NH2 
(40) 
Scheme 19 
16 
(37) 
Another method involves the condensation of nitroaniline (41) with cyanamide or 
mono sodium cyanamide under acidic condition yielding o-nitrophenylguanidine (40) 
which was cyclised directly in alkaline media (Scheme 20) to (37) with a yield of 60%. 
(XN02 ~ I HzNCN. ~ HCI 
NH2 
(41) 
~ I NaOH (XN02 ~ NH-C==NH 
I 
NH (40) 2 
Scheme 20 
o 
I 
(X~:--N • ~ I rl 
N NH2 
(37) 
Oxidation of3-amino-l,2,4-benzotriazine-l-oxide (37) by hydrogen peroxide in acetic 
acid at 50°C affords 3-amino-l ,2,4-benzotriazine-l ,4-dioxide (36). 37 
17 
1.2 RESULTS AND DISCUSSION. 
Tricyclic quinones were obtained from quinoxaline-5,8-dione (9) and 2,3-dimethoxy-
5,8-dione (42) by the use of the Diels-Alder reaction. 
o 
RXN ~ I 
~ 
R N 
o 
(9)R=R 
(42) R =OCR3 
The synthesis of qunoxaline-5,8-dione was accomplished in three steps from 1,4-
dimethoxybenzene (43). Nitration of(43) using concentrated nitric acid in glacial acetic 
acid gave a mixture of 1,4-dimethoxy-2,3-dinitrobenzene (44) and 1,4-dimethoxy-2,5-
dinitrobenzene (45) (Scheme 21).38 
OCR3 OCR3 OCR3 
N02 N02 
• + 
N02 02N 
OCR3 OCR3 OCR3 
(43) (44) (45) 
Scheme 21 
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At this stage it was not necessary to separate the two isomers as 80% of the mixture 
was 1,4-dimethoxy-2,3-dinitrobenzene (44) and the isomer, 1,4-dimethoxy-2,5-
dinitrobenzene (45) cannot produce a quinoxaline in subsequent reactions. 
The reduction of the mixture of dinitro isomers (44) and (45) by catalytic 
hydrogenation over palladium on charcoal at room temperature gave the mixture of 
2,3 -diamino-l, 4-dimethoxybenzene ( 46) and 2,5-diamino-l, 4-dimethoxybenzene 
(47).39 
(46) (47) 
The diamines are not stable in air at room temperature so the mixture of diamines (46) 
and (47) was quickly treated with appropriate dicarbonyl compound when only the 0-
diamine (46) gave the quinoxaline.40 5,8-Dimethoxyquinoxaline (23) has been prepared 
by the condensation of2,3-diamino-l,4-dimethoxybenzene with the glyoxal-sodium 
bisulfite adduct (48) (Scheme 22). 
OCH3 OCH3 
NH2 H N) " CO + 2 H20. + I .. 
CO 
NH2 \ N H 
OCH3 
OCH3 
(46) (48) (23) 
Scheme 22 
19 
The 5,8-dimethoxyquinoxaline (23) showed a singlet at 4.03 ppm due to two methoxy 
groups while the aromatic hydrogens gave rise to two singlets at 6.96 and 8.83 ppm 
respectively in the 1H NMR spectrum. 
However 1,4-dihydro-2,3-dioxo-5,8-dimethoxyquinoxaline (49) is conveniently 
prepared by boiling a mixture of the o-phenylene diamine (46) with oxalic acid 
dihydrate in 4M hydrochloric acid. 41 In the present work a mixture of the diamino 
compounds (46) and (47) was refluxed with an excess of diethyl oxalate using an air 
condenser so that the ethyl alcohol formed by intermolecular condensation was allowed 
to escape (Scheme 23).42 
The 1,4-dihydro-2,3-dioxo-5,8-dimethoxyquinoxaline (49) was purified by repeated 
dissolution in aqueous sodium hydroxide followed by precipitation by the addition of 
acetic acid. 
1 ~ 
(46) 
OCH3 
H 
~ NXO ii 
.. 
N 0 
H 
OCH3 
(49) 
(50) 
Reagents: (i) diethyl oxalate, (ii) phosphol)'l chloride, 
(iii) sodimn methoxide in methanol 
Scheme 23 
20 
(28) 
The useful synthetic application of 1, 4-dihydro-2,3 -dioxo-5, 8-dimethoxyquinoxaline 
(49) is the conversion into 2,3-dichloro-5,8-dimethoxyquinoxaline (28) by the 
treatment with a mixture of phosphoryl chloride and N, N-dimethylaniline.43 The 
reaction is normally carried out under reflux for periods between 1-4 h in 42% yield. 
The presence of the two chlorine atoms was confirmed by the appearance of three 
molecular ion peaks at 262,260 and 258 daltons, due to the isotopes of chlorine. 
Many nucleophilic displacement reactions have been carried out on 2,3-dichloro-5,8-
dimethoxyquinoxaline (28). It was expected that (28) would be a useful precursor for 
the preparation of some 2,3 -disubstituted-5, 8-dimethoxyquinoxaline derivatives, e. g. 
2,3,5,8-tetramethoxyquinoxaline (50), by nucleophilic substitution (Scheme 23). 
Treatment of compound (28) with sodium methoxide at reflux for 3 h gave the 
tetramethoxy compound (50) in 80% yield. The methoxyl groups at the 2-,3-, 5- and 
8-positions produced two singlets at 4.00 and 4.21 ppm whereas the 6- and 7-
aromatic protons gave rise to a singlet at 6.86 ppm in the IH NMR spectrum. The mass 
spectrum of (50) showed a molecular ion peak at 250 daltons. 
These quinoxalines (23) and (50) were to be used as precursors of quinones. 
Heterocyclic quinones have been prepared by using the following general methods:-
a. The oxidation of heteroaromatic compounds. 
b. Cyclisation of acyclic intermediates or from addition reactions. 
It is probably true to say that most preparations of heterocyclic quinones are through 
an oxidation process. Various classical strong oxidising agents such as Fremy's salt 
(potassium nitrosodisulphonate, O-N(S03K)2) are particularly effective reagents for 
oxidation of aromatic rings containing only one hydroxy or amino groUp.44 
Nitric acid17 still finds wide applications and another useful oxidising agent is ceric 
ammonium nitrate (CAN).4S 
2l 
Generally, the fonnation of quinones from dimethoxyquinoxaline has been achieved by 
using relatively long routes. 46 In the present work, attempts were made to obtain the 
different heterocyclic quinones in a single step from the p-dimethoxyquinoxaline by 
using ceric ammonium nitrate (CAN) as an oxidising agent in aqueous acetonitrile 
medium.47 
An attempt to prepare diazanaphthaquinones directly from their dimethoxy derivatives 
(23) and (50) by the action of CAN gave the required quinoxaline-5,8-dione (9) 
(Scheme 8) and 2,3-dimethoxyquinoxaline-5,8-dione (42) (Scheme 24). 
OCH3 0 
NXOCH3 • 
NXOCH3 
N OCH3 N OCH3 
OCH3 0 
(50) (42) 
Scheme 24 
These compounds (9) and (42) showed strong absorptions at 1678 and 1670 cm-1 
respectively due to the carbonyl groups, and the methoxy groups of compound (42) 
at position 2 and 3 showed a singlet at 4.24 ppm in the IH NMR, whereas the 6- and 
7- aromatic protons gave rise to a downfield singlet at 6.99 ppm. 
22 
Quinoxaline-5,8-quinones containing electron donating groups, e.g. OCR3, OC2lis. at 
the 2- and 3- positions are stable at room temperature in the crystalline form and in 
solution form. The probable reason for the stability of these Quinones is the resonance 
(51) ~ (52) (Fig 1). 
o 
o o 
(51) (52) 
Fig 1: Resonance stabilization of2,3-diethoxyquinoxaline-5,8-dione. 
23 
1.2.1 The Diels-Alder reaction. 
In the present work we used the Diels-Alder reaction for the synthesis of linear tricyclic 
quinones. For example the reaction of substituted quinoxaline-5,8-diones (9) and (42) 
with l-acetoxy-l,3-butadiene (53) produced the fully aromatized compounds, 1,4-
diazaanthracene-9, 10-dione (54) and 2,3-dimethoxy-l ,4-diazaanthracene-9, 10-dione 
(55) respectively, presumably by the elimination of acetic acid from the initial 
[4+2]cyc1oaddition product followed by the oxidative aromatization (Scheme 25). 48 
o 
R N ):1 
R N 
o 
(9)R=H 
(42) R=OCH3 
+ 
OCOCH3 
(53) 
~. ~NI ~N 
o 
o 
(54) R= H 
(55) R = OCH3 
Scheme 25 
24 
o 
The IR spectra of 1,4-diazaanthracene-9,10-dione (54) and 2,3-dimethoxy-1,4-
diazaanthracene-9,10-dione (55) showed strong absorptions at 1678 and 1684 cm-I, 
respectively, due to the carbonyl groups. The IH NMR spectra of these compounds 
also showed the symmetrical nature of the molecule produced by the elimination of 
acetic acid from the intermediate adducts.The IHNMR spectrum of (54) showed two 
double doublets at 7.97 and 8.26 ppm (J = 6.1 and 3.6 Hz) due to the 6-, 7- and 5- and 
8-aromatic protons respectively, and a singlet at 9.12 ppm due to the 2- and 3-
aromatic protons. 
The 2,3-dimethoxy-1,4-diazaanthracene-9,10-dione (55) showed a singlet at 4.29 ppm 
caused by the 2- and 3-methoxy groups and the 6-, 7- and 5- and 8-aromatic protons 
gave rise two double doublets at 7.80 and 8.26 ppm (J = 5.9 and 3.2 Hz) respectively. 
The mass spectra of (54) and (55) showed the expected molecular ion peaks in 
agreement with molecular formulae C12~N202 and CI4HlON204, respectively. 
1.2.2 Synthesis of fused-ring heterocyclic compounds 
2,3- Dichloroquinoxaline (4) (obtained from 2,3-quinoxalindione by treatment with 
phosphoryl chloride) and thiourea were allowed to react in a mixture of 
dimethylformamide and triethylamine in a 1: 1 molecular proportion to give the poly 
cyclic compound 1,4-dithia[2,3-b:5,6-b]diquinoxaline (27) in 28% yield (Scheme 12). 
It has been reported that this type of polycyclic compound is of current interest as a 
functional material for electronic, opto-electronic and photonic devices.49 Matsuota49 
have reported the reaction between 2,3-dichloroquinoxaline and thiourea but gave the 
wrong structural formula for the product. However the error was corrected. 50 
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In the present work, a successful attempt was made to synthesise (27) and the expected 
intermediate the bis(2-chloroquinoxaline-3-yl)sulfide (57) was isolated. However, the 
yield of 1,4-dithia[2,3-b:5,6-b]diquinoxaline (27) obtained in this work (Scheme 12) 
was not significantly higher then that reported by Matsuota. 50 Therefore an attempt 
was made to improve the yield of (27) by the increasing the quantity of thiourea in the 
reaction. 
It was found that the compound (27) can be prepared in excellent yield by using 1: 1 
molecular quantities of(4) and dithioxamide (56), respectively in the mixture of N,N-
dimethylformamide (DMF) and triethylamine. After completion of the reaction, the 
compound (27) was separated by filtration directly from the cold reaction due to its 
high insolubility in several organic solvents, whereas the second, and more soluble 
compound (57), was separated from the filtrate by the addition of water followed by 
solvent extraction (Scheme 26). 
(4) (56) 
o:N:(S1N~ 1.0 /- ~~ N N 
CI CI 
(57) 
Scheme 26 
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The 1H NMR spectrum of (57) indicated its unsymmetrical structure by the 
appearance of two double doublets at 7.86 ppm and 8.05 ppm for aromatic protons 
due to the attachment of different atoms (sulfur and chlorine) to the heterocycle. The 
mass spectrum of (57) confirmed the presence of the two chlorine atoms by the 
presence of three molecular ion peaks which were in accordance with the structural 
formula. 
The reaction between 2,3-dichloroquinoxaline (4) and dithioxamide (56) seems to be 
initiated by the nucleophilic attack of sulfur at the 2- and 3-position of the 2,3-dichloro 
quinoxaline as reported in the literature. 51,52 
1.2.3 Reaction of bis(2-chloroquinoxalin-3-yl)sulfide (57) with amines. 
It has been reported that florubin (35) is produced when 2,3-dichloroquinoxaline (4) 
is treated with 2,3-diaminoquinoxaline (34).27 
However, in the present work a new route for the synthesis offlorubin (35) derivatives 
is reported and the compound (57) was utilised as an intermediate in reactions with 
several amines, e.g. n-butylamine, benzyl amine, aniline, cyanamide, ethylenediamine. 
These amines make a nucleophilic attack on the carbon atom to which chlorine is 
attached. The 2- and 3-position of quinoxaline are easily attacked because the electron 
attracting properties of the ring nitrogen produce a positive charge on the adjacent 
carbon atom. 
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When bis(2-chloroquinoxalin-3-yl)sulfide (57) was treated with n-butylamine in 
anhydrous tetrahydrofuran (THF) at reflux for 6h, the product 6,13-dibutyl-
5,6,7,12,13,14-hexaazapentacene (58) was obtained after work-up in 45 % yield 
(Scheme 27). 
~ (XX :)) 
a a 
Bu~ U:x:x:n 
(57) 
Scheme 27 
I 
CJlJ 
(58) 
A symmetrical structure for (58) is indicated by the IH NMR spectrum which shows 
a triplet at 1.03 ppm caused by the 2 x NCH2CH2CH2CH3 groups, multiplets at 1.54 
ppm and 1.78 ppm due to 4 x NCH2CH2CH2CH3, triplet at 4.45 ppm due to 2 x 
NCH2CH2CH2CH3 and two double doublets at 7.32 ppm (J = 6.2 and 2.5 Hz) and 
7.57 ppm (J = 6.2 and 2.5 Hz) corresponding to eight aromatic protons respectively. 
The mass spectrum of (58) showed a molecular ion peak at 398 daltons, which was in 
agreement with a molecular formula of C24H26N6' 
A successful alternative route to (58) utilizes 1,4-dithia[2,3-b:5,6-b]diquinoxaline (27). 
When (27) was treated with n-butylamine in anhydrous dimethyl sulphoxide (DMSO) 
the product (58) was obtained in a low yield, but an unexpected product (59) was also 
isolated by column chromatography. 
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The first eluted component (11 % yield) was characterised as 6,13 -dibutyl-
5,6,7,12, 13, 14-hexaazapentacene (58). The second component was characterised as 
13-butyl-6, 13-dihydro-6-thia-5,7, 12, 13, 14-pentaazapentacene (59) (Scheme 28). 
(X:x:x:X) 
(27) 
+ (XI N;S~NX)~ ~ NANAN ~ 
I 
C4~ 
(59) 
ReagetIs: (i) n-but}bIire, D M SO 
Scheme 28 
The unsymmetrical structure of (59) was clear from its IH NMR spectrum which 
showed a triplet at 1.05 ppm caused by NCH2CH2CH2CH3 group, two multiplets at 
1.53 and 1.87 ppm respectively due to NCH2CH2CH2CH3 protons, triplet at 4.54 ppm 
caused by NCH2CH2CH2CH3 and two multiplets at 7.52 and 7.71 ppm for aromatic 
protons due to the attachment of different atoms (sulfur and nitrogen). 
The mass spectrum and the elemental analysis of 13-butyl-6,13-dihydro-6-thia-5,7, 
12,13,14-pentaazapentacene (59) were in agreement with the molecular formula 
C2Ji17NSS. 
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The conversion of (27) to (S8) was thought to go through the intermediate (S9) which 
undergoes intermolecular attack by butylamine at the very electron deficient bridge-
head atom followed by intramolecular cyclisation with elimination of hydrogen sulfide 
(Scheme 29). 
(27) BuNH~ a:x:x:n 
Scheme 29 
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Several nucleophilic substitution reactions of(S7) are also reported in this work. When 
bis(2-chloroquinoxalin-3-yl)sulfide (S7) was separately treated with benzylamine, 
ethylene diamine and cyanamide in anhydrous THF at reflux for 6h, the products 
obtained were 6, 13-dibenzyl-S,6, 7,12,13, 14-hexaazapentacene (60), 13-(2-amino-
ethyl)-6, 13-dihydro-6-thia-S, 7,12,13, 14-pentaazapentacene (61) and 6,13 -dihydro-6-
thia -S, 7, 12, 13, 14-pentaazapentacene (62 ) respectively. 
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(60) 
These compounds were characterised on the basis of their 1H NMR spectra, mass 
spectra and elemental analyses. However, when aniline was used no reaction occurred. 
The failure of the reaction was probably due to lower availability of the unshared 
electron pair on the nitrogen atom, which in this case is delocalised on to the 7t orbital 
of the nucleus producing a less nucleophilic amine. 
When compound (57) was treated with cyanamide, 6, 13-dihydro-6-thia-5, 7,12,13,14-
pentaazapentacene (62) was unexpectedly obtained in 60% yield. The IR spectrum 
showed an N-H stretching absorption at 3446 cm -1 and the 1H NMR spectrum of (62) 
shows a multiplet at 7.51 ppm for aromatic protons and an exchangeable singlet at 
11.90 ppm due to the N-H group. The above spectral data and the presence of the 
principal molecular ion peak at 303 daltons in the EI mass spectrum confirmed the 
molecular formula of C16~N5S. The formation of (62) presumably occurred by 
hydrolysis of the first formed N-cyano compound in the work up process followed by 
decarboxylation to give (62). 
~NX/-SX::;;.-'NJO~ 
~N N N .0 
H 
(62) 
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These compounds (58), (59), (60), (61) and (62) are very sparingly soluble in water, 
have high melting points and display green fluorescence in ultraviolet light. 
1.2.4 3-Amino-5,6-dimethoxy-l,2,4-benzotriazine. 
A great number of 1,2,4-benzotriazine derivatives have been investigated for their 
biological activity, and the increase of interest in this class of compound is related to 
their noticeable antitumour activity. 30 
3-Amino-l,2,4-benzotriazine-l,4-dioxide (also known as SR4233 and tirapazamine) 
(37) shows significant selective toxicity towards hypoxic cells in solid tumours?2 Thus, 
our aim was to prepare a 5,8-disubstituted 1,2,4-benzotriazine nucleus in order to 
attempt the preparation of5,8-dioxo-I,2,4-benzotriazine-I,4-dioxide (63). 
0 0 
I 
N =f~N 
I~ +......::: 
N NH I 2 
0 0 
(63) 
This compound was of interest because the quinone may not have anticancer activity 
but would be expected to be reduced in hypoxic cells to give a benzenoid ring and the 
resultant compound would then be expected to be cytotoxic at the tumour. In this way, 
it was hoped to obtain a cytotoxic effect more specifically targeted to hypoxic cells. 
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It was hoped to obtain the benzotriazine quinone (63) from the corresponding 5,8-
dimethoxy-1 ,2, 4-benzotriazine-1 ,4-dioxide (Scheme 30). 
o 0 
I 
N 1-'~N 
I A'" +~ 
N NH I 2 
o 0 
(63) 
Scheme 30 
The synthesis of (63) required a series of reactions starting with the nitration of 1,4-
dimethoxybenzene (43). As described earlier in this thesis, nitration of 1,4-
dimethoxybenzene gives the isomeric, 2,3- and 2,5-dinitro-1,4-dimethoxybenzenes. 
However, in the present work, separation of these two isomers was achieved using 
column chromatography. 
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The first isomer eluted was 2,5-dinitro-l,4-dimethoxy isomer (45) possibly due to the 
2,3-dinitro isomer (44) being more polar then 2,5-dinitro isomer. Previous work has 
concluded from results obtained by gas chromatography, that the 2,3-dinitro isomer 
( mp 180°C) and 2,5-dinitro isomer ( mp 202°C) are present in the proportion of 88% 
and 12% respectively. 53 
These isomers were identified in the work reported here by mp. and yield. The 3- and 
6- hydrogen atoms of2,5-dinitro-l,4-dimethoxybenzene (45) showed a singlet at 7.91 
ppm in the IH NMR spectrum while the 5- and 6-hydrogen atoms of2,3-dinitro-l,4-
dimethoxybenzene (44) displayed a singlet at 7.68 ppm due to its symmetrical 
structure. 
The 2,3 -dinitro isomer had mp 186°C and was present as 80% of the mixture, while 
the 2,5-dinitro isomer had mp 205°C and was the remaining 20%. 
The third isomer, i.e. 1,4-dimethoxy-2,6-dinitrobenzene (64) (mp 109-111 °C), was 
reported by Burger and Fitchett 54 and had a different melting point from the 2,3 - and 
2,5-dinitro isomers. 
OCH3 
(64) 
It is easier to reduce both nitro groups of 2,3-dinitro and 2,5-dinitro isomers than to 
reduce only one nitro group. Several selective reduction methods have been reported 
and three were tried in this work, e.g. hydrazine hydrate55, hydrazine hydrate in the 
presence of Raney nickel 56, and sodium dithionite. 57 
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The first method tried was the reduction of (44) with hydrazine hydrate in the 
presence of Raney nickel but only starting material was obtained. The other potentially 
selective method tried for the reduction of one nitro group in a 
dinitrodimethoxybenzene (44) was treatment with hydrazine hydrate alone. The 
unexpected product 1-hydroxy-4,7-dimethoxy-1,2,3-benzotriazole (65) was obtained 
in excellent yield. 
The suggested mechanism for the formation ofbenzotriazole is that a nitro group of 
dinitro compound (44) is readily displaced by hydrazine to give the hydrazino 
derivative. This then undergoes intramolecular cyclisation by nucleophilic attack of the 
amino group on the adjacent nitrogen followed by elimination of a hydroxyl group to 
give compound (65) (Scheme 31). 
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The product was characterised by spectral data and elemental analysis. The IR NMR 
spectrum showed a singlet at 3.92 ppm for the six protons of the 4- and 7 -methoxy 
groups, a doublet at 6.65 ppm (J = 8.0 Hz) caused by the 6-proton, a doublet at 6.83 
ppm (J = 8.0 Hz) due to the 5-proton. In addition the spectrum contained an 
exchangeable singlet at 13.5 ppm due to OR group. The mass spectrum of (65) 
showed a molecular ion peak at 195 daltons which was in the agreement with the 
molecular formula,C8~N303' 
Finally, successful partial reduction of2,3-dinitro-1,4-dimethoxybenzene (44) and 2,5-
dinitro-1,4-dimethoxybenzene (45) was carried out by the use of sodium dithionite 
under alkaline conditions to give 2,5-dimethoxy-6-nitroaniline (66) and 2,5-
dimethoxy-4-nitroaniline (67), respectively (Scheme 32). The NH2 groups of(66) and 
(67) gave rise to broad singlets in IR NMR spectra at 3.85 ppm and 4.58 ppm 
respectively, which disappeared on addition of D 20. 
OCR3 OCR3 
N02 N02 Na2S204 
.. 
THF, MeOR 
N02 NR2 
OCR3 OCR3 
(44) (66) 
OCR3 OCR3 
N02 N02 
Na2S204 .. 
02N 
THF, MeOR R2N 
OCR3 OCR3 
(45) (67) 
Scheme 32 
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The compound (66) was used as an intermediate for further reactions. Condensation 
of 2,5-dimethoxy-6-nitroaniline (66) with cyanamide under acidic condition according 
to the procedure described by Mason and Tennant58 gave N-(2,5-dimethoxy-6-
nitrophenyl)guanidine (68) in 67% yield (Scheme 33). 
OCH3 OCH3 
N02 
+ N02 
+ H2NCN H • NH 
NH2 II N-C-NH2 
OCH3 OCH3 H 
(66) (68) 
Scheme 33 
The IR spectrum of the product showed NH2 stretching vibrations at 3400 and 
3186 em-I. The molecular ion peak in the mass spectrum of (68) was at 240 daltons 
which was in agreement with the molecular formula CJI12N404' 
However, when compound (68) was treated with aqueous base it gave 3-amino-5,6-
dimethoxy-1,2,4-benzotriazine-1-oxide (69), and the unexpected product 4,7-
dimethoxy-1,2,3-benzotriazole (70) (Scheme 34). 
N02 
OH • 
NH 
II 
N-C-NH2 
OCH3 H 
(68) (69) (70) 
Scheme 34 
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The IH NMR spectrum of (69) showed two singlets caused by the two methoxy groups 
at 3.83 and 3.81 ppm, a doublet at 6.66 ppm (J = 9.0 Hz) due to an aromatic proton, 
a doublet at 7.13 (J = 8.0 Hz) caused by an aromatic proton and an exchangeable 
singlet due to NH2 group at 7.11 ppm. The IR spectrum of(69) showed the presence 
of an NH2 stretching vibrations at 3406 and 3286 cm-I.The molecular ion peak in the 
mass spectrum of (69) was at 222 daltons which was in agreement with the molecular 
formula CJIlON 40 3 . 
The compound (70) was thought to be formed through a molecular rearrangement 
caused by the action of excess hot alkali. The rearrangement can be explained as an 
attack by the hydroxy ion at the 3 -position of the triazine ring to form an intermediate 
(71). The key steps in the proposed mechanism59 are the formation of azoxy 
intermediate (73) and its rearrangement to the diazonium hydroxide (74), which then 
gives rise to the triazole ring (Scheme 35). 
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In the present work it was shown that (70) can be formed in high yield from (69) by 
treatment with strong concentrated solution of sodium ethoxide in ethanol. 
The lH NMR spectrum of 4,7-dimethoxy-l,2,3-benzotriazole (70) displays its 
symmetrical structure shows a singlet due to the 4- and 7 -methoxy groups at 3.94 ppm, 
an exchangeable singlet at 6.21 ppm caused by NH group and a singlet due to 5- and 
6-proton at 6.72 ppm. 
An attempt was made to oxidise (69) to the corresponding 5,8-dimethoxy-l,2,4-
benzotriazine-l,4-dioxide (75) with hydrogen peroxide. However the failure of the 
reaction was probably due to the steric hindrance caused by the 5-methoxy group. 
OCH3 0 I 
~ ~::-'N 
N~NH I 2 
OCH3 0 
(75) 
Compound (69) was treated with CAN in an attempt to obtain the corresponding 
quinone (76). A colour change from pale yellow to dark brown was observed during 
the reaction and the IR spectrum of the crude product showed a peak at 1680 cm-l 
which is probably due to the quinone carbonyl group. However, the product 
decomposed at room temperature during the attempted work-up procedure. 
0 0 
I 
~, 
'N 
N~NH2 
0 
(76) 
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EXPERIMENTAL 
SYNTHESIS 
The following abbreviations have been used in the experimental section: 
Me (methyl), Et (ethyl), Ph (phenyl), Ar (aromatic), conc. (concentrated), EtOH 
(ethanol), AcOH (glacial acetic acid), Pd/C (palladium (I 0%) on charcoal), DCM 
(dichloromethane), petroleum spirit (petroleum ether, bp. 40-60 °C), DMF (dimethyl 
formamide), DMSO (dimethyl sulfoxide), DMSO-d6 (hexadeuterodimethyl sulfoxide), 
THF (tetrahydrofuran), MeCN (acetonitrile), MeOH (methanol), mp (melting point), bp 
(boiling point), h (hour), min (minutes) and ether (diethyl ether). 
Unless otherwise stated, solutions in organic solvents were dried over anhydrous 
sodium sulfate. 
All melting points were determined using an Electrothermal Digital apparatus and are 
uncorrected. 
Infrared spectra (IR) were recorded using a Perkin Elmer 1600 FTIR and 1420 Ratio 
Recording IR spectrophotometer in the range of 600-4000 cm-1 as KBr disc unless 
otherwise stated. 
Proton nuclear magnetic resonance eHNMR) spectroscopy was carried out using a 
Varian CFT-20 (90 MHz), a Jeol FX 200 (200 MHz) and a Bruker AM 360 (360 MHz) 
instruments and spectra were recorded for solutions in deuterated solvent relative to 
tetramethylsilane (internal standard). Resonances are reported in the form: (instrument 
frequency; solvent); () = shift in ppm from tetramethylsilane at 0 ppm and the multiplicity 
of signals as s, singlet; d, doublet; dd, double doublet; q, quartet; t, triplet; m, multiplet; 
br, broad. 
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Low resolution electron impact mass spectra were recorded on an AE1 MS902 
spectrometer. Low resolution fast atom bombardment (FAB) spectra and both E1 and 
F AB accurate mass determinations were provided by the EPSRC Mass Spectrometry 
Services Centre, Department of Chemistry, University of Wales, Swansea. 
Microanalysis were performed by MEDAC Ltd and Natural Resource Management Ltd, 
on a Carlo Erba 1106 elemental analyser (dynamic combustion system) or on a Control 
Equipment Corporation Model 240 XA (static combustion system). 
Purification by column chromatography were performed on Kieselgel60 (230-400 mesh 
ASTM) using redistilled solvents. Columns were generally packed dry and developed 
under light positive pressure. Thin layer chromatography (TLC) was carried out on 
commercial silica plates [ Camlab, 0.25 mm with fluorescence indicator UV254]. 
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2,3- and 2,5-Dinitro-l,4-dimethoxybenzene (44) and (45). 
Nitric acid (18 cm3, sp. gravity 1.42) was added to a solution of 1, 4-dimethoxybenzene 
(43) (13.8 g, 100 mmol) in glacial acetic acid (35 cm). After the reaction subsided, more 
conc. nitric acid (18 cm3) was added. The reaction mixture was heated for 5 minutes at 
80-90 °C, and then diluted with water (300 cm3). A mixture of2,3- and 2,5-dinitro-l,4-
dimethoxybenzene was filtered off and crystallised from glacial acetic acid (18 g), 
mp 160-164 °C (lit./8 mp 155-160 °C). 
2,3- and 2,5-Diamino-l,4-dimethoxybenzene (46) and (47). 
A mixture of2,3- and 2,5-dinitro-l,4-dimethoxybenzene (5 g, 25.2 mmol) in absolute 
ethanol (75 cm3) was hydrogenated over palladium charcoal (10%,300 mg) for 2 days at 
50 Ib/in2 in a Parr hydrogenator. The catalyst was filtered off and the solution containing 
2,3- and 2,5-diamino-l,4-dimethoxybenzene was immediately used in further reactions. 
5,8-Dimethoxyquinoxaline (23). 
The solution containing the mixture of 2,3 - and 2,5-diamino-l, 4-dimethoxybenzene was 
evaporated in vacuo to obtain a deep violet residue which was immediately added to a 
warm saturated solution of glyoxal sodium bisulfite adduct (6 g) in water (50 cm3). The 
reaction mixture was stirred and heated at 70°C for 45 min., and then filtered to remove 
the black residue. The filtrate was basified with sodium hydroxide pellets and filtered 
again to obtain a blood-red solution, which was extracted with dichloromethane (3 x 100 
cm) The extract was then washed with water, dried over anhydrous sodium sulfate and 
percolated through a column of neutral alumina. The bright yellow eluate was 
concentrated to afford greenish-yellow crystals of 5,8-dimethoxyquinoxaline (3 g), mp 
149-150 °C (lit.,53 mp 147-148 °C); IR(KBr) v max/cm-1 2234, 1608 (C=N), 1484, 1350, 
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1268, 1104, 820, 696, 546; lHNMR (90 MHz, CDCI3) 0 4.03 (6H, s, 5- and 8-0CH3)' 
6.96 (2H, s, 6-and 7-H), 8.83 (2H, s, 2- and 3-H); MS, mJz(r.i.) 192 (27%), 190 (M+, 95), 
175 (M- CH3, 100),161 (M- 2 x CH3, 81),147 (35),82 (37). 
1,4-Dihydro-2,3-dioxo-5,8-dimethoxyquinoxaline (49). 
Diethyl oxalate (40 g) in glacial acetic acid (25 cm3) was added to a solution of 2,3- and 
2,5-diamino-1,4-dimethoxybenzene and refluxed with stirring for 3 h. After cooling the 
reaction mixture, the resultant crystals were separated by filtration, washed thoroughly 
with water and finally with acetone, to give light-green, 1,4-dihydro-2,3-dioxo-5,8-
dimethoxyquinoxaline (49). The compound was purified by repeated dissolution in alkali 
(aqueous NaOH; 2M) followed by precipitation with acetic acid, to give the quinoxaline 
(49) (3.0 g), mp 322-325 °C (lit.,60 mp 325-329°C); IR(KBr) v max fcm- l 3052, 1712 
(CO), 1530, 1338, 1240, 1118,852; IHNMR (90 MHz, DMSO-d6) 03.80 (6H, s, 5- and 
8-0CH3), 6.70 (2H, s, 6- and 7-H), 11.01 (2H, s, I-and 4-H); MS, mJz(r.i.) 222 (M+, 
71%),207 (M - CH3 32), 179 (43),83 (100). ,
2,3-Dichloro-5,8-dimethoxyq uinoxaline (28). 
1,4-Dihydro-2,3-dioxo-5,8-dimethoxyquinoxaline (49) (lg, 4.5 mmol) was heated under 
reflux with phosphoryl chloride (10 cm3) and N,N-dimethylaniline (5 cm') for 4 h. The 
cool reaction mixture was slowly poured into stirred ice-water (200 cm3) and the product 
was extracted with dichloromethane (3 x 100 cm3). The extract was washed with water, 
dried over anhydrous sodium sulfate, evaporated in vacuo, and the greenish-yellow 
residue was percolated through a neutral alumina column to yield yellow crystals of2,3-
dichloro-5,8-dimethoxyquinoxaline (28), (0.54 g, 42 %), mp 215-216 °C (lit.,60 mp 215 
°C); IR(KBr) v max Jcm-1 1598, 1272, 1180, 1104, 824; IHNMR (90 MHz, CDCI3) 0 7.03 
(2H, s, 6- and 7-H), 4.01 (6H, s, 5- and 8-0CH3); MS, mJz(r.i.) 262 (5%), 260 (M+ for 
37CI + 35CI, 50),258 (M+ for 35CI, 95), 229 (M - 20CH3, 96),215 (15), 164 (100). 
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2,3,5,8-Tetramethoxyquinoxaline (50). 
A solution of2,3-dichloro-5,8-dimethoxyquinoxaline (28) (1 g, 3.8 mmol) in methanol (10 
cm
3) was added to a freshly prepared solution of sodium methoxide [obtained by the 
addition of sodium hydride (0.92 g) to methanol (40 cm3)]. The reaction mixture was 
refluxed for 3 h., and then poured into ice-water (50 cm3). The resulting precipitate was 
filtered off, washed with water, and crystallised from methanol to give 2,3,5,8-
tetramethoxyquinoxaline (50) (0.92g, 80%), mp 174-175°C (lit./6 mp 174°C); IR(KBr) 
v max /cm-1 2924, 1616, 1466, 1414, 1344, 1236, 1114, 1020, 995, 792; IHNMR (90 MHz, 
CDCI3) 04.00 (6H, s, 5- and 8-0CH3), 4.21 (6H, s, 2- and 3-0CH3), 6.86 (2H, s, 6- and 
7-H); MS, m1z(r.i.) 251(14%), 250 (M+, 100),235 (M - CH3, 83), 220 (M-CH3' 76), 192 
(21). 
GENERAL METHOD OF OXIDATION OF 5,8-DIMETHOXY QUINOXALINES. 
A stirred solution/suspension of appropriate quinoxaline (1 mmol) in a mixture of 
acetonitrile and water (20 cm3, 4: 1 v/v) was treated with ceric ammonium nitrate (CAN) 
(4 mmol) in an ice-bath. The stirring was continued for 3 h., and the mixture was diluted 
with water (50 cm3).The quinone was extracted with dichloromethane (3 x 10 cm3) and 
the extract washed repeatedly with water. The combined extract was dried (anhydrous 
sodium sulfate), the solid removed, the solvent evaporated in vacuo, and the residue 
crystallised from an appropriate solvent. 
Quinoxaline-5,8-dione (9). 
5,8-Dimethoxyquinoxaline (23) (0.190 g) yielded the quinoxaline-5,8-dione (9) which 
was crystallised from ethyl acetate (0.155 g, 97%), mp 172-174 °C (lit.,61 mp 172°C); 
IR(KBr) v max /cm-1 1678 (CO), 1606, 1482, 1268, 1168, 11 02, 962; IHNMR (90 MHz, 
CDCI3) 0 7.27 (2H, s, 2- and 3-H), 9.08 (2H, s, 6- and 7-H); MS, m1z(r.i.) 162 (M+, 
97%), 160 (M - 2H, 97), 147 (M- CH3, 54), 132 (M- 2CH3, 42), 130 (100), 104 (26), 83 
(31). 
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2,3-Dimethoxyquinoxaline-5,8-dione (42). 
2,3,5,8-Tetramethoxyquinoxaline (50) (0.25 g) gave the 2,3-dimethoxyquinoxaline-5,8-
dione which was crystallised from a mixture of ethyl acetate and dichloromethane (9: 1) 
(0.207 g, 94%), mp 229-230 °C (lit., 61 mp 224 ° C); IR(KBr) v max fcrn1 2878, 1670 
(CO), 1595, 1484, 1020, 854, 760, 694, 546 ; IHNMR (90 MHz, CDCI3) t> 4.24 (6H, s, 
2- and 3-0CH3)' 6.99 (2H, s, 6- and 7-H) ; MS, mlz(r.i.) 222 (35%), 221 (16),220 (M+, 
100),206 (40),189 (M - OCH3, 29),175 (66),162 (25),82 (26). 
REACTION OF DIAZANAPHTHOQUINONES AND l-ACETOXY-l,3-BUTA-
DIENE. 
General Method. 
A mixture ofdiazanaphthoquinone (1 mmoI), l-acetoxy-l,3-butadiene (1.2 mmoI) and 
anhydrous benzene (20 cm3) was refluxed for 2 h. After evaporation of the solvent in 
vacuo, the residue was dissolved in ethanol and refluxed for 2-4 h. On completion of the 
reaction (monitored by T.L.C.), the solvent was evaporated in vacuo and the residue 
crystallised from ethanol. 
1,4-Diazaanthracene-9, lO-dione (54). 
Quinoxaline-5,8-dione (9) (0.160 g) and l-acetoxy-l,3-butadiene (0.134 g) afforded 1,4-
diazaanthracene-9,10-dione (54) (0.11 g, 54%), mp above 300°C; IR(KBr) v max fcm-1 
2924, 1734, 1678 (CO), 1480, 1176, 1062, 939, 843, 697, 567; IHNMR (200 MHz, 
DMSO-d6) t> 7.97 (2H, dd, J = 6.1 and 3.6 Hz, 6- and 7-H), 8.26 (2H, dd, J = 6.1 and 3.6 
Hz, 5- and 8-H), 9.12 (2H, s, 2- and 3-H); MS, mlz(r.i.) 212 (21%), 211 (12),210 (M+, 
100), 186 (92), 182 (92), 154 (16), 104 (19) (Found: C, 68.26; H, 2.81; N, 13.15. 
C12~N202 requires C, 68.57; H, 2.85; N, 13.33 %). 
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2,3-Dimethoxy-l,4-diazaanthracene-9,1 O-dione (55). 
2,3-Dimethoxyquinoxaline-5,8-dione (42) (0.22 g) and l-acetoxy-l,3-butadiene (0.13 g) 
gave 2,3-dimethoxy-l,4-diazaanthracene-9,lO-dione (55) (0.169 g, 63%), mp 274-275 
°C; IR(KBr) v max /cm-1 1736, 1684 (CO), 1624, 1591, 1526, 1402, 1308, 1284, 986, 869, 
745, 567, 542; IHNMR (200 MHz, CDCI3) 0 4.29 (6H, s, 2- and 3-0CH3), 7.8 (2H, dd, 
J = 5.9 and 3.2 Hz, 6- and 7-H), 8.32 (2H, dd, J = 5.9 and 3.2 Hz, 5- and 8-H); MS, 
mlz(r.i.) 270 (M+, 100),255 (M- CH3, 15),240 (M - 2CH3, 43), 225 (22), 213 (17),149 
(7), 104 (16), 85 (48) (Found: C, 62.12; H, 3.81; N, 10.15. C14HlON204 requires C, 62.22; 
H, 3.73; N, 10.370/0). 
2,3-Dichloroquinoxaline (4). 
2,3-Quinoxalindione (2 g, 12 mmol) was heated under reflux with phosphoryl chloride 
(20 cm3) and N,N-dimethylaniline (10 cni) for 3.5 h. The cooled reaction mixture was 
slowly poured into ice-water and extracted with dichloromethane. The extract was dried 
over anhydrous sodium sulfate, evaporated in vacuo, and the greenish yellow residue was 
dissolved in dichloromethane and percolated through a neutral alumina column to yield 
crystals of2,3-dichloroquinoxaline on evaporation of the solvent (1.5 g, 62%), mp 150-
151 °C(lit./mp 150°C);IR(KBr)vmax/cm-11596, 1272, 1182,1104,804; IHNMR(200 
MHz, CDCI3) 0 7.80 (2H, dd, J 7,8 = 6.4 Hz, J 8,6 = 2.7 Hz, 8-H), 8.03 (2H, dd, J 5,6 = 
6.3 Hz, J 57 = 3.0 Hz, 5-H); MS, m/z (r.i.) 202 (M+ for 37CI, 10 %),200 (M+ for 37CI + 
, 
35CI, 65), 198 (M+ for 35CI, 100), 165 (29), 163 (91), 102 (72). 
1,4-Dithia[2,3-b:5,6-b]diquinoxaline (27). 
A stirred mixture of2,3-dichloroquinoxaline (4) (1.75 g, 8.8 mmol), thiourea (0.688 g, 
8.8 mmol), DMF (30 cm3) and triethylamine (1.8 g) was refluxed for 5 h. A yellow 
precipitate formed during the reaction. The solid was collected and washed with water 
and then methanol to give the title compound (27) (0.50 g, 28%), mp above 300°C (lit.,50 
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mp 300°C); IR(KBr) v max /cm-1 1674, 1552, 1334, 1256, 1102, 894, 782, 592 /HNMR 
(200MHz, DMSO-d6) l> 7.79 (4H, m, Ar-H), 7.81 (4H, m, Ar-H); MS mJz(r.i.) 320 (M+, 
100%), 288 (M - S, 4),276 (5), 214 (5), 85 (23). 
Bis(2-chloroquinoxalin-3-yl)sulfide (57). 
2,3-Dichloroquinoxaline (4) (0.50 g, 2.5 mmol) and dithioxoamide (0.16 g, 2.5 mmol), 
was dissolved in DMF (15 cm3) and triethylamine (0.50 g) was added with stirring. The 
reaction mixture was refluxed for 5h. The yellow product precipitated out during the 
reaction. After cooling the reaction mixture the compound (27) was collected by filtration 
and washed with water and methanol (0.32 g, 40 %). 
Addition of water to the initial filtrate from the above reaction gave more product. The 
solid was collected and crystallised from chloroform and petroleum spirit to give bis(2-
chloroquinoxalin-3-yl)sulfide (57) (0.360 g, 40%) mp 174-176 °C; IR(KBr) v max /cm-1 
1554,1526,1476,1256,1174,1110,996,799; IHNMR (360 MHz, CDC13) l> 7.76 (4H, 
m, 6- and 7 -H), 7.86 (2H, dd, J = 7.6 Hz, J = 1.7 Hz, 5-H), 8.05 (2H, dd, J = 7.6 Hz, 
J= 1.7 Hz, 8-H); MS, mlz(r.i) 360 (M+ for 37CI + 35CI, 1.5%),358 (M+for 35Cl, 2), 326 
(M - S, 17), 324 (M - H2S, 84),323 ( 100),288 (4), 109 (9) (Found: C, 53.31; H, 2.25; 
N, 15.74. C16HgN4SCl2 requires: C, 53.50; H, 2.22; N, 15.60%). 
REACTION OF BIS(2-CHLOROQUINOXALIN-3-YL)SULFIDE WITH AMINES. 
General Method. 
The bis(2-chloroquinoxalin-3-yl)sulfide (57) (0.39 g, 1.1 mmol) and amine (4.4 mmol) 
were dissolved in anhydrous THF (50 cm3) containing anhydrous potassium carbonate 
(1 g) and refluxed for 6h. After completion of the reaction, the solvent was evaporated 
In vacuo. 
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6,13-Dibutyl-5,6,7,12,13,14-hexaazapentacene (58). 
Bis(2-chloroquinoxalin-3-yl)sulfide (57) and n-butylamine (0.32 g) produced a residue 
which was dissolved in water, the product was extracted with dichloromethane, dried 
(anhydrous sodium sulfate) and purified by column chromatography using petroleum ether 
(bp 40-60 °C) and dichloromethane (90: 10) and crystallised from a mixture of 
dichloromethane and petroleum ether (bp 40- 60°C) to give 6, I3-dibutyl-5, 6,7,12,13,1-1-
hexaazapentacene (0.19 g, 45%); mp 271-271.5 °C; IR(KBr) v max fcm-1 1556, 1506, 
1456, 1374, 1306, 1136, 760; 1HNMR (200MHz, CDCI3) () 1.03 (6H, t, 2 x N-CH2-
CH2-CH2-CH3), 1.54 (H, m, 2 x N-CH2-CH2-CH2-CH3) , 1.78 (4H, m, 2 x N-CH2-CH2-
CH2-CH3), 4.45 (4H, t, 2 x N-CH2-CH2-CH2-CH3), 7.32 (4H, dd, J 12 = 6.2 Hz, J 13 = 2.5 , , 
Hz, 2, 3, 9, 10-H), 7.57 (4H, dd, J 89= 6.2 Hz, J 810 = 2.5 Hz, 1,4, 8, ll-H); MS, 
, , 
m/z(r.i.) 399 (30%),398 (M+, 100), 355 (7), 340 (19), 300 (19), 286 (41), 285 (10), 198 
(19), 117 (22) (Found: C, 72.12; H, 6.5; N, 20.90. C24H26N6 requires: C, 72.36; H, 6.5; 
N,21.10%). 
6,13-Dibenzyl-5,6, 7 ,12,13,14-hexaazapentacene (60). 
When benzyl amine (0.47 g) was used with (57) a soild was filtered off and purified by 
chromatography using petroleum ether (40-60 °C) and dichloromethane (90: 10), to give 
the 6,I3-dibenzyl-5,6,7,I2,I3,I4-hexaazapentacene, (0.12 g, 36%), mp 367-368°C; 
IR(KBr) v mroJcm-1 2313, 2213, 1504, 1456, 1374, 1232, 1145, 1098, 998, 876, 758, 708, 
696, 574, 542; MS m/z(r.i.) 467 (50%), 466 (M+, 100), 376 (26), 375 (73), 91 (16) 
IHNMR (200MHz, TFA) () 4.91 (4H, m, 2 x N-CH2), 7.44 (6H, m, 2 x 3-, 2 x 4-, and 2 
x 5-benzylic-H), 7.70 (4H, m, 2 x 2- and 2 x 6-benzylic-H), 7.86 (8H, m, 1-, 2-, 3-, 4-, 
8-, 9-, 10- and ll-Ar-H); MS ([FAB; NOBA)): M+ 466.1906. C3oli22N6 requires 
M+ 466.1896 daltons. (Found: C, 76.52; H, 4.75; N, 17.60. C3oli22N6 requires: C, 77.23; 
H, 4.75; N,18.00%). 
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6,13-Dihydro-6-thia-5, 7, 12, 13, 14-pentaazapentacene (62). 
Bis(2-chloroquinoxalin-3-yl)sulfide (57) and cyanamide (0.18 g) yielded a solid which 
was separated by filtration and crystallised from ethanol to give the title compound (62), 
(0.10 g, 60%), mp above 300°C; IR(KBr) v max /cm-1 3446 (NH), 2314, 2213, 1616, 1578, 
1478,1392,1237,1198,1076,998,876,740,665,567, 543,521; 1~(200~, 
DMSO-d6) () 7.51 (8H, m, 1-, 2-, 3-, 4-, 8-, 9-, 10- and 11-Ar-H), 11.90 (1H, s, 
exchangablewithD20, 13-H), MS, mlz(r.i.) 304 (18%), 303 (M+, 100),302 (9), 271(4), 
128 (10) (Found: C, 63.02; H, 2.91; N, 23.00. C16~N5 S requires: C, 63.36; H, 2.97; N, 
23.100/0). 
13-(2-Aminoethyl)-6,13-dihydro-6-thia-5, 7 ,12,13,14-pentaazapentacene (61). 
Ethylene diamine (0.229 g, 4.4 mmol) in anhydrous THF (50 cm 3) was added dropwise 
to the mixture ofbis(2-chloroquinoxalin-3-yl)sulfide (57) (0.393 g) in anhydrous THF 
and potassium carbonate and the mixture refluxed for 6 h. After completion of the 
reaction, the solvent was evaporated in vacuo, and the residue was crystallised with 
ethanol to yield 13-(2-aminoethyl)-6, 13-dihydro-6-thia-5, 7,12,13, 14-pentaazapentacene 
(0.250 g, 65%), mp 258.5-259 DC; IR(KBr) v max /cm-1 3445 (NH2), 3420, 1698, 1468, 
1410, 1292, 768; l~ (200MHz, DMSO-d6) () 1.22 (2H, s, exchangable with D20, 
NH2), 3.26 (2H, t, CH2-CH2-NH2), 4.53 (2H, t, CH2-CH2-NH2), 7.62 (8H, m, Ar-H); 
MS, mlz(r.i.) 346 (M+, 7), 330 (M - NH2, 7), 329 (23), 328 (21), 218 (9), 317 (34),305 
(13), 303 (100), 73 (31) (Found: C, 62.22; H, 4.02; N, 24.16. ClsH14N6S requires: C, 
62.42; H, 4.07; N, 24.26%). 
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6,13-Dibutyl-5,6, 7 ,12,13-hexaazapentacene (58) and 13-butyl-6,13-dihydro-6-thia-
5,7,12,13,14-pentaazapentacene (59) from 1,4-dithia[2,3-b:5,6-b]diquinoxaline (27). 
To a solution of 1,4-dithia[2,3-b:5,6-b]diquinoxaline (27) (0.352 g, 1.1 nunol) in 
anhydrous dimethyl sulfoxide (40 cm3), n-butylamine (0.321 g, 4.4 nunol) was added and 
the mixture refluxed for 10 h. The solid was collected from the cooled reaction mixture. 
T.L.C analysis showed two components which were separated by column chromatography 
using a mixture of petroleum spirit (40-60 °C) and dichloromethane (50:50). The first 
component eluted was characterised as 6, 13-di butyl-5, 6, 7, 12, 13-hexaazapentacene (58) 
(0.05 g, 11%) by comparison of its physical data with those of compound (58) obtained 
earlier. The second component eluted was characterised as 13-butyl-6,13-dihydro-6-
thia-5, 7,12, 13, 14-pentaazapentacene (59) (0.215 g, 54%), mp 221.4-222 °C; IR(KBr) 
v max /cm-1 1558, 1512, 1464, 1410, 1336, 1292, 1218, 1130, 762; 1 HNMR (200MHz, 
DMSO-d6) () 1.05 (3H, t, NCH2CH2CH2CH3), l.53 (2H, t, NCH2CH2CH2CH3), l.87 (2H, 
t, NCH2CH2.CH2CH3), 4.54 (2H, t, N CH2CH2CH2 CH3), 7.52 (4H, m, 2-, 3-, 9-,10-H), 
7.71 (4H, m, 1-,4-, 8-, 11-H); MS, mJz(r.i.) 360 (13%), 359 (M+, 49), 330 (8), 317 (22), 
316 (15), 304 (25), 303 (78), 245 (56), 112 (13), 83 (100); MS ([FAB; NOBA]): M+ 
359.1201. C2Ji17NSS requires M+ 359.1205 daltons. 
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Separation of 2,3- and 2,5-dinitro-l,4-dimethoxybenzene isomers, (44) and (45) 
respectively. 
These two isomers were separated by column chromatography using a mixture of 
petroleum spirit (bp 40-60 °C) and ethyl acetate (70:30) as solvent system. 
2,3-Dinitro-l ,4-dimethoxybenzene (44). 
This isomer (80% of the total dimethoxybenzenes) had mp 189°C (lit}3 mp 1860C), 
IR(KBr) vmax fcm-12292, 1542, 1494, 1436, 1350 (NOJ, 1128, 1054, 810; 1HNMR (200 
l\1Hz, DMSO-d6) 03.90 (6H, s, 1- and 4-0CH3), 7.68 (2H, s, 5- and 6-H); MS m/z (r.i.) 
228 (M+, 23%), 227 (M - H, 100), 182 (M - N02, 7), 136 (7), 106 (7), 76 (23). 
2,5-Dinitro-l ,4-dimethoxybenzene (45). 
The minor isomer (20%) had mp 205°C (lit.,s3 mp 202°C) ; IR(KBr) v max fern -1 2292, 
1542, 1494, 1436, 1354 (NOJ, 1128, 1054, 810; 1HNMR (200 MHz, DMSO-d6) 0 3.90 
(6H, s, 1- and 4-0CH3), 7.91 (2H, s, 3- and 5-H); MS m/z(r.i.) 228 (M+, 23%), 227 (M-
H, 100), 136 (7), 106 (7), 76 (23). 
PARTIAL REDUCTION OF 2,3- AND 2,5-DINITRO-l,4-DIMETHOXYBEN-
ZENE. 
(i) Attempted reduction with hydrazine hydrate. 
I-Hydroxy-4, 7 -dimethoxy-l,2,3-benzotriazole (65). 
A mixture of2,3-dinitro-1,4-dimethoxybenzene (44) (5.7 g, 25 mmol) and 60% hydrazine 
hydrate (3.75 g, 75 mmol) was stirred for 10 min at 28-30 °C. The temperature was then 
raised to 90 ° C during 45 min. and stirring was continued for 18 h at 90° C on a water 
bath. The reaction mixture was neutralized with dilute hydrochloric acid and, after cooling 
the reaction mixture, the resultant crystals of I-hydroxy--I,7-dimethoxy-l,2,3,-benzo-
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triazole (65) were collected and recrystallised from ethanol (4.80 g, 78%), mp 230-231 
°C; IR(KBr) v max /cm-l 3014 (OH), 2362, 2161, 1532, 1234, 1070, 802, 776, 689, 546; 
IHNMR (360 MHz, DMSO-d6) 0 3.92 (6H, s, 4- and 6-0CH3), 6.65 (1H, d, J = 8.2 Hz, 
6-H), 6.83 (lH, d, J = 8.0 Hz, 5-H), 13.50 (1H, s, 1-0H); MS, mlz(r.i.) 195 (M+, 65), 
180 (M- CH3, 12), 179 (100), 165 (11), 136 (6) (Found: C, 49.33; H, 4.74; N, 21.89; 
C8~N303 requires: C, 49.23; H, 4.61; N, 21.53%). 
(ii) Reduction with sodium dithionite. 
General Method. 
A freshly prepared solution of sodium dithionite (17.2 mmol) in water (50 cm3) was added 
dropwise to a hot solution of dinitrodimethoxybenzene (2.19 mmol) in a mixture of 
tetrahydrofuran (11 cm3) and methanol (22 cm3). The reaction mixture was heated for a 
few minutes and diluted with water (25 cm3) and heating was continued for a further 45 
min. Completion of the reaction was monitored by T.L.C. Organic solvents were 
evaporated off using the rotary evaporator. The aqueous solution was cooled in an ice-
bath to give a solid which was purified by column chromatography using a mixture of 
ethyl acetate and petroleum spirit (bp 40-60 °C) (1: 1) 
2,5-Dimethoxy-6-nitroaniline (66). 
1,4-Dimethoxy-2,3-dinitrobenzene (44) (0.50 g) was yielded 2,5-dimethoxy-6-
nitroaniline (66) (0.175 g , 40%) ; mp 72-74 °C; IR(KBr) v max /cm-l 3480 (NH2), 3348 
(NHJ, 2936, 1618, 1592 (N02), 1522, 1464, 1340 (N02), 1268, 1128, 1098, 998, 867, 
776,675,543,521; IHNMR (200 MHz, DMSO-d6) 0 3.83 (6H, s, 2- and 5-0CH3), 3.85 
(2H, s, exchangeablewithD20, NHJ, 6.20 (1H, d,J= 8.7 Hz, 4-H), 6.73 (1H, d, J= 9.3 
Hz, 3-H); MS, mlz(r.i.) 199 (22%), 198 (M+, 96), 183 (100), 182 (M - NHb 19), 152 (M-
N02, 19), 122 (55), 107 (15), 105 (9), 98 (21) (Found: C, 48.48; H, 5.03; N, 13.84. 
CsHlON204 requires: C, 48.48; H, 5.05; N, 14.14%). 
53 
2,5-Dimethoxy-4-nitroaniline (67). 
Reduction of 1,4-dimethoxy-2,5-dinitrobenzene (45) (0.50 g) with sodium dithionite 
(3 g) in a procedure similar to that described for (66) gave 2,5-dimethoxy-4-nitroaniline 
(67) (0.26 g, 60%), mp 156-158 °C; IR(KBr) v max /cm-1 3470 (NH2), 3342 (NH2), 1638, 
1528 (N02), 1448, 1384 (N02) , 1286, 1256, 1038, 987, 886, 774, 654, 543, 521; 
IHNMR (200 MHz, DMSO-d6) () 3.87 (3H, s, 2-0CH3), 3.90 (3H, s, 5-0CH3), 4.58 (2H, 
s, exchangeable with D20 NH2), 6.28 (lH, s, 6-H), 7.57 (lH, s, 3-H); MS, mJz(r.i.) 199 
(12%), 198 (M+,100), 183 (66%), 182 (M - NH2,15), 152 (M - N02, 19), 122 (23),107 
(35),89 (9) (Found: C, 48.48; H, 5.05; N, 13.63. CgHlON204 requires: C, 48.48; H, 5.05; 
N,14.14%). 
N-(2,5-Dimethoxy-6-nitrophenyl)guanidine (68), 3-amino-5,8-dimethoxy-l,2,4-
benzotriazine-l-oxide (69) and 4,7-dimethoxy-l,2,3-benzotriazole (70). 
A mixture of the 2,5-dimethoxy-6-nitroaniline (66) (0.73 g, 3.7 mmol) and cyanamide (1.5 
g, 35 mmol) was fused at 100°C. The mixture was cooled to room temperature, treated 
with concentrated hydrochloric acid (2 cm3) and warmed briefly at 100°C until a vigorous 
reaction occurred. After the reaction had subsided, the mixture was cooled to room 
temperature and a solution of sodium hydroxide (1.5 g) in water (2 cm3) added and 
warmed at 100°C for 1 h. A yellow solid separated on cooling and after addition of 
water the yellow solid was collected and crystallised from aqueous methanol to yield N-
(2,5-dimethoxy-6-nitrophenyl)guanidine (68), (0.59 g, 67 %), mp 250-251 °C; IR(KBr) 
v rnax /cm-1 3400 (NHJ, 3186 (NHJ, 1670,1580,1526,1488,1252; IHNMR (200 MHz, 
DMSO-d6) () 3.68 (3H, s, 5-0CH3), 3.74 (3H, s, 8-0CH3), 5.09 (2H, s, exchangeable with 
D20, NHJ, 6.58 (lH, d, J = 9.2 Hz, 6-H), 6.90 (lH, d, J = 8.7 Hz, 7-H); MS, mJz(r.i.) 
240 (M+, 82%),225 (M - CH3, 35), 224 (M - NH2, 10),209 (M - OCH3, 18), 198 (M-
CH2N2> 100) (Found: C, 44.90; H, 5.10; N, 23.13. CJI12N404 requires: C, 45.00; H, 5.04; 
N,23.33%). 
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The aqueous layer from which (66) deposited was evaporated, the residue dissolved in 
ethanol and separated by column chromatography [silica gel, mixture of ethyl acetate and 
petrolem spirit (bp 40-60 °C) (70:30)] to give 3-amino-5,8-dimethoxy-I,2,-I-
benzotriazine-l-oxide (69), (0.16 g, 20%) and followed by 4,7-dimethoxybenzotriazole 
(70), (0.07 g, 11 %). The compound (69) was crystallised from methanol and had mp 
229-231 °C; IR (KBr) v max /cm-1 3406 (NH2), 3286 (NH2), 1622, 1510, 1288, 1070; 
IHNMR (200MHz-DMSO-d6) 0 3.81(3H, s, 5-0CH3), 3.83 (3H, s, 8-0CH3), 6.66 (IH, 
d, J = 9.0 Hz ,6-H), 7.11 (lH, d, J = 8.0 Hz, 7-H), 7.13 (2H, s, exchangeable with 0 20, 
3-NH2); MS, mlz(r.i.) 236 (35%), 222 (M+, 100), 207 (M - CH 3, 34), 206 (M - H, 25), 
205 (33), 177 (10) (Found: C, 48.50; H, 4.59; N, 25.14. CJIlON40 3 requires: C, 48.65; 
H, 4.50; N, 25.22%). 
The 4, 7-dimethoxy-I,2,3-benzotriazole (70) had mp 154-156 °C; IR (KBr) v max /cm-1 
3415, 1560, 1540, 1455, 1289, 1004, 804; IHNMR (200 MHz-DMSO-d6) 0 3.94 (6H, 
s, 4- and 7-0CH3), 6.21(1H, s, exchangeable with D20), 6.72 (2H, s, 5- and 6-H); MS, 
mlz(r.i.) 180 (11%),179 (M+, 100), 164 (M- NH, 5),149 (M- 2CH3, 24),136 (16),57 
(10) (Found: C, 53.30; H, 5.02; N, 23.08. C8~N302 requires: C, 53.63; H, 5.06; N, 
23.46%). 
3-Amino-5,8-dimethoxy-l,2,4-benzotriazine-l-oxide (69) and 4,7-dimethoxy- 1,2,3-
benzotriazole (70). 
N-(2,5-dimethoxy-6-nitrophenyl)guanidine (68) (0.50 g) was dissolved in aqueous 
sodium hydroxide (1.5 g) and warmed at 100°C for Ih. The aqueous layer was 
evaporated and solid was collected and purified by column chromatography using mixture 
of ethyl acetate and petrolem spirit (bp 40-60°C) (70:30)] to give (69), (0.30 g, 60%) and 
(70), (0.10 g, 20%). The structures were confirmed by IR and IH NMR spectroscopy, 
mass spectrometry and elemental analysis and the compounds were shown to be identical 
to those obtained earlier. 
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Attempted preparation of 3-amino-l,2,4-benzotriazine-l,4-dioxide (75). 
A suspension of the I-oxide (69) (0.005 mole) in acetic acid (25 cm3) was stirred and 
heated at 45-50 °C for 20-60 h with 30% aqueous hydrogen peroxide (12 cm3), but only 
starting material was obtained. 
Attempted preparation of 3-amino-l,2,4-benzotriazine-l-oxide-5,8-quinone (76). 
To a stirred solution of3-amino-5,8-dimethoxy-l,2,3-benzotriazine-l-oxide (69) (0.10 
g) in a mixture of acetonitrile and water (10 cm3 , 4: 1 v/v) was added portionwise ceric 
ammonium nitrate (0.96 g, 4 mmol) while the mixture was cooled in an ice-bath. The 
stirring was continued for 15-20 min at O°C and then the mixture was diluted with water 
(50 cm3). The reaction mixture slowly changed colour at room temperature. The mixture 
was extracted with dichloromethane and the solvent evaporated in vacuo to give a dark 
brown residue which was crystallised from ethyl acetate, the product had mp above 
330°C but the IR and IHNMR spectra were complicated, perhaps due to the decomposi-
tion of the expected product. 
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2.1 INTRODUCTION 
2.1.1 Bleomycin (BLM). 
CHAPTER: 2 
The naturally occurring glycopeptide bleomycin exhibits both antibiotic and antitumour 
properties and was originally isolated from Streptomyces verticillus in 1966.62 There 
are apparently several modes of action by which bleomycin (BLM) exerts its 
antitumour activity. One firmly established mechanism involves interaction with DNA 
in the presence of a metal ion cofactor and subsequent degradation of the double 
helix. 63,64 
BLM is used in the treatment of several types of cancer including squamous cell 
carcinomas of skin, head, neck and tumours of the testis. The clinically used mixture 
ofBLM, known as Blenoxane, consists mainly ofBLM congeners A2 and B2, which 
differ only in their C-terminal groups (Fig 2). Structurally, BLM is a linear hexapeptide 
consisting of both common and uncommon amino acids and it also contains a 
disaccharide bonded through a glycoside linkage to an amino acid side chain. 
Previous studies have shown that the bleomycin molecule consists of two distinct and 
relatively independent regions. One region is localized around the bithiazole containing 
moiety and the cationic terminus and is responsible for the association with DNA, the 
other region is comprised of the pyrimidine group which contains the metal binding 
site. 65,66,67 
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Fig 2: Structure ofbleomycins. 
o 
Several metal complexes of bleomycin are known to bind with and cause degradation 
of DNA. 68 
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The proposed mechanism of oxygen activation by Fe (11)-BLM is shown in Fig 3. The 
ferrous complex is activated in the presence of molecular oxygen, binds with DNA and 
causes degradation of the DNA.69 
Fe (III) + BLMye 
+ + 
DNA Fe (III) - BLM 
activated Fe - BLM Fe (II) - BLM 
-BLM - Fe (III) -Q 
Fig 3: Fe (II)-BLM complex 
The Fe (II) centre binds oxygen and undergoes one electron reduction and protonation 
to form the Fe (111)- hydroperoxide. This hydroperoxide undergoes heterolytic 0-0 
bond scission to produce the putative perferryl species, which abstracts the 4'-H from 
deoxyribose to initiate DNA damage. 62 
Chemotherapy with increased doses of bleomycin, or even small doses applied 
frequently, are not acceptable because of severe cumulative pulmonary toxicity but the 
drug continues to interest oncologists because of its remarkable lack of bone marrow 
toxicity. However, because of pulmonary toxicity, BLM is used clinically in low doses 
mainly in synergistic combinations with other anticancer agents, e.g cisplatin, 
mitomycin and methotrexate. 70 
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Another approach to improving chemotherapy based on BLM is to find compounds 
(amplifiers) that alone do not have significant activity or toxicity but which enhance the 
activity of the drug (or which act directly at the DNA level and have focused on the 
BLM reaction). Amplifiers of the cytotoxic effect of bleomycin may in general:-
1. Increase the intracellular level of the drug. 71 
n. Inhibit DNA repair or synthesis. 72 
Ill. Bind with DNA and by so doing stimulate directly drug-induced DNA 
fragmentation. 73 
A number of unfused aromatic cations have been found to bind to DNA by 
intercalation and to amplify the bleomycin catalysed cleavage of DNA. 
These compounds which bind to DNA interact with the duplex through three primary 
modes. (Fig 4) 
1. Electrostatic interactions with the anionic sugar-phosphate backbone of 
DNA. 
n. Intercalation .. 
Ill. Interaction in the DNA major and minor groove. 
, 
External 
electrosta tic . Interc:Jlauon 
, 
'- I 
Groove 
Fig 4: The three primary binding modes of DNA.. 
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2.1.2 Structure of DNA. 
The double helical structure of DNA was first described by Watson and Crick in 1953. 
I 
The DNA molecule consist of two antiparallel strands of bases, adenine (A) and 
thymine (T), guanine (G) and cytosine (C), supported on a sugar phosphate backbone 
(Fig 5). 
: ~5'-end 
I 
O-CH2 0 
o 
I 
O=P-O-CH" I -
0-
sugar-
phosphate 
backbone 
o 
I 
O=p-O-CH" I -
0-
Fig 5: General structure of DNA; Base = A, T, G and C. 
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2.1.3 External electrostatic interactions. 
Nucleic acids are highly charged polyelectrolytes whose anionic phosphate groups 
strongly affect their structure and interactions. Therefore cations of organic amines 
such as 1,3-diaminopropane and unfused aromatic intercalators interact strongly with 
DNA. 74 
1,3 -Diaminopropane 
Unfused aromatic intercalator. 
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2.1.4 Intercalation. 
Some planar molecules, usually having two to four fused aromatic rings and a positive 
charge which is needed for activity 75 on the ring or on a substituent, e.g. proflavine 
(77), ethidium (78) and quinacrine (79) (generally known as classical intercalators), are 
capable of insertion between the base pairs of duplex DNA. They bind only to double 
stranded DNA and insertion between base pairs causes the helix to lengthen 76,77,78,79,80,81 
(Fig 7). 
Proflavine (77) 
Ethidium (78) 
CH3 / + 
H_N-CH (CH2)3 NH (CH2CH3h 
OCH3 
CI 
Quinacrine (79) 
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Fig 7: The intercalation model: (a) representation of DNA 
(b) same molecule containing intercalated ~g molecules. 
2.1.5 Groove binding molecules. 
Many unfused aromatic compounds with terminal basic functions exhibit binding 
specificity primarily through groove interactions. These types of molecules bind 
covalently to guariine in the major groove through hydrogen-bonding. However, the 
compounds that bind noncovalently in the minor groove of DNA are long, flexible 
molecules with one or two positively charged end groups,82 e.g. pentamidine (80). 
Pentamidine (80) 
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For groove binding the sutface of the ligand must be helically concave to complement 
the curvature of the groove surface. Typical groove binding molecules contain an 
unfused aromatic system with terminal basic functions. Torsional freedom between 
aromatic rings allows the molecules to form a non-planar shape which closely matches 
the helical curvature of the minor groove. 
2.2.1 Bleomycin amplifiers. 
As described before in this thesis (2.1.1), BLM can only be used clinically in low doses 
due to pulmonary toxicity but it may be possible to enhance the activity of BLM by 
giving the patient compounds that alone may have no activity or toxicity but that 
amplify the action ofBLM. The mechanism of amplication is not fully understood. 
Previous studies by Povirk and co-workers83 have suggested that the region of 
bleomycin molecule containing the bithiazole moiety is important for interaction with 
DNA. Therefore a number of chemically prepared bithiazole derivatives were tested 
for their ability to inhibit the interaction of bleomycin with DNA. This work showed 
that the bithiazole moiety plays an important role in the binding ofBLM to DNA.84 
The best amplifiers of bleomycin cytotoxicity are composed of at least two fused or 
unfused conjugated aromatic rings which are cationic or can acquire a positive charge 
by protonation of a nitrogen. Generally, an anionic or potential anionic centre 
decreases the activity of the molecule. Since these factors affect the interaction of an 
aromatic molecule with DNA in the same way, then binding of an amplifier molecule 
to DNA must be essential for amplification. 85 
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A number of unfused aromatic cations such as the compound shown in Fig 8 have 
been found to enhance the degradation of DNA by bleomycin. These compounds do 
not necessarily have biological activity of their own and have thus been termed 
amplifiers to distinguish their effects from drug synergism. It was found that these 
compounds are DNA intercalators. 86,87,88 
Fig 8: Unfused heteropolyaromatic intercalator molecules: R = S or NH 
These types of compounds increase the rate of DNA degradation by bleomycin and 
have a conformationally flexible, unfused polyaromatic system and a cationic side 
chain (protonated in water) in the molecule. These are desirable features for amplifiers 
because the unfused ring systems are better amplifiers than rigid, planar intercalators. 
This may be due to the torsional conformational freedom in the unfused molecules 
which causes more extensive lengthening of DNA and breathing of DNA base pairs 
in the intercalation complex than fused systems of similar molecular area. 89,90,91 
This class of compound shows promise for development as amplifiers of the BLM-type 
drugs and several mono-, di- and tri-cationic compounds have been synthesized. The 
electrostatic interaction of these cationic groups with the anionic DNA backbone 
enhances groove binding or intercalation of the aromatic portion of the molecule by 
increasing the overall stability of the amplifier-DNA complex.92 
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Previous studies have shown that compounds binding with DNA by this dual mode also 
show increased bleomycin amplification in comparison to the activity of both 
noncationic aromatic derivatives and nonaromatic polycationic amines. 93 
It has been observed that unfused aromatic ring compounds with a terminal basic 
function bind to DNA in one of the grooves and amplify the degradation of DNA by 
bleomycin. The dipyrimidinythiophene (81) is the best amplifier of bleomycin in vitro 
found so far and exhibits the greatest amplification activity at high concentration. Its 
DNA binding constant (13 x 106 M-1) exceeds that ofBLM (105 M-1).89 
(81) 
Compound (81) and similar unfused intercalators have tertiary amine side chains which 
are cationic in water. This is an important feature because it not only increases the 
solubility of the compound but also increases the DNA binding constant through 
electrostatic interaction with the anionic DNA backbone while the positively polarized 
aromatic system intercalates with DNA base pairs. 94 
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Studies have shown that the tricyclic unfused compounds, e.g 82-85, intercalate 
strongly with DNA and are better amplifiers than ethidium (a classical intercalator). 
They cause more lengthening of DNA at low concentration and protonation of the 
basic amino side chain depends on the separation of the adjacent amino groups. 89 
(82) RI = R2 = N (CH3)2 
(83) RI = R2 = NHCH2CH2N(CH3h 
(84) RI= R2 =NHCH2CH2CH2NH2 
(85) ~ = H, W = NHCH2CH2N(CH3)2 
For both the amino functions to be protonated in an aliphatic diamine at pH 7 the 
nitrogen atoms must be separated by at least three methylene groups. Thus compounds 
(81), (82), and (83) are dicationic while (84) is tetra- and (85) is mono-cationic. 
The length of the cationic side chain is also important in another way. Here a short 
cationic side chain is favourable since the cation binds in close proximity to the DNA 
phosphate backbone which positions the aromatic system favourably for intercalation. 95 
Only the molecules which have the aromatic system polarised extensively in the 
direction of the side chain, so that the intercalating part constitutes a positive part of 
the dipole, show strong intercalative binding with DNA. 96 
69 
Therefore, for intercalation to occur the polarity of the unfused rings is of primary 
importance. The cationic side chain of the amplifier interacts electrostatically with the 
anionic DNA phosphate backbone while the positively polarised aromatic system 
intercalates with the DNA base pairs.97 
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2.2 Chemistry of 2,6-diarylpyridines and related compounds. 
The pyridine nucleus is a major components of a variety of natural products and 
drugs98 and a very small number of substituted pyridine compounds are found in nature 
mostly in enzymes and alkaloids. Some are obtained by degradation of complex natural 
materials such as coal, shale and various alkaloids. 
The substituted pyridines e.g. nicotyrine (86), 2,3-bipyridine (87), myosmine (88), 
nicotine (89) and nicotelline (90) were obtained from alkaloids by fractional 
extraction. 99 
Nicotyrine (86) 
N 
H 
Myosmine (88) 
~ 
N 
2,3-Bipyridine (87 
N 
Me 
Nicotine (89) 
Nicotelline (90) 
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There are few methods reported in literature for the synthesis of2,6-diarylpyridines. 
These methods generally involve complex reaction processes and result in low yields 
of the product. However, the condensation of aldehydes, ketones, a,~-unsaturated 
carbonyl compounds or various derivatives of such compounds with ammonia or its 
derivatives to form substituted pyridines is the one of the oldest organic reactions. 100 
This reaction was studied extensively by Chichibabin and his co-workers101 and can be 
regarded as an aldol condensation, generally in conjunction with a Michael type 
reaction and ring closures involving ammonia. 
Two general methods were used for the preparation of substituted pyridines. The first 
method required the reaction of carbonyl compounds with an aldehyde-ammonia in a 
sealed tube. The second method involved the passing of ammonia and the carbonyl 
compound together in the vapour phase over a catalyst such as alumina. However, 
these methods gave low yields of pyridines102 (Scheme 36). 
CHO 
/ 
CH 
II 
CH3CH 
CH=GICH3 I 
CHO 
NH3 
Scheme 36 
Frank and Seven 102 reported the yield is not higher than 20%, and high temperature, 
sealed tubes or vapour phase reaction over heated catalysts were necessary. While 
Frank and Seven modified the synthesis by employing aqueous ammonia and catalytic 
amounts of ammonium acetate the reaction still required the use of a steel autoclave 
at a temperature of250 °C with pressures up to 1450 p.s.i. 
However because of the formation of mixtures of pyridines and of various byproducts, , 
. c. h' 103 the method has had a poor reputatIOn lor synt etlc purposes. 
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Weiss improved the procedure by causing the reaction of aromatic aldehydes with 
aryl methyl ketones in glacial acetic acid in the presence of ammonium acetate. He 
found that the carbon atom of the formyl group occurs at the 4-position of the pyridine 
with methyl group carbon atoms occurring at position 3 and 5 in the pyridine 
nucleus. lOl 
The reaction is thought to proceed by initial condensation of the aldehyde (91) with an 
aryl methyl ketone, e.g. acetophenone (92) to form an aldol condensation product (93) 
and this is followed by a Michael type addition reaction to form a 1,5-diketone (94). 
(Scheme 37). 
RCHO 
(91) 
+Q;H5COCH3 
(92) 
~4===_;;;: RCH = CHCOC6H5 + H20 
(93) 
RCH = CHCOC6H5 + C{,H5COCH3 
(93) (92) 
(94) + NH3 
(95) 
(96) + RCH = CHCOC6H5 
(93) 
~ C6H5COCH2CHRCH2COC6H5 
(94) 
R 
(97) 
+ R CH2CH2COC6H5 
C6H5 
(98) 
Scheme 37 
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The diketone then condenses with ammonia (95) to form a 1,4-dihydropyridine (96) 
which, in tum is dehydrogenated to a pyridine (97) (Scheme 37). The aldol and 
Michael reaction steps are reversible. However, the yield from these reactions is very 
low. 
Another route to the difficultly accessible 2,6-diphenylpyridines and fused ring 
pyridines is by pyrolysis of a-methylenic ketone N,N,N-trimethylhydrazonium 
fluoroborates. This has been reported to be the best method for the synthesis of2,6-
diarylpyridines. 104 
In this process the ketone (99) reacts directly with anhydrous N,N-dimethylhydrazine 
to give excellent yields of the corresponding N ,N-dimethylhydrazone (100).105 
Treatment of (100) with alcoholic methyl iodide produces the N,N,N-trimethyl-
hydrazonium iodide (101) which can be easily converted into the corresponding N,N,N-
trimethylhydrazonium fluoroborate (102).106 
Pyrolysis of N,N,N-trimethylhydrazonium fluoroborate (102) at 200°C under a slow 
stream of nitrogen affords a substituted pyridine (103) (Scheme 38). This method has 
the disadvantage of providing only symmetrically substituted pyridines and usually in 
low yield. 
The pyrolysis conditions for most fluoroborates can be varied considerably with little 
effects on the overall yield of the pyridine products. 
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(100) 
R 
Ar 
(102) R=H (103) 
Scheme 38 
The suggested mechanism107 (Scheme 39) for the formation of (103) is that the 
NNN-trimethylhydrazonium cation (102) undergoes simple N-N cleavage as the most 
likely thermal process, independent of interaction with the anion, to produce the imine 
(104) and the dimethylmethyleneammonium cation (105) by migration of hydrogen. 
+ 
(102) (104) 
(105) 
Scheme 39 
75 
The imine (104) is sufficiently stable to undergo subsequent tautomerism and reacts as 
the enamine. Thus, tautomerism of (104) to ct-aminostyrene (106) followed by 
electrophilic alkylation of the resulting enamine with the dimethylmethyleneammonium 
cation (Mannich reagent) (105) gives p-dimethylaminopropiophenone iminium ion 
(107) (Scheme 40). 
(108) 
Scheme 40 
Under pyrolysis conditions the iminium ion (107) loses dimethyl amine to give the diene 
(108) which is the one of the reactive intermediates (Scheme 40). 
After the formation of these fragments, the reaction of the electron rich p-carbon of 
the enamine (106) with (108) by a Michael addition gives the intermediate (109) 
which, after elimination of ammonia gives the dihydropyridine (111). Aromatization 
of the pyridine nucleus can occur by transfer of hydrogen to molecules with isolated 
double bonds108 or by loss of molecular hydrogen109 (Scheme 41). 
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R R t~ C • (~ 'Ar Ar/ "NH Ar H2N 
(108) (106) 
~ 
H 
R R R 
III( 
... 
-NH3 Ar 
Ar Ar 
(103) (111) (110) 
Scheme 41 
Some of the best methods for the preparation of diarylpyridines were reported by 
Krohnke. In 1961 he describedllo a route to some substituted pyridines. In this method 
the methyl ketone (112) is brominated to give a bromomethyl ketone (113) which 
reacts with anhydrous pyridine to produce the pyridinium salt (114). The pyridinium 
salt then can be treated with ammonium acetate in glacial acetic acid, or with an 
unsaturated ketone (115) in water, or with a Mannich basell1 to give the 1,5-diketone 
(116) intermediate via Michael addition reaction. 
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The 1,5-diketone (116) which is rarely isolated, undergoes ring closure on treatment 
with ammonium acetate to produce substituted pyridines (117) (Scheme 42) which 
may be 2,6-diarylpyridines. 
o 
1 II R-C-CH3 
o 0 0 
1 II N 1 II ~~ 
·R-C-CH2Br • R-C-CH2-NW_ (112) 
o 
II ~-CH=CH-C-R2(115) 
• N}40Ac, AcOH 
(117) 
(113) (114) Br-
H ~ , / 
0 + /C ......... N-CH CH2 ~ h I CI-O C==O ,-
~ ~ 
(116) Br-
Scheme 42 
This method has some advantages over the previously described routes. The reaction 
proceeds at reflux temperature and the yield of2,6-diarylpyridine is generally greater 
than can be obtained by the previously described routes. Secondly the synthesis of bis-, 
ter- and up to septa-pyridines can be achieved starting from the pyridinium salts and 
unsaturated ketone (or Mannich bases) under mild conditions. 
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Krohnke (1968) has shown 1,3-dicarbonyl compounds may be used instead of 
pyridinium salts for the synthesis ofpyridines. When acetylacetone (118) reacts with 
1,3-diphenyl-l-oxoprop-2-ene (119) in ethanol containing sodium hydroxide to form 
the 1,5-diketone (120) and in this case the (120) can be isolated. 112 (Scheme 43) 
o 
II 
HC-C-CH2 
3 I 
H3C 
C==O 
/ 
(118) 
Scheme 43 
Treatment of (120) with ammonium acetate in methanol gives the 1,4-dihydropyridine 
(121),113 which can be dehydrogenated by the treatment with sodium nitrite in glacial 
acetic acid to give pyridine (122). The substituted pyridine (122) can also be obtained 
directly from (120) by treatment with ammonium acetate and ferric chloride in glacial 
acetic acid (Scheme 44). 
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(120)----1 
(122) 
Scheme 44 
An alternative to 1,3-diketone (118) an aryl cyanomethyl ketone (123) can also be used 
to form dihydropyridine (124) with ammonium acetate in glacial acetic acid. The (124) 
was dehydrogenated by the treatment with sodium nitrite in glacial acetic acid to 
produce 2,4,6-triphenyl-5-cyanopyridine (125) (Scheme 45).114 
NC-CH2 I 
C==O 
H5C( 
(123) 
NC 
(125) 
Scheme 45 
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Recently, Shibata and co-workers 115 reported a new method for the preparation of2,6-
diaryl-3-cyano-4-(trifluoromethyl)pyridine and some other fluorine containing 2,6-
diarylpyridines (Fig 9). 
x 
Fig 9: The 2,6-diarylpyridines: R = CF3, F, Cl; X = OMe, SMe. 1l5 
In their process, a trifluoromethyl-substituted p-diketone (129) is reacted with p-
amino-p-aryl acrylonitrile (128) in a Michael addition-cyclization reaction. The starting 
enaminonitriles (128) can be obtained in excellent yield by the reaction of acetonitrile 
(126) with aryl nitriles (127) in the presence of potassium t-butoxide (Scheme 46). 
CH3CN + KCN 
(126) (127) 
1 
Reagetts: (i) t-BuOK, benzene 
Scheme 46 
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The trifluoromethyl-substituted p-diketones (129) can be prepared by condensation of 
ethyl trifluoroacetate with methyl ketones in the presence of potassium t -butoxide in 
good yield. 116 Trifluoromethyl-substituted p-diketones (129) are present as keto-enol 
tautomers (129 and 130) in solution. (Fig 10) 
CF3 CF3 
0 HO 
.. 
-
0 0 
RI 
(129) (130) 
Fig 10: Keto-enol tautomers of trifluoromethyl-substituted p-diketone 
Reaction of trifluoromethyl-substituted p-diketones (129) and p-amino-p-aryl 
acrylonitrile (128) in ethanol at reflux for 8 hours gave the 2,6-diaryl-3-cyano-4-
(trifluoromethyl)pyridine (131) in 53% yield (Scheme 47). 
K CN 
(129 and 130) + ~ 
H2N CN 
(128) (131) 
Scheme 47 
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Use of I-propanol as a solvent produced an increase in the amount of by-products and 
reduced the yield of(131) to 48%. To obtain a high yield of the product it was crucial 
to use two equivalents of p-amino-p-aryl acrylonitrile (128) for a prolonged reaction 
time (24 hour). 115 
If the compound (129) bears a 4-methoxyphenyl group adjacent to the carbonyl carbon 
the product is the corresponding pyridine in low yield. However, the nitrile compound 
(128) having a 4-methoxyphenyl group at p-carbon afforded high yields of the pyridine 
product. On the basis of these results it was concluded that for the high yields of the 
substituted pyridines, it is necessary to use p-diketones having an electron-withdrawing 
group and also an enaminonitrile containing an electron-releasing group. 
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2.3 RESULTS AND DISCUSSION. 
The aim of present work was to synthesize a DNA binder which was to be 
incorporated into an analogue of bleomycin A2 . Previous studies have shown that in 
the bleomycin molecule the presence of a bithiazole nucleus, which contains a 
cationic substituent, is responsible for the association with DNA. 117,118 Several poly-
heteroaromatic compounds with flexible substituents containing cationic groups have 
been prepared and their binding with DNA studied. Also their effects on the bleomycin 
mediated degradation of double strand DNA have been investigated. 119 
It has been shown 120 that unfused polycyclic systems are better amplifiers of bleomycin 
cytotoxicity than fused classical intercalators. The effective unfused aromatic 
compounds have a conformationally flexible side chain and a cationic region e.g. (81), 
(82) and (83). This class of compound shows promise for development as amplifiers 
of the biological effects of bleomycin type drugS. 121,122,123 
Therefore, the intention in the present work was to prepare and characterise some 
novel unfused tricyclic molecules which contain a terminal and potentially cationic 
substituent, which can bind with DNA. 
2.3.1 2,6-Bis(4-metbyJpbenyJ)pyridine (136). 
The first route attempted for the preparation of2,6-bis(4-methylphenyl)pyridine (136) 
was by pyrolysis of a ketone NNN-trimethylhydrazonium tetratluoroborate, (see 
Introduction for a general discussion of the reaction). The key step in the synthesis of 
2,6-bis(4-methylphenyl)pyridine was the conversion of 4-methylacetophenone (132) 
into 4-methyl acetophenoneNN-dimethylhydrazone (133) by reaction with anhydrous 
N,N-dimethylhydrazine in glacial acetic acid and absolute ethanol. After the usual 
work-up procedure, a yellow oil was obtained which was purified by distillation to give 
4-methylacetophenone N N-dimethylhydrazone in 80% yield. 
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The IH NMR spectrum of (133) showed a singlet at 2.35 ppm caused by the two C-
methyl groups, a singlet at 2.58 ppm was due to two N-methyl groups and two 
doublets at 7.61 ppm and 7.64 ppm were due to the aromatic protons. 
When 4-methylacetophenone N N-dimethylhydrazone was treated with methyl iodide 
the product was 4-methylacetophenone NNN-trimethylhydrazonium iodide (134) 
(Scheme 48). 
(132) 
o 
II 
C-CH3 
1 
(133) 
(136) 
Reagent: (i) Me2NNH2, AcOH, HOB; (ii) Mel; 
(tit) NaBF4; (iv) Isoprop)fuenzene. 
Scheme 48 
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A hot aqueous solution of (134) was treated with aqueous sodium fluoroborate to 
give a precipitate of the fluoroborate (135). When (135) was slowly heated in 
isopropyl- benzene (cumene), the exothermic reaction caused the solution to reflux. The 
crude product was obtained as a solid from the reaction mixture and purified to give 
a disappointingly low yield (17%) of2,6-bis(4-methylphenyl)pyridine (136). 
The two methyl groups of (136) gave rise to a singlet at 2.41 ppm in the IH NMR 
spectrum, while the four benzene ring protons at positions of3- and 5- gave multiplets 
at 7.41 ppm. The 3- and 5-protons of the pyridine nucleus gave multiplets at 7.62 ppm 
and a triplet at 7.83 ppm was caused by the 4-proton of pyridine ring . The 
resonances at 8.10 ppm were due to the four 2- and 6-protons of the carbocyclic 
systems. The mass spectrum of(136) showed the expected molecular ion peak at 259 
daltons. 
An alternative approach to 2,6-diarylpyridine was reported by Krohnke 110 (see 
introduction p.77). This route was investigated in an attempt to increase the yield of 
(136). The initial step in the synthesis of 2,6-bis(4-methyl pheny1)pyridine by this 
method was the conversion of 4-methylphenacyl bromide (137) into 1-(4-
methylphenacyl) pyridinium bromide (138) (Scheme 49). 
N I - ----------------.~ Er § 
(137) H3
C (138) 
Scheme 49 
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The IR spectrum of 1-(4-methylphenacyl)pyridinium bromide (138) showed the 
expected carbonyl stretching absorption at 1688 cm-1 and the IH NMR spectrum 
showed singlets at 2.42 ppm and 6.47 ppm caused by the methyl and methylene 
groups respectively. The protons on the aromatic nucleus of the tolyl group gave rise 
to two doublets at 7.41 ppm (J = 7.4 Hz) and 7.92 ppm (J = 7.4 Hz) .The 3- and 5-
protons of the pyridine ring gave a triplet at 8.27 ppm, a multiplet at 8.73 was due to 
the 4-proton, and the 2- and 6-protons caused a triplet at 9.01 ppm. 
1-( 4-Methylphenyl)-3-( dimethylamino )propan-1-one hydrochloride (141) was prepared 
by the Mannich reaction. 124 Heating a mixture of 4-methylacetophenone (132), 
paraformaldehyde (139) and dimethyl amine hydrochloride (140) in absolute ethanol 
gave the tertiary amine hydrochloride (141) in good yield (Scheme 50). 
(132) 
(141) 
Scheme 50 
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(CH3h NH. HCI 
(140) 
The mechanism of this reaction may involve the intermediate formation of 
dimethylaminomethanol which, under the influence of acid was converted into a 
reactive methylene ammonium salt. Reaction of the ammonium salt with 4-
methylacetophenone gave 1-( 4-methylphenyl)-3 -( dimethyl amino )propan-l-one 
hydrochloride (Scheme 51). 
+ 
(CH3hNH + (CH20 )n-- (CH3hNCH20H H .. (CH3hN = CH2 
Scheme 51 
CH3 
(141) 
The IHNMR spectrum of(141) showed a singlet at 2.43 ppm due to the C-CH3 group, 
a singlet due to resonance by N-( CH3)2 at 2.87 ppm and two triplets at 3.54 and 3,73 
ppm due to the methylene protons. Two doublets at 7.26 and 7.87 ppm were caused 
by four aromatic protons and a singlet at 13. 01 ppm was due to the NH group. 
IR spectrum of 1-( 4-methylphenyl)-3-( dimethyl amino )propan-l-one hydrochloride 
(141) showed a peak at 1674 cm-1 due to the carbonyl group, 
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When compounds (138) and (141) were refluxed with ammonium acetate in glacial 
acetic acid a Michael addition reaction occurred to give (142) which then underwent 
ring closure on treatment with ammonium acetate to give 2,6-bis(4-
methylphenyl)pyridine (136) in 35% yield (Scheme 52). 
H H 
(138) + (141) _....!o...l_.~ 
" / O~+ /C N-CH "CH2 - I I 0 C==O C=== 
(142) 
~ 
N 
(136) 
Reagents: (i) annnonimn acetate, glacial acetic acid. 
Scheme 52 
Spectral data for (136) were in good agreement with its structure and the yield was 
improved to 67% by using methanol as a solvent instead of glacial acetic acid. 
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2.3.2 2-Phenyl-6-(4-tolyl)pyridine (144). 
The 2-phenyl-6-(4-tolyl)pyridine (144) was synthesised according to (Scheme 53). The 
precursor (phenylacylpyridinium bromide) (143) was prepared by treating phenacyl 
bromide with dry pyridine. 
~ Br 
(143) (144) 
Scheme 53 
Compounds (143) and 1-( 4-methylphenyl)-3-( dimethylamino )propan-l-one hydro-
chloride (141) were treated with ammonium acetate in methanol to produce 2-phenyl-
6-( 4-tolyl)pyridine (144) in 67% yield. 
The IH NMR spectrum of2-phenyl-6-(4-tolyl)pyridine (144) showed a singlet at 2.41 
ppm caused by the C-CH3 group, a doublet at 7.29 ppm due to 3- and 5-protons of the 
tolyl nucleus and multiplets at 7.42-7.49 ppm due to the three aromatic protons. The 
3- and 5-protons of the pyridine nucleus gave rise to a doublet at 7.66 ppm, a triplet 
at 7.79 ppm was caused by the 4-proton of the pyridine ring and two doublets at 8.05 
ppm and 8.15 ppm were due to four protons adjacent to pyridine on the carbocyclic 
systems. 
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Bromination of 2-phenyl-6-( 4-tolyl)pyridine (144) with N-bromosuccinimide (NBS) 
in carbon tetrachloride (CCI4) using benzoyl peroxide as an initiator gave a complex 
mixture from which 2-([4-bromomethyl]phenyl)-6-phenylpyridine (145) was isolated 
in 60% yield by column chromatography (Scheme 54). 
(144) 
Reagents: (i) NBS, CC4 
Scheme 54 
(145)R= CH2Br 
(146)R = CHBr2 
R 
2-(4-[Bromomethyl]phenyl)-6-phenylpyridine (145) was characterised by its IH NMR 
spectrum which had a singlet at 4.56 ppm due to the methylene group, as well as other 
expected peaks (see Experimental section). The mass spectrum showed the presence 
of molecular ions at 325 and 323 daltons in the relative abundance ratio 1: 1 due to the 
81Br and 7'13r isotopes respectively. 
Treatment of (145) with n-butylamine in tetrahydrofuran (THF) to form a secondary 
amine as described by Strekowski and co-workers92 was unsuccessful and resulted in 
the recovery of the starting material. A similar result was obtained when anhydrous 
ethanol was used as a solvent and the reaction mixture retluxed overnight. 
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To overcome the problem associated with monobromomethyl derivative (145) an 
alternative approach was tried in which the 2-phenyl-6-( 4-tolyl)pyridine was converted 
into 2-(4-[dibromomethylphenyID-6-phenylpyridine (146) by using 2 molecular 
equivalents of N-bromosuccinimide (Scheme 54). 
The IH N1\1R spectrum of (146) showed a singlet at 6.71 ppm due to the CHBr2. 
Treatment of(146) with sodium ethoxide ( sodium dissolved in ethanol) in anhydrous 
ethanol at reflux afforded 2-(4-[ diethoxymethyl]phenyl)-6-phenylpyridine (147) in 
47% yield and the hydrolysis of (147) with hydrochloric acid (3M) gave a complex 
mixture from which 2-(4-formylphenyl)-6-phenylpyridine (148) was isolated in only 
19% yield by column chromatography (Scheme 55). 
(146) (147) 
;/ 
(148) CHO 
Reagents: (i) NaOEt, EtOH; (ii) aq. HCI 
Scheme 55 
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2-(4-FOlmylphenyl)-6-phenylpyridine (148) was characterised by its IR spectrum which 
showed the presence of a C=O group by a signal at 1704 em-I. The IH NMR spectrum 
showed multiplets at 7.43 ppm due to the five benzene ring protons and multiplet at 
7.62 ppm caused by the 3- and 5-protons of pyridine nucleus, a triplet at 7.81 ppm 
caused by the 4-proton of pyridine. Four aromatic protons gave rise to a multiplet at 
8.10 ppm and a singlet at 10.04 ppm due to the CHO group. The unsatisfactory yield 
of (148) made this route unattractive for further reactions but it showed that the 
nucleophilic displacement reaction did not take place under mild conditions. 
The successful nucleophilic displacement of both bromine atoms in 2-(4-[ di 
bromomethylphenyl])-6-phenylpyridine (146) encouraged us to try this method with 
compound (145). This gave an excellent yield of 2-(4-[ethoxymethyl]phenyl)-6-
phenylpyridine (149) (Scheme 56) and the product was characterised by its IH NMR 
spectrum which showed the appearance of extra triplet at 1.12 ppm caused by CH3 
group and quartet due to the CH20CH2CH3 at 3.42 ppm. 
(145) 
Scheme 56 
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R 
(149) R = CH20CH2CH3 
(150) R = CH20(CH2)3NH2 
These results seem to indicate that the nucleophilic displacement reaction of 2-(4-
[bromomethyl]phenyl)-6-phenylpyridine (145) required more vigorous reaction 
conditions than were tried earlier. When 2-( 4-[bromomethyl]phenyl)-6-phenylpyridine 
(145) was treated with 3-aminopropanol in the presence of anhydrous potassium 
carbonate the product was 2-( 4-[3-aminopropoxymethyl] phenyl)-6-phenylpyridine 
(150) (Scheme 56). 
Separation of this highly polar product from impurities was achieved by column 
chromatography by using a mixed solvent system (chloroform, methanol and 
ammonia). The structure of (4-[3-aminopropoxymethyl]phenyl)-6-phenylpyridine (150) 
was confirmed by IR spectrum which showed absorptions at 3320 and 3210 cm-1 due 
to the NH2 stretching vibration. The IH NMR spectrum exhibited two multiplets at 
1.73 ppm and 2.91 ppm due to the OCH2CH2CH2NH2 and a triplet at 3.83 ppm was 
caused by OCH2CH2CH2NH2. The benzylic CH2 gave rise to a singlet at 3.86 ppm, 
the NH 2 group gave a singlet at 2.42 ppm, which was exchangeable with D20 and five 
aromatic protons gave rise to a multiplet at 7.48 ppm. A multiplet at 7.67 ppm was 
caused by 3- and 5-protons of pyridine nucleus, a triplet at 7.79 ppm due to the 4-
proton of pyridine ring and a multiplet at 8. 13 ppm was caused by four protons of 
carbocylic systems. 
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2.3.3 Substitution reaction of amines with 2-(4-[bromomethyl]phenyl)_ 
6-phenylpyridine (145). 
When 2-(4-[bromomethyl]phenyl)-6-phenylpyridine (145) was separately dissolved in 
ethylenediamine, 1,3 -diaminopropane and 1, 6-diaminohexane containing anhydrous 
potassium carbonate and retluxed for several hours the product were 2-(4-[ 4-amino-2-
azabutyl]phenyl)-6-phenylpyridine (151 ), 2-(4-[ 5-amino-2-azapentyl]phenyl)-6-phenyl 
pyridine (152) and 2-( 4-[8-amino-2-azaoctyl]phenyl)-6-phenylpyridine (153), 
respectively (Scheme 57). 
(145) • 
(151)n=2 
(152) n = 3 
(153) n = 6 
Scheme 57 
The IR spectrum of (1 51 ) showed absorptions at 3420,3330 and 3240 cm-1 due to 
NH2 and NH stretching vibrations. The IH NMR spectrum showed a broad singlet due 
to the NHCH2CH2NH2 groups at 1.66 ppm, the two adjacent methylene groups gave 
rise to triplets at 2.73 and 2.83 ppm and a singlet at 3.87 ppm was caused by aromatic 
methylene group. Accurate mass measurement of the molecular ion peak agreed with 
that expected for the molecular formula. 
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Compounds (152) and (153) were also characterised on the basis of their IH NMR and 
IR spectra and accurate mass determination on the molecular ion. 
Bromination of2,6-bis(4-methylphenyl)pyridine (136) with an equimolecular quantity 
of the N-bromosuccinimide in carbon tetrachloride (CCI4) containing benzoyl peroxide 
gave a mixture of(136), 2-(4-[bromomethyl]phenyl)-6-(4-tolyl)pyridine (154) and 2,6-
bis(4-[bromomethyl]phenyl)pyridine (155) (Scheme 58). Separation of the products 
was achieved by column chromatography and they were purified by crystallisation. 
(136) 1 
(154) It= CH3, R-= CH2Br 
(155)R1= K= CH2Br 
Reagents: (i) NBS, CC4 
Scheme 58 
The IH NMR spectrum of 2-(4-[bromomethyl]phenyl)-6-(4-tolyl)pyridine (154) 
showed two singlets at 2.42 and 4.55 ppm due to the aromatic methyl and methylene 
groups, two doublets at 7.31 and 7.52 ppm were caused by 2 x 3- and 5-protons of 
carbocyclic rings. A multiplet at 7.67 ppm was due to the 3- and 5-protons of pyridine 
nucleus and a triplet at 7.83 ppm was caused by the 4-proton of the pyridine ring. Four 
aromatic protons gave rise to two doublets at 8.05 and 8.13 ppm. 
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The nucleophilic displacement reactions of bromine in (154) and (155) with 1,6-
amino hexane at reflux afforded 2-( 4-[8-amino-2-azaoctyl]phenyl)-6-( 4-methylphenyl) 
pyridine (156) and 2,6-bis(4-[8-amino-2-azaoctyl]phenyl)pyridine (157), respectively 
(Scheme 59). 
(154) or (155)----.~ 
Reagents: for (156) and (157), H2N(CH2)6NH2; 
(158), HS(CH2)2N(CH3)2 HCI 
Scheme 59 
Compounds (156) and (157) were characterised through their IR and IH NMR spectra 
and by accurate mass measurementof the molecular ion. The IR spectrum of compound 
(156) showed peaks at 3330 and 3210 cm-1 attributed to the NH2 group and at 3420 
cm-1 due to the NH group. The IH NMR spectrum of (1 56) showed mutiplets at 1.23-
1.54 ppm caused by the four adjacent methylene groups in NHCH2 CH2 CH2 CH2 CH2 
CH2 NH2, the NH2 and NH groups gave rise to a broad singlet at 1.88 ppm and there 
was singlet at 2.42 ppm due to the CH3 group. The terminal methylene groups in 
NHCH2CH2 CH2CH2CH2CH2 NH2 gave rise to a multiplet at 2.66 ppm and the 
benzylic CH2 group gave a singlet at 3.85 ppm. In addition, the spectrum showed the 
presence of all the expected aromatic protons. 
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2-( 4-[ 4-Dimethylamino-2-thiabutyl]phenyl)-6-( 4-methylphenyl)pyridine (158) was 
prepared by a reaction of (154) with 2-( dimethyl amino )ethanethiol hydrochloride in 
ethanolic sodium ethoxide solution with added base to abstract protons from 2-
(dimethyl amino )ethanethiol hydrochloride to generate a negative charge on sulfur and 
to scavenge the HBr liberated during the reaction (Scheme 59). 
The IH NMR spectrum of 2-(4-[ 4-dimethylamino-2-thiabutyl]phenyl)-6-( 4-
methylphenyl) pyridine (158) showed a singlet at 2.21 ppm and 2.43 ppm due to the 
N(CH3):o and CH3 aryl substituent respectively. The multiplet at 2.51 ppm was due to 
two CH2 groups. 
After obtaining diarylpyridines having one basic side chain it was of interest to prepare 
compounds having two different terminal cationic side chains that might be expected 
to show strong interaction with DNA. 
In addition we investigated the preparation of this type of compound in a series of 
reactions starting with the synthesis of 1-( 4-bromophenacyl)pyridinium bromide (160). 
The compound (160) was obtained in quantitative yield by reaction of commercially 
available 4-bromophenacyl bromide (159) with dry pyridine (Scheme 60). 
o 
II +O~ C-CH2--N _ 
(159) (160) 
Scheme 60 
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The reaction of 1-(4-bromophenacyl)pyridinium bromide (160) with 1-(4-methyl-
phenyl)-3-( dimethylamino )propan-l-one hydrochloride (141) and cyclisation with 
ammonium acetate yielded 2-(4-bromophenyl)-6-(4-tolyl)pyridine (161) (Scheme 61). 
(160) + (141) __ ..=......1 --•• (161) 
Br 
(162) 
Regents: (i) ammonium acetate, methanol; (ii) NBS, CCl4 
Scheme 61 
The compound (161) was characterised by its IH NMR spectrum, which showed a 
singlet at 2.42 ppm due to the methyl group, a doublet at 7.31 ppm was caused by the 
3- and 5-protons oftolyl ring and a multiplet at 7.61 ppm was due to five protons of 
carbocyclic and pyridine rings. Two doublets at 8.02 and 8.08 ppm due to four 
aromatic protons. 
The second stage involved the bromination of 2-( 4-bromophenyl)-6-( 4-tolyl)pyridine 
(161) with N-bromosuccinimide in the presence of benzoyl peroxide to give 2-(4-
[bromo methyl]phenyl)-6-(4-bromophenyl)pyridine (162) in 50% yield (Scheme 61). 
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Evidence for the two bromine atoms in (162) was obtained by the appearance of three 
molecular ion peaks at 405,403 and 401 daltons due to the isotopes of bromine. Apart 
from all the expected peaks associated with carbocyclic ring and pyridine nucleus, the 
IH NMR spectrum showed a singlet at 4.55 ppm due to the bromomethyl group. 
The nucleophilic displacement reaction of the alkyl bromide from (162) was carried out 
with 2-( dimethyl amino )ethanethiol hydrochloride in the presence of sodium ethoxide 
to give 2-(4-[ 4-dimethylamino-2-thiabutyl]phenyl)-6-( 4-bromophenyl)pyridine (163) 
(Scheme 62), which was purified by column chromatography. 
(162) 1 
Br 
BrMg 
Hooe 
~ 
N 
(163) 
fn 
Reagents: (i) NaOEt, HS(CH2)2N(CH3)2; (iii) Mg, Et20 
Scheme 62 
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The mass spectrum of (163) showed the presence of molecular ions at 428 and 426 
daltons in the relative abundance ratio 1: 1 due to the 8lBr and 7~r isotopes respective-
ly. The IH NMR spectrum showed all expected peaks in the aromatic region including 
a singlet at 2.36 ppm which was caused by N(CH3)2 and multiplets at 2.40-2.79 due 
to the two methylene groups. The benzylic methylene gave rise to a singlet at 3.70 
ppm. 
An attempt to prepare the carboxylic acid (165) by the formation of a Grignard reagent 
(164) and its reaction with carbon dioxide was unsuccessful and failed to afford the 
required compound (165) (Scheme 62). 
An alternative approach to the target acid (165) required the preparation of 1-(4-
cyanophenyl)-3-(dimethylamino)propane-l-one hydrochloride (167) as the first step. 
The treatment of 4-cyanoacetophenone (166) with paraformaldehyde (139) and 
dimethyl amine hydrochloride (140) in absolute ethanol containing concentrated 
hydrochloric acid gave the desired (167) in satisfactory yield (Scheme 63). 
NC 
(166) 
NC 
o 
II 
C-CH3 
+ (CH20)u+ 
(167) 
Scheme 63 
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(CH3)2 NH. HC! 
(140) 
The IR spectrum of (167) indicated the presence of both carbonyl and cyanide groups 
by the appearance of sharp peaks at 1688 cm-1 and 2226 cm-1 respectively. The 
IHNMR spectroscopy provided evidence of the proposed structure. A singlet at 2.86 
ppm was caused by two N(CH3)2 groups, two triplets at 3.45 ppm and 3.72 ppm were 
due to two CH2 groups and the aromatic protons gave rise to two doublets at 8.09 
ppm and 8.17 ppm. The elemental analysis agreed with the molecular formula 
C12H1SN20Cl. 
The cyclisation of 1-( 4-cyanophenyl)-3-( dimethyl amino )propan-l-one hydrochloride 
(167) and 1-(4-methylphenyl)pyridinium bromide (138) with ammonium acetate in 
methanol proceeded well and the 2-( 4-cyanophenyl)-6-( 4-tolyl)pyridine (168) was 
separated upon cooling the reaction mixture at room temperature (Scheme 64). 
(167) + (138)t---oLl_ .. ~
NC 
Reagents: (i) ammonium acetate, methanol 
Scheme 64 
The structure of the compound (168) was shown by its IH NMR spectrum which had 
a singlet at 2.42 ppm due to the methyl group, a doublet at 7.31 was caused by the 3-
and 5-protons of carbocyclic ring and a multiplet at 7.77 ppm was due to the five 
protons of carbocyclic and pyridine rings. Four aromatic protons gave rise to two 
doublets at 8.02 and 8.23 ppm. The IR spectrum of(168) showed the presence ofa 
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CN group by a signal at 2230 em-I. The elemental analysis and mass spectrum of 2-(4-
cyanophenyl)-6-(4-tolyl)pyridine (168) were in accordance with the structural and 
molecular formula. 
The 2-( 4-[bromomethyl]phenyl)-6-( 4-cyanophenyl)pyridine (169) was prepared from 
(168) by reaction with a mixture ofN-bromosuccinimide (NBS) and benzoyl peroxide 
in carbon tetrachloride at reflux (Scheme 65). The product was purified by column 
chromatography and the structure was confirmed by the IH NMR spectrum, which 
showed a singlet at 4.56 ppm caused by the bromomethyl group. The aromatic protons 
were present as expected. The mass spectrum showed the presence of molecular ions 
at 350 and 348 daltons in the relative abundance ratio 1: 1 due to the 8IBr and 79Br 
isotopes, respectively. 
(168) 1 
NC 
NC 
-I- -
Reagents: (i) NBS, CCI4; (ii) NaOEt, HS(CH2)2N(CH3hHCl 
Scheme 65 
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The reaction of 2-(4-[bromomethyl]phenyl)-6-(4-cyanophenyl)pyridine (169) with 2-
(dimethylamino )ethanethiol hydrochloride containing ethanolic sodium ethoxide 
(prepared from sodium metal and absolute ethanol) yielded the corresponding sulfide 
derivative, 2-(4-[ 4-dimethylamino-2-thiabutyl]phenyl)-6-( 4-cyanophenyl)pyridine 
(170) (Scheme 65). 
The compound (170) was characterised by its IH NMR spectrum which, in addition to 
other expected peaks, showed the presence of a singlet at 2.21 ppm due to N(CH3h 
Multiplets at 2.48-2.57 ppm were caused by two CH2 groups and the benzylic Cl\ 
gave rise to a singlet at 3.79 ppm. The accurate mass measurement on the molecular 
ion was in accord with the molecular formula. When the reaction was repeated it was 
found to be difficult to isolate the product in a pure state. At least two components 
were present in the mixture as shown by TLC. 
An attempt to obtain 2-(4-[ 4-dimethylamino-2-thiabutyl]phenyl)-6-( 4-[ methoxy-
carbonyl]phenyl)pyridine (171) by hydrolysis of the cyano group of impure 2-(4-[4-
dimethylamino-2-thiabutyl]phenyl)-6-( 4-cyanophenyl)pyridine (170) in dry methanol 
by passing dry hydrogen chloride gas, failed and starting material was obtained 
(Scheme 66). 
(171) 
Scheme 66 
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When an attempt was made to convert the less complex cyano compound, 2-(4-
cyanophenyl)-6-(4-tolyl)pyridine (168) into the corresponding ester (172) by treatment 
with acidified methanol a product was obtained which showed a broad OH absorption 
at 3210 cm-l and a carbonyl absorption at 1682 cm-l . The IH NMR spectrum showed 
a singlet at 2.35 ppm assigned to the CH3 groups, a broad singlet at 5.16 ppm due to 
OH and a doublet at 7.32 ppm due to two aromatic protons. The three protons of the 
pyridine nucleus and two protons of the carbocyclic ring gave rise to a multiplet at 7.94 
ppm and two doublets at 8.11 and 8.14 ppm were caused by four aromatic protons. 
The elemental analysis and mass spectrum data were in agreement with molecular 
formula C1JilSN02 and the compound was hence thought to be 4-(2-[6-{ 4-
tolyl}pyridyl])benzoic acid (173) (Scheme 67). 
(168) 
Hooe 
Scheme 67 
The formation of (173) probably occurred by hydrolysis of the first formed 
corresponding ester (172). The overall yield of 4-(2-[6-{ 4-tolyl}pyridyl])benzoic acid 
(173) was low. 
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In order to obtain higher yields of (173) an alternative route was tried by causing 
hydrolysis of 4-cyanoacetophenone (166) with aqueous sodium hydroxide and 
subsequent acidification to yield 4-acetylbenzoic acid (174) (Scheme 68). 
NC 
(166) 
o 
II 
C-CH3 
1 
HOOC 
(174) 
o 
II 
C-CH3 
Reagents: (i) NaOH, EtOH and then aq. HCI 
Scheme 68 
The IR spectrum showed the disappearance of the peak due to the cyano group and 
the appearance of c=o absorption at 1684 cm-1 and the IH NMR spectrum showed the 
presence of two singlets at 2.61 and 8.09 ppm due to methyl group and aromatic 
protons. An exchangeable singlet at 11.0 was caused by OH group. The compound 
(174) was used as a the starting material for the next stage of the reaction series. 
When the mixture of 4-acetylbenzoic acid, paraformaldehyde (139) and dimethylamine 
hydrochloride (140) were refluxed in ethanol, the required 4-(3-dimethylamino 
propanoyl)benzoic acid hydrochloride (175) was obtained (Scheme 69). 
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HOOC 
HOOC 
(170) 
o 
II 
C-CH3 
+ (CH20)n+ 
o 
(Ir 
(CH3hNH. HCI 
(140) 
II + _ 
r(YC-CH2CH2NH(CH3)2 CI 
~ (175) 
Scheme 69 
The IR spectrum of (175) showed the expected stretching vibration at 1650 cm-1 due 
to the C=O group and a broad absorption at 3431cm-1 due to OH group. The IH NMR 
spectrum showed the presence of a singlet at 2.86 ppm due to the N(CH3)2 group, a 
multiplet at 3.45-3.61 ppm was caused by the two CH2 groups and a singlet at 8.19 
ppm due to the four aromatic protons. The NH and OH groups gave rise to 
exchangeable broad singlets at 9.18 ppm and 11.0 ppm, respectively. 
The Krohnke cyclization of(175) and 1-(4-methylphenacyl)pyridinium bromide (138) 
in the presence of ammonium acetate in methanol gave 4-(2-[6-{ 4-
tolyl}pyridyl])benzoic acid (173) in high yield (Scheme 70). 
(175) + (138) • 
(173) 
Hooe 
Scheme 70 
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The physical data of the product were identical with the compound obtained earlier 
in this work. 
The next step was the preparation of an amide from the substituted benzoic acid. The 
acid (173) was treated with protected 2-(tert-butoxycarbonylamino )ethylamine (176) 
(prepared by the reaction of 1,2-diaminoethane with di-tert-butyldicarbonate in 
dichloromethane)63 in the presence of 1-[(3-dimethylamino)propyl]-3-ethylcarbo-
diimide hydrochloride (EDCI) and I-hydroxybenzotriazole (HOBT) in DMF to give 
the desired N-( 2-[ tert -butoxycarbonylamino ] ethyl )-4-( 2-[ 6-{ 4-tolyl } pyridyl]) 
benzamide (177) (Scheme 71). 
(173) 1 
(177) 
Scheme 71 
Compound (177) was characterised by comparison of its IR spectrum with that of 
(173) which showed the disappearance of a broad peak at 3055 cm-1 due to the OH 
group of (173) and the appearance of a peak at 3342 cm-1 due to the NH group. The 
comparison between the IH NMR spectra of (173) and (177) also showed the 
disappearance ofa peak due to the OH group in (173) but showed extra peak at 1.34 
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ppm (due to the three methyl groups of C( CH3)3), a singlet at 2.38 ppm due to the 
methyl group and a multiplet at 3.14-3.36 ppm was caused by four methylene protons. 
The two NH groups gave rise to exchangeable singlets at 6.81 ppm and 8.42 ppm. 
An attempt to brominate (177) with N-bromosuccinimide (NBS) and benzoyl peroxide 
in carbon tetrachloride failed to produce any product and only starting material was 
detected by analytical t.l.c. This was due to the insolubility of compound (177) in 
organic solvents. 
It was then decided to convert the carboxylic acid group of (173) into the 
corresponding ester. Esterification of 4-(2-[6-{4-tolyl} pyridylDbenzoic acid (173) was 
achieved by dissolving it in ethanol containing few drops of concentrated sulfuric acid 
at reflux to give ethyI4-(2-[6-{4-tolyl}pyridyIDbenzoate (178) (Scheme 72). 
(173) 1 (178) 
Reagents: (i) H2S04, EtOH 
Scheme 72 
The compound (178) showed a triplet at 1.45 ppm due to the methyl group and a 
quartet at 4.42 ppm caused by the methylene protons in the IH NMR spectrum as well 
as other expected absorptions. The IR spectrum showed the presence of a carbonyl 
group by the appearance of a sharp peak at 1686 cm-I. 
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EthyI4-(2-[6-{4-bromomethylphenyl} ]pyridyl)benzoate (179) was made by a reaction 
of compound (178) with NBS and benzoyl peroxide in carbon tetrachloride (Scheme 
73). The IHNMR spectrum of(179) showed the disappearance ofa peak at 2.42 ppm 
due to the aromatic methyl group and the appearance of a peak due to two protons 
as a singlet at 4.57 ppm due to the bromomethyl group. The mass spectrum and 
elemental analysis data indicated the molecular formula to be C12H18N02Br. 
(179) 
Scheme 73 
110 
The nucleophilic displacement reaction of the alkyl bromide group in (179) was 
carried out with 2-( dimethylamino )ethanethiol hydrochloride in the presence of sodium 
ethoxide in ethanol. The crude product was purified by column chromatography to give 
colourless crystals of ethyI4-(2-[6-{4-(2-[dimethylamino]ethyl)thiomethyl}pheny1]-
pyridyl)benzoate (180) (Scheme 73). 
The structure of compound (180) was shown by its IH NMR spectrum which had a 
triplet at 1.43 ppm due to the ester CH3 group and a singlet at 2.24 ppm due to the of 
a N(CH3)2 group. The multiplet at 2.49-2.58 ppm was caused by the two CH2 groups, 
a singlet at 3.80 ppm was assigned to the benzylic CH2 and a quartet was observed at 
4.4 ppm due to the OCH2 group in addition to other expected resonances for the 
protons of the carbocycles and pyridine protons. The accurate mass data for the 
molecular ion were in accordance with the molecular formula. 
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2.3.4 Aminolysis of ethyI4-(2-[6-{4-(2-[dimethylamino]ethyl)thiomethyl} 
phenyl]pyridyl)benzoate (180). 
The nucleophilic displacement reaction of ethyl 4-(2-[ 6-{4-(2-[ dimethyl amino ] 
ethyl)thiomethyl} phenyl]pyridyl)benzoate (180) separately with ethylene diamine, 1,4-
diaminobutane and 1,6-diaminohexane in the presence of anhydrous potassium 
carbonate produces N-(2-aminoethyl)- (181), N-( 4-aminobutyl)- (182) and N-( 6-
aminohexyl)-4-(2-[6-{4-(2-[dimethylamino]ethyl)thiomethyl}phenyl]pyridyl) 
benzamide (183) respectively (Scheme 74). These highly polar compounds were 
purified by column chromatography. 
J 
(181)=n=2 
(182) = n = 4 
(183) = n = 6 
Scheme 74 
112 
The IR spectrum of (181) exhibits a carbonyl stretching absorption at 1718 cm-I due 
to the amide group and NH and NH2 stretching vibration at 3340, 3320 cm-! and 3212 
em-I. Comparison of the IHNMR spectra of(180) and (181) showed the expected the 
disappearance of a triplet and a quartet at 1.43 and 4.42 ppm due to the ethyl group 
in (180) and the appearance of multiplets at 2.71-3.17 ppm due to two vicinal 
methylene groups adjacent to NH and NH2 groups. The NH and NH2 groups gave rise 
to a triplet and singlet at 3.29 ppm and 8.55 ppm, respectively. These data and accurate 
mass measurement on the molecular ion are in accord with the assigned structural 
formula. 
Compounds (182) and (183) were also characterised by their IR spectra, IH NMR 
spectra and by accurate mass measurement on their molecular ions. 
2.3.5 Synthesis of the acetyl derivatives of (181), (182) and (183). 
When the amines (181), (182) and (183) were separately reacted with glacial acetic 
acid and acetic anhydride the products were N-(2-[ acetamido ]ethyl)-4-(2-[ 6-{4-(2-
[dimethylamino]ethyl)thiomethyl}phenyl]pyridyl)benzamide (184) and the correspond-
ing N-(4-[acetamido]butyl)- and N-(6-[acetamido]hexyl)- amides (185) and (186) 
respectively, in quantitative yield (Scheme 75). 
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(184) =n = 2 
(185)=n=4 
(186) = n = 6 
CNH(CH2) NHCOCH3 \\ n 
o 
Reagents: (i) glacial acetic acid, acetic anhydride 
Scheme 75 
Compound (184) was characterised by its IR spectrum which showed a peak at 3282 
cm-
1 due to the NH stretching vibration. The carbonyl stretching frequencies were 
observed at 1675 cm-1 and 1628 cm-1 and assigned to the amide groups. 
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All the expected peaks associated with the carbocyclic system and the pyridine nucleus 
were present in the IHNMR spectrum of(184). There was also a singlet at 1.82 ppm 
due to the methyl group and a singlet at 2.10 ppm caused by the N(CH3)2 group. The 
resonance at 2.48-2.50 ppm was due to the two methylene groups, multiplets at 3.29-
3.39 were caused by two methylene groups adjacent to nitrogen and a singlet at 3.82 
ppm was due to the benzylic methylene group. The NH and NH2 groups gave rise to 
two triplets at 8.10 ppm and 8.71 ppm. Mass spectral data and accurate mass 
measurement on the molecular ion were in agreement with the molecular formula 
C27H32N402S. 
Compounds (185) and (186) were also characterised by their IR, IH NMR spectra and 
accurate mass measurements. 
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EXPERIMENTAL 
4-Methylacetophenone N,N-dimethylhydrazone (133). 
A mixture of 4-methylacetophenone (132) (13.3 g, 100 mmol), anhydrous N,N-
dimethylhydrazine (18.0 g, 300 mmol), absolute ethanol (20 cm3) and glacial acetic 
acid (1-2 cm3) was heated at reflux for 24 h. During this period the colourless solution 
became bright yellow. The volatile reactants and solvent were removed under reduced 
pressure and the residual oil fractionally distilled through a 10 cm Vigreux column to 
give the hydrazone (13.9 g, 80%) bp 64-65 °C (0.5 mm Hg) (lit.,lOS bp 55-56°C (0.5 
mm Hg)); IR (KBr) v maxi cm-1 2952,1604,1510, 1486, 1458, 1358,816; IHNMR 
(360 MHz, CCI4) 0 2.35 (6H, s, 2 X CH3) 2.58 (6H, s, 2 X CH3), 7.61 (2H, d, J = 6.3 
Hz, Ar-H), 7.64 (2H, d, J = 6.3 Hz, Ar-H); MS, m/z (ri) 177 (26%), 176 (M+, 100), 
161 (M- CH3, 30), 146 (M- 2 X CH3, 32), 132 (14). 
4-Methylacetophenone N,N,N-trimethylhydrazonium iodide (134). 
4-Methylacetophenone N,N-dimethylhydrazone (133) (5.0 g, 28 mmol) and excess 
methyl iodide in anhydrous methanol (25 cm3) were refluxed under nitrogen for 6 h. 
After cooling the solution, cold anhydrous ether was added, the precipitate collected 
and crystallised from a mixture of absolute ethanol and ethyl acetate to give the 
methiodide (134) (8.08 g, 90%), mp 160-162 °C (lit./oS mp. 159-160 °C ); IR (KBr) 
v ~cm-l 1596, 1470, 1404, 1364, 1288, 1238, 942, 813; IHNMR (360 MHz, D20) 
o 2.41 (3H, s, Ar-CH3), 2.80 (3H, s, C-CH3), 3.65 (9H, s, N(CH3)3), 7.35 (2H, d, J 
= 6.3 Hz, Ar-H), 7.73 (2H, d, J= 6.3 Hz, Ar-H). 
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4-Methylacetophenone N,N,N-trimethylhydrazonium tetrafluoroborate (135). 
A hot aqueous solution of sodium fluoroborate (2.0 g) was slowly added to a refluxing 
solution of 4-methylacetophenone N,N p-trimethylhydrazonium iodide (134) (2.0 g, 
6.2 mmol) dissolved in the minimum volume of water to ensure complete dissolution. 
The mixture was then cooled to room temperature, the crystals were filtered off and 
dried in vacuo, (1.64 g, 96%), mp 160-162 °C (lit.,105 mp 159-160 °C)~ IR (KBr) 
v ~cm-11604, 1562, 1478, 1370, 1288, 1060, 1030, 826, 696~ IHNMR. (360 MHz, 
DMSO-d6) 0 2.41 (3H, s, Ar-CH3), 2.81 (3H, s, C-CH3), 3.65 (9H, s, N(CH3)3), 7.35 
(2H, d, J = 6.3 Hz, Ar-H), 7.76 (2H, d, J = 6.3 Hz, Ar-H). 
2,6-Bis( 4-methylphenyl)pyridine (136). 
4-Methylacetophenone N,N p-trimethylhydrazonium tetrafluoroborate (1.0 g, 3.6 
mmol) in cumene (2.0 g) was slowly heated to about 150°C. The exothermicity of the 
reaction then caused the solution to reflux. The mixture was refluxed for a further 
1 h. After cooling the liquid was decanted and concentrated in vacuo. The crude 
product was purified by column chromatography using a mixture of petroleum spirit 
(bp 40-60 °C) and ethyl acetate (98:2) to give the title compound (0.16 g, 17%), mp 
160-162 °c (lit./o6 mp. 165-166 °C)~ IR (KBr) v rnax/cm-1 1922, 1896, 1588, 1510, 
1304,1148,1114,1042,1014,990,950,860,836,794, 744, 722,666~ IHNMR.(360 
MHz, CDCI3) 0 2.41 (6H, s, 2 x CH 3 ), 7.41 (4H, m, 2 x 3- and 2 x 5-tolyl-H), 7.62 
(2H, m, 3- and 5-py-H), 7.83 (IH, t, 4-py-H), 8.03 (4H, m, 2 x 2- and 2 x 6-tolyl-H)~ 
MS, mlz (r.i.) 260 (59%), 259 (M+' 100), 258 (M - H, 26), 257 (6), 244 (M- CH3, 6), 
196 (21),181 (6),119 (8),117 (41),109 (32),105 (10),104 (8),98 (12), 76 (4). 
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GENERAL METHOD FOR PREPARATION OF MANNICH BASES (141), 
(167) AND (175). 
A mixture of dry dimethylamine hydrochloride (140) (13.2 g, 163 mmol), 
paraformaldehyde (5.0 g, 166 mmol), the appropirate acetophenone ( 125 mmol) and 
absolute ethanol (20 cm3) to which concentrated hydrochloric acid (1-2 drops) has 
been added was refluxed for 2 h. The reaction mixture usually became homogenous but 
any remaining solid was filtered off Acetone (100 cm3) was added to the warm liquid 
and the product left in a refrigerator overnight. The crystals were filtered and washed 
with acetone. 
1-( 4-Metbylpbenyl)-l-( dimethylamino )propan-l-one hydrochloride 
(141). 
The product (141) from 4-methylacetophenone (16.75 g, 0.125 mol) was crystallised 
from a mixture of chloroform and petroleum spirit (bp 40-60 °C) to give colourless 
crystals of 1-(4-methylphenyl)-3-(dimethylamino)propan-l-one hydrochloride (141) 
(20.0 g, 70%), mp 161-162 °C; IR (KBr) v nw!cm-1 2438, 1674 (C=O),1602, 1338, 
1306, 1226, 1180, 1076, 1008, 962, 850,786, 722; IHNMR (360 MHz, CDCI3) 0 
2.43 (6H, s, 2 x Ar-CH3), 2.87 (6H, s, 2 x C~), 3.54 (2H, t, J= 6.5 Hz, CHJ, 3.73 
(2H, t, J = 6.5 Hz, CH;J, 7.26 (2H, d, J = 7.8 Hz, Ar-H), 7.87 (2H, d, J =7.8 Hz, Ar-
H), 13.01 (1H, broad signal, exchangable with D20, NH) MS, m/z (r.i.) 191 (M+ for 
C12H17N, 19%), 146 (M -NH (CH3)2), 75), 131 (M - NH(CH3)2 -CH3, 45), 120 (58), 
119 (89), 118 (39), 117 (30), 115 (24), 91 (89), 89 (52), 72 (49), 58 (100) (Found: 
C, 63.21; H, 7.99; N, 6.13. C12H 18CINO requires: C, 63.29; H, 7.91; N, 6.15%). 
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1-(4-Cyanophenyl)-3-(dimethylamino)propan-l-one hydrochloride (167). 
4-Cyanoacetophenone (166) (18.1 g, 125 mmol) yielded a product crystallised from 
a mixture of chloroform and petroleum spirit (bp 40-60 °C) to give yellow 1-(1-
cyanophenyl)-3-(dimethylamino)propan-1-one hydrochloride (167) (19.26 g, 76%), 
mp 159-160 °C; IR (KBr) v ~cm-l 2556, 2370, 2226 (CN), 1688 (C=O), 1480, 
1382, 1332, 1220, 962, 858, 786, 730, 578; IHNMR (360 MHz, DMSO-d6) 0 2.86 
(6H, s, 2 x CH3), 3.45 (2H, t, J= 6.5 Hz, CH2), 3.72 (2H, t, J= 6.5 Hz, CH2), 8.09 
(2H, d, J = 8.1 Hz, Ar-H), 8.17 (2H, d, J = 8.1 Hz, Ar-H) , 10.5 (1H, broad signal, 
exchangable with D20, NH); MS, m/z (r.i.) 202 (M+for C12HI4N20, 19%), 185 (4), 
159 (4), 158 (24), 157 (M -NH(CH3)3, 94), 156 (11), 149 (12), 131 (45), 130 (100), 
129 (43), 102 (26) (Found: C, 60.43; H, 6.28; N, 11.58. C12HI5CI N20 requires: C, 
60.37; H, 6.28; N, 11.74%). 
4-(3-Dimethylaminopropanoyl)benzoic acid hydrochloride (175). 
4-Acetylbenzoic acid (170) (20.5 g, 125 mmol) afforded the pale yellow Mannich 
base hydrochloride (175) (20.2 g, 62.%), mp 190-191 °C; IR (KBr) v max/cm-l 3431 
(0R),2944, 1665 (C=O), 1540, 1412, 1323, 1289, 1215, 962, 858, 786, 730, 578; 
IHNMR (360 MHz, DMSO-d6) 0 2.86 (6H, s, 2 x CH3), 3.45-3.61 (4H, m, 2 x CH2), 
8.19 (4H, s, Ar-H), 9.18 (IH, broad signal, exchangeable with D20, NH) , 11.0 (IH, 
broad signal, exchangable with D20, OH); MS, m/z (r.i.) 204 (M+for (C12 &sNQ) 
-OH, 12%), 177 (M+ for (C12HI5N03)-C02, 23), 176 (96), 159 (16), 149 (100), 148 
(12),45 (46), 44 (75) (Found: C, 55.50; H, 6.26; N, 5.53. C12HI6Cl N03 requires: C, 
55.90; H, 6.21; N, 5.43%). 
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GENERAL METHOD FOR PREPARATION OF PYRIDINIUM BROMIDE 
(138), (143) AND (160). 
The appropriate phenacyl bromide (4.7 mmol) was added to dry pyridine (10 cm3) and 
stirred for 30 min at room temperature. The solid was filtered off and crystallised from 
mixture of methanol and diethyl ether. 
1-(4-Methylphenacyl)pyridinium bromide (138). 
4-Methylphenacyl bromide (137) (1.0 g) yielded the title compound (1.20 g, 87 %), 
mp 212-213 DC, IR (KBr) v max/cm-1 2286, 1688 (CO), 1634, 1592, 1342, 1218, 
1152, 994, 754, 722, 682; IHNMR (360 MHz, DMSO-d6) () 2.45 (3H, s, Ar-CH3), 
6.45 (2H, s, CH~, 7.41 (2H, d, J = 7.4 Hz, 3- and 5- Ar-H), 7.92 (2H, d, J = 7.4 Hz, 
2- and 6-Ar-H), 8.27 (2H, t, 3- and 5-py-H), 8.73 (IH, m, 4-py-H), 9.01 (2H, m, 2-
and 6-py-H) (Found: C, 54.52; H, 5.02; N, 4.42. C14H14Br NO requires: C, 54.98; H, 
4.81; N, 4.81 %). 
Pbenylacylpyridinium bromide (143). 
Phenacyl bromide (0.93 g) gave colourless phenylacylpyridinium bromide (143) (1.21 
g, 93%), mp. 201-202 °C, IR (KBr) v max/cm-1 2272, 1688 (CO), 1618, 1576, 1342, 
1218,1145,1154,1045,1023,1018,1005,996,886,845, 823,756,745,732,722, 
682,645,606; IHNMR (360 MHz, DMSO-d6) () 6.54 (2H, s, CH2), 7.67 (2H, m, 3-
and 5-Ar-H), 7.80 (IH, m, 4-Py-H), 8.07 (2H, m, 3- and 5-Ar-H), 8.29 (2H, m, 2- and 
6-Ar-H), 8.70 (IH, m, 4-py-H), 9.05 (2H, m, 2- and 6-py-H) (Found: C, 88.10; H, 
6.08; N, 5.65. C13H12Br NO requires: C, 88.16; H, 6.12; N, 5.71 %). 
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1-(4-Bromophenacyl)pyridinium bromide (160). 
4-Bromophenacyl bromide (159) (1.3 g) yielded a solid which was crystallised to give 
colourless 4-bromophenacylpyridinium bromide (160) (1.45 g, 87%), mp 251-251.5 
°c, IR(KBr) v nwlcm-1 2722,2369,1868,1718,1694 (CO), 1635, 1558, 1506, 1490, 
1308, 1180, 1070, 988, 816, 722, 682, 599; IHNMR (360 MHz, DMSO-d6) {) 6.53 
(2H, s, CH;J, 7.90 (2H, d, J = 7.2 Hz, 3- and 5-Ar-2H), 8.00 (2H, m, 3- and 5-py-H), 
8.32 (2H, d, J = 7.2 Hz, 2- and 6-Ar-H), 8.74 (IH, m, 4-py-H), 9.02 (2H, d ,J = 7.2 
Hz, 2- and 6-py-H) (Found: C, 43.89; H, 3.02; N, 3.54. C13H11Br2 NO requires: C, 
43.94; H, 3.09; N, 3.94 %). 
GENERAL METHOD FOR PREPARATION OF THE 2,6-DIARYL 
PYRIDINES (136), (144), (161), (168) AND (173). 
General method using methanol as solvent 
A mixture of the appropriate pyridinium salt (6 mmol), the Mannich base ( 6 mmol) 
and ammonium acetate (4 g) in methanol (20 cm3) was refluxed for 4 h. The reaction 
mixture was cooled and maintained at 0 °c for 24 h. The precipitate was filtered off 
and purified. 
2,6-Bis( 4-methylphenyl)pyridine (136). 
The pyridinium salt (138) (1.74g), 1-(4-methylphenyl)-3-(dimethylamino)propan-l-one 
hydrochloride (141) (1.36 g) and ammonium acetate (4 g) afforded a product which 
was purified by column chromatography (chloroform:petroleum spirit, 50:50) and 
crystallised from a mixture of chloroform and petroleum spirit to give the 2,6-bis( 4-
methylphenyl)pyridine (1.12 g, 72 %), mp 160-162 °c (lit.,l06 mp 165-166° C); IR 
(KBr) v ma/cm-1 1922, 1896, 1588, 1510, 1304, 1148, 1114, 1042, 1014,990,950, 
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860, 836, 794, 744, 722, 666; IHNMR (360 MHz, CDCI3) {) 2.41 (6H, s, 2 x C~), 
7.41 (4H, m, 2 x 3- and 5-tolyl-H), 7.68 (2H, m, 3- and 5-py-H), 7.81 (1H, t, for 4-py-
H), 8.03 (4H, m, 2 x 2- and 2 x 6-tolyl-H); MS, m/z (r.i.) 260 (34%), 259 (M+, 100)~ 
258 (M- H, 26), 257 (6), 244 (M- CH3, 6), 196 (21),181 (6), 119 (8). 
2-Phenyl-6-(4-tolyl)pyridine (144). 
A mixture of the pyridinium salt (143) (1.66 g), 1-(4-methylphenyl)-3-(dimethyl 
amino)propan-l-one hydrochloride (141) (1.36 g) and ammonium acetate (4 g) in 
methanol (20 cm3) gave a product which was purified by column chromatography 
(chloroform: petroleum spirit, 50:50) to give the 2-phenyl-6-(4-tolyl)pyridine (144) 
(0.98 g, 67 %), mp 90-93 °C; IR (KBr) v ma.icm-1 2360, 1566, 1306, 1156, 996,804, 
760,722,692; IHNMR (360 MHz, CDCI3) {) 2.41 (3H, s, C~), 7.29 (2H, d, J= 8 
Hz, 3- and 5-tolyl-H), 7.42 (1H, m, 4- Ph-H), 7.49 (2H, m, 3- and 5-Ph -H), 7.66 (2H, 
d, J = 9 Hz, 3- and 5-py-H), 7.79 (1H, t, 4-py-H), 8.05 (2H, d, J = 8 Hz, 2- and 6-
tolyl-H), 8.15 (2H, d, J = 6Hz, 3Hz, 2- and 6- Ph-H); MS, m/z (r.i.) 246 (M+ + 1, 
69%),245 (M+, 100),244 (M- H, 95),243 (36),242 (30), 241(22),230 (M- CH3, 35), 
229 (20), 228 (25),215 (11),202 (20), 167 (10) (Found: C, 88.10; H, 6.08; N, 5.45. 
C18H1SN requires: C, 88.16; H, 6.12; N, 5.71 %). 
2-(4-Bromophenyl)-6-(4-tolyl)pyridine (161). 
A mixture of the pyridinium salt (160) (2.13 g), 1-(4-methylphenyl)-3-(dimethyl 
amino)propan-1-one hydrochloride (1.36 g) and ammonium acetate (4 g) yielded a 
product which was purified by column chromatography (diethyl ether : petroleum 
spirit, 10: 90) and crystallised from a mixture of chloroform and petroleum spirit to give 
the colourless 2-(4-bromophenyl)-6-(4-tolyl)pyridine, (1.0 g, 57 %), mp 194-195 °C; 
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IR (KBr) v malcm-1 2724, 1854, 1734, 1654, 1632, 1592, 1543, 1523, 1443, 1423, 
1414,1376,1323,1303,1274,1265,1234, 1114, 1014,996,986,842,830,796,758, 
722,684, 554; IHNMR (360 MHz, CDCI3) l> 2.42 (3H, s, CH3), 7.31 (2H, d, J = 7.8 
Hz, 3- and 5-tolyl-H), 7.61 (5H, m, 3- and 5-Ar, 3-, 4- and 5-py-H), 8.02 (2H, d, J = 
8.0 Hz, 2- and 6-tolyl-H), 8.08 (2H, d, J = 8.0 Hz, 2- and 6-Ar-H); MS, mJz (r.i.) 325 
(M+for 81 Br, 44),324 (7), 323 (M+ for 79 Br, 75), 322 (100),321(43),308(5%),244 
(M- Br, 31), 243 (15),242 (15), 241(91), 230 (7), 149 (10), 122 (11),84 (41) 
(Found: C, 66.56; H, 4.12; N, 4.21. C18H14Br N requires: C, 66.87; H, 4.33; N, 
4.33%). 
2-( 4-Cyanophenyl)-6-( 4-tolyl)pyridine (168). 
The pyridinium salt (138) (1.74 g), 1-(4-cyanophenyl)-3-(dimethylamino)propan-l-one 
hydrochloride (167) (1.43 g) and ammonium acetate (4 g) gave a product which was 
purified by column chromatography (chloroform:petroleum spirit, 90: 10) and then 
crystallised from a mixture of chloroform and petroleum spirit to give the colourless 
2-(4-cyanophenyl)-6-(4-tolyl)pyridine (168) (1.50 g, 93%), mp 161-162 °C; IR (KBr) 
v malcm-1 2360,2230 (CN), 1942, 1654, 1633, 1588, 1558, 1540, 1432, 1407,1308, 
1237, 1213, 1188, 1165, 1114, 1016, 988, 866, 800, 744, 758, 722, 668, 654, 608, 
598, 554.505; IHNMR (360 MHz, CDCI3) l> 2.42 (3H, s, CH3), 7.31 (2H, d, J = 7.8 
Hz, 3- and 5-tolyl-H), 7.77 (5H, m, 3- and 5-Ar, 3-, 4- and 5-py-H), 8.02 (2H, d, J = 
7.8 Hz, 2- and 6-tolyl-H), 8.23 (2H, d, J = 7.8 Hz, 2- and 6-Ar-H); MS, mJz (r.i.) 271 
(25%),270 (M+, 100),268 (8), 267 (7),266 (6), 208 (9), 156 (54), 149 (35), 135 (7), 
134 (10), 133 (6), 128 (9), 126 (8), 121 (7), 120 (9), 113 (45), 105 (7), 99 (10), 97 
(13), 86 (10) (Found: C, 84.31; H, 5.10; N, 10.28. Cl~14N2 requires: C, 84.44; H, 
5.18; N, 10.37%). 
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4-(2-(6-{4-Tolyl}pyridyl])benzoic acid (173). 
The pyridinium salt (138) (1.74 g), 4-(3-dimethylaminopropanoyl)benzoic acid 
hydrochloride (175) (1.54 g) and ammonium acetate (4 g) gave a product which was 
purified by crystallisation from methanol (decolourising charcoal) to give the -1-(2-[6-
{4-tolylJpyridylJ)benzoic acid (173) (0.90 g, 52 %), mp 287-287.5 °C~ IR (KBr) 
v malcm-1 3055 (OH), 1579, 1560, 1406, 1343, 1234, 1209, 1116, 1098, 1010, 996, 
987,866,800,744,758,722,667,654,556,543, 523,511, 510,506,504~ l~ 
(360 MHz, DMSO-d6) 0 2.35 (3H, s, CH3), 5.16 (1H, broad signal, exchangable with 
D20, OH), 7.32 (2H, d, J = 7.8 Hz, 3- and 5-tolyl-H), 7.99 (5H, m, 3- and 5-Ar-H, 3-, 
4-and 5-py-H), 8.11 (2H, d, J= 7.8 Hz, 2- and 6-tolyl-H), 8.14 (2H, d, J= 7.8 Hz, 2-
and 6-Ar-H); MS, mlz (r.i.) 290 (M+ 1, 17%),289 (M+, 100),288 (24), 259 (6), 245 
(6),244 (M -COjI, 23),243 (12),242 (11), 228 (11), 223 (6),215 (6), 196 (9), 186 
(54), 149 (8), 130 (32), 96 (23), 64 (17) (Found: C, 78.64; H, 5.31; N, 4.52. 
Cl~15N02 requires: C, 78.89; H, 5.19; N, 4.84%). 
2-Phenyl-6-( 4-tolyl)pyridine (144) 
Second method using glacial acetic acid as the solvent. 
A mixture of the pyridinium salt (143) (1.66 g, 6 mmol), 1-(4-methylphenyl)-3-
(dimethylamino)propan-l-one hydrochloride (141) (1.36 g, 6 mmol) and ammonium 
acetate (4 g) in glacial acetic acid was heated at 80 °C for 2 h. The mixture was 
treated with water (20 cm3) , the precipitate was filtered off and purified by column 
chromatography (chloroform: petroleum spirit, 50: 50) the product was crystallised 
from a mixture of chloroform and petroleum spirit to give the colourless 2-phenyl-6-
(4-tolyl)pyridine, (0.210 g, 35 %), having physical data identical to that reported on 
(p. 122). 
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Ethyl 4-(2-[6-{4-tolyl}pyridyl])benzoate (178). 
A mixture of 4-(2-[6-{4-tolyl}pyridyl])benzoic acid (173) (20.0 g, 70 mmol), absolute 
ethanol (25 cm3) and concentrated sulfuric acid ( 10 cm') was refluxed for 1 h. The 
reaction mixture was allowed to reach room temperature and then extracted with 
dichloromethane. The extract was washed with water and then with sodium 
bicarbonate solution (5%), dried, filtered, concentrated in vacuo and the solid purified 
by column chromatography (ethyl acetate: petroleum spirit, 50: 50) to give ethyl 4-(2-
[6-{4-tolyl)pyridyIJ)benzoate (178) (16.70 g, 76 %), mp 113-114 °C; IR (KBr) 
v malcm-1 1686 (CO), 1638, 1588, 1534, 1448, 1366, 1328, 1282, 1252, 1166, 1089, 
1065, 970, 996, 860, 770, 630, 545, 534, 520, 518; IHNMR (360 MHz, CDCI3) {) 1.45 
(3H, t, CH3), 2.43 (3H, s, Ar-CH3) 4.42 (2H, q, CH2), 7.33 (2H, d, J = 7.9 Hz, 3- and 
5-tolyl-H), 7.79 (2H, d, J = 7.8 Hz, 3- and 5-py-H), 7.81 (IH, t, 4-py-H), 8.04 (2H, 
d, J = 7.9 Hz, 3- and 5-Ar-H), 8.15-8.21 (4H, m, 2 x 2- and 6-Ar and tolyl-H); MS, 
mlz (r.i.) 318 (M+ 1, 82%), 317 (M+' 96), 316 (31), 290 (20), 289 (M- C2H4, 76), 288 
(20),274 (12), 273 (76),272 (100), 264 (18), 254 (45), 245 (43),244 (M- C02C2Hs, 
92),242 (29),229 (16), 187 (12), 156 (12), 149 (18), 132 (9). 123 (23), 109 (10), 65 
(14), 58 (18), 57 (13) (Found: C, 79.29; H, 5.95; N, 4.40. C21H19N02 requires: C, 
79.49; H, 5.99; N, 4.41%). 
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GENERAL METHOD FOR THE MONO-BROMINATION OF METHYL 
SUBSTITUTED 2,6-DIARYLPYRIDINES. 
A mixture of2,6-diarylpyridine (2.5 mmol), N-bromosuccinimide (0.45 g, 2.5 mmol), 
benzoyl peroxide (15 mg) and carbon tetrachloride (15 cm3) was refluxed, the reaction 
mixture was cooled and the solid filtered off. The filtrate was evaporated under 
reduced pressure and the residue purified. 
2-([4-Bromomethyl]phenyl)-6-phenylpyridine (145). 
After refluxing the mixture of2-phenyl-6-p-tolylpyridine (144) (0.60 g), NBS, benzoyl 
peroxide and carbon tetrachloride for 10 h, yielded 2-([4-bromomethyljphenyl)-6-
phenylpyridine (145) which was purified by column chromatography (petroleum spirit 
and diethyl ether, 90:10) (0.48 g, 60%), mp 91-92 °C; IR (KBr) v mal/Cm-l 1596, 1570, 
1444,1423,1314,1226,1156,1072,1016,986,844, 790, 762,696; 1~(360 
MHz, CDCI3) 0 4.56 (2H, s, CH2Br), 7.50 (5H, m, 3-,4- and 5-Ph, 3- and 5-tolyl-H), 
7.68 (2H, m, 3- and 5-py-H), 7.80 (1H, t, 4-py-H), 8.12 (4H, d, J = 4 Hz, 2- and 6-Ph, 
2- and 6-tolyl-H); MS, rn/z (r.i) 326 (5%), 325 (M+ for 8lBr, 29), 324 (7), 323 (M+ for 
7~r, 29), 259 (12), 246 (21), 245 (79),244 (M- Br, 100),243 (31), 242 (36),241(27), 
230 (7),215 (10), 122 (11), 84 (41) (Found: C, 66.56; H, 4.21; N, 4.08. Cl8H14Br N 
requires: C, 66.87; H, 4.33; N, 4.33%). 
2-(4-[Bromomethyl] phenyl)-6-( 4-tolyl)pyridine (154). 
A mixture of2,6-bis(4-methylphenyl)pyridine (136) (0.647 g), N-bromosuccinimide 
, benzoyl peroxide in carbon tetrachloride was refluxed for 18 h to afford a crude 
product which was purified by column chromatography (petroleum spirit and diethyl 
ether, 90: 10) to give colourless 2-(4-[bromomethyljphenyl)-6-(4-tolyl)pyridine (154) 
(0.180 g, 28%), mp 60-61 °C; IR (KBr) v max/cml 1734,1588,1510,1432,1308, 
1226, 1204, 1114, 1014, 966, 864, 769, 744, 668 , 602; lHNMR (360 MHz, CDCI3) 
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& 2.42 (3H, s, CH3), 4.55 (2H, s, CH~r), 7.31 (2H, d, J = 8 Hz, 3- and 5-tolyl), 7.52 
(2H, d, J = 8 Hz, 3- and 5-Ar-H), 7.67 (2H, m, 3- and 5-py-H), 7.83 (1H, t, 4-py-H), 
8.05 (2H, d, J = 8.2 Hz, 2- and 6-tolyl-H), 8.13 (2H, d, J = 8.2 Hz, 2- and 6-Ar-H); 
MS, m/z (r.i.) 339 (M+ for 81Br, 31 %), 337 (M+ for 7~r, 32), 293 (12),260 (9), 259 
(53), 258 (100), 257 (12), 168 (9), 145 (12), 134 (6), 130 (9), 129 (11), 109 (7), 84 
(19), 82 (28) (Found: C, 67.32; H, 4.64; N, 4.10 .C1Ji16BrN requires: C, 67.65; H, 
4.74; N, 4.15 %). 
2,6-Bis( 4-[bromomethyl] phenylpyridine (155). 
The mixture containing 2,6-bis(4-methylphenyl)pyridine (136) (0.647 g), N-
bromosuccinimide, benzoyl peroxide and carbon tetrachloride was refluxed for 18 h 
to afford colourless 2,6-bis(4-[bromomethyl]phenylpyridine (0.280 g, 35%), mp 152-
153°C (lit.,92 mp. 150-153 °C); IR (KBr) v max/cml 1588, 1568, 1508, 1444, 1432, 
1353, 1323, 1314, 1270, 1228, 1202, 1143, 1121, 1104, 1014, 1010, 990, 852, 798, 
730, 672, 600; IHNMR (360 MHz, CDCI3) & 4.55 (4H, s, 2 x CH2Br), 7.49 (4H, m, 
3- and 5-Ar-H), 7.66 (2H, m, 3- and 5-py-H), 7.81 (lH, t, 4-py-H), 8.10 (4H, m, 2-
and 6-Ar-H); MS, m/z (r.i.) 419 (M+for 81Br, 19%),417 (M+ for 81Br and 79Br, 34), 
415 (M+for 7~r, 18),338 (M- 81Br, 100),336 (M- 79Br, 90), 292 (26), 272 (21), 259 
(20),258 (49), 257 (44), 124 (8), 113 (21), 98 (6), 95 (5), 85 (37), 54 (7). 
2-(4-[Bromomethyl] phenyl)-6-( 4-bromophenyl)pyridine (162). 
A mixture containing 2-(4-bromophenyl)-6-(4-tolyl)pyridine (161) (0.807 g), N-
bromosuccinimide , benzoyl peroxide and carbon tetrachloride was refluxed for 4 h. 
to afford the crude product which was purified by column chromatography (petroleum 
spirit and diethyl ether, 90: 10) to give the title compound (162) (0.50 g, 50%), mp 
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177-178 DC; IR (KBr) v max/cm-1 1718,1560,1510,1480,1443,1382,1362,1220, 
1204, 1123, 1098,962,858, 769, 744, 668 ,602; IHNMR (360 MHz, CDCI
3
) {:, 4.55 
(2H, s, CH2Br), 7.61 (2H, d, J = 8 Hz, 3- and 5-Ar-H), 7.62 (4H, m, 2 x 3- and 5-Ar-
and py-H), 7.81 (1H, t, 4-py-H), 8.02 (2H, d, J = 8 Hz, 2- and 6-Ar-H), 8.08 (2H, d, 
J = 8 Hz, 2- and 6-Ar-H) ; MS, m/z (r.i.) 405 (M+ for 81Br, 5%),403 (M+ for 81Br and 
7~r, 11),401 (M+ for 79Br, 5), 359 (23), 356 (16), 343 (18), 342 (35), 341 (60), 338 
(34),325 (M- 79Br, 95), 323 (M- 81Br, 100),322 (92),308 (4), 296 (7), 264 (19), 261 
(33),244 (38), 242 (33), 123 (9), 115 (21), 98 (6), 88 (12), 67 (6), 54 (6) (Found: C, 
53.59; H, 3.61; N, 3.42. C18H13Br2N requires: C, 53.86; H, 3.24; N, 3.49%). 
2-(4-[Bromometbyl] pbenyl)-6-( 4-cyanopbenyl)pyridine (169). 
Application of the general method to 2-( 4-cyanophenyl)-6-( 4-tolylpyridine) (168) 
(0.675 g) yielded a product which was purified by column chromatography (petroleum 
spirit and diethyl ether, 70: 30) to give colourless 2-([ 4-bromomethylJphenyl)-6-(I-
cyanophenyl)pyridine (169) (0.49 g, 56%), mp 157-158 DC; IR (KBr) v max/cm-1 2226 
(CN), 1696, 1288, 1228, 1114, 1014, 936, 866, 843, 798, 726, 669, 645, 643, 632, 
608, 591; IHNMR (360 MHz, CDC13) {:, 4.56 (2H, s, CHj3r), 7.39 ( 2H, d, J = 7.4 Hz, 
3- and 5-Ar -H), 7.79 (5H, m, 3- and 5-Ar- and 3-,4-,5- py-H), 8.10 (2H, d, J = 7.4 
Hz, 2- and 6-Ar-H), 8.21 (2H, d, J = 7.4 Hz, 2- and 6-Ar-H); MS, m1z (r.i.) 350 (M+ 
for 81Br, 7%), 348 (M+ for79 Br, 7), 271 (M- 79 Br, 16), 270 (81), 269 (M- 81 Br, 100), 
268 (10), 267 (12), 266 (9), 167 (5), 158 (9), 154 (12), 149 (21), 144 (9), 134 (7), 129 
(5), 127 (5), 113 (7) (Found: C, 65.29; H, 4.01; N, 7.99. C1~13Br N2 requires: C, 
65.51; H, 3.73; N, 8.04 %). 
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Ethyl 4-(2-[6-{4-bromomethylphenyl}]pyridyl)benzoate (179). 
A mixture of ethyl 4-(2-[6-{4-tolyl}pyridyIDbenzoate (178) (0.79 g), N-bromo 
succinimide, benzoyl peroxide in carbon tetrachloride refluxed for 1.5 h afforded 
colourless ethyI4-(2-[6-{4-bromomethylphenyIJ}pyridyl)benzoate (179) which was 
purified by column chromatography (petroleum spirit and diethyl ether, 80:20) ( 0.49 
g, 50%), mp 104-104.5 °C; IR (KBr) v mdcm-1 2934, 1716 (CO), 1698), 1608, 1598, 
1560, 1450, 1388, 1368, 1312, 1280, 1226, 1180, 1110, 1016, 998, 968, 956, 870, 
865, 808, 772, 744, 650, 543, 542, 540; IHNMR (360 MHz, CDCI3) 0 1.42 (3H, t, 
CH3), 4.40 (2H, q, CH2) 4.57 (2H, s, CH2Br), 7.53 (2H, d, J = 8.0 Hz, 3- and 5-Ar-
H), 7.69 (2H, m, 3- and 5-py-H), 7.85 (1H, t, 4-py-H), 8.12 (2H, d, J = 8.0 Hz, 3- and 
5-Ar-H), 8.21 (4H, m, 2 x2- and 6-Ar-H); MS, m1z (r.i.) 316 (M- HBr, 19%),277 (6), 
270 (5), 262 (100), 213 (9), 198 (16), 158 (14), 154 (21), 150 (2), 149 (6), 141(19), 
136 (13), 122 (5), 106 (6), 105 (12), 77 (8) (Found: C, 63.70; H, 4.50; N, 3.50. 
C21H18BrN02 requires: C, 63.79; H, 4.55; N, 3.54 %). 
2-(4-[Dibromomethylphenyl])-6-phenylpyridine (146). 
A mixture of 2-phenyl-6-( 4-tolyl)pyridine (144) (0.60 g), N-bromosuccinimide (0.80 
g), benzoyl peroxide (20 mg) and carbon tetrachloride (15 cm3) was refluxed for 18 
h and then the reaction mixture was cooled and filtered. The filtrate was evaporated 
under reduced pressure and residue was purified by column chromatography 
(petroleum spirit and diethyl ether, 90: 10) to give the title compound (146) (0.46 g, 
47%), mp 146-147 °C; IR (KBr) v mdcm-1 1586, 1566, 1444, 1434, 1316, 1232, 1212, 
1184,1165,1072,1040,996,987,964,954,850,814,812, 766, 756, 736,696,654, 
632, 618, 612, 546, 532, 512, 510; IHNMR (360 MHz, CDCI3) 0 6.71 (lH, s, 
CHBr2),7.45 (3H, m, 3-,4- and 5-Ph-H), 7.67 (4R, m, 3- and 5-py-H), 7.81 (lR, t, 
4-py-H), 8.13 (4H, m, 2 x 2- and 6-Ar and py-H); MS, m1z (r.i.) 404 (M+ for 81Br, 
129 
110/0),402 (M+ for slBr and 79Br, 21), 400 (M for 79 Br, 10), 324 (39), 323 (M -Br, 
100),321(88),258 (39), 256 (15), 245 (9),244 (11), 230 (20), 210 (12), 116 (23), 
106 (8), 98 (5), 96 (13), 86 (7), 84 (41) (Found: C, 53.69; H, 3.33; N, 3.33. 
ClsH13Br2N requires: C, 53.86; H, 3.24; N, 3.49%). 
2-(4-[Dietboxymetbyl]pbenyl)-6-pbenylpyridine (147). 
2-(4-[Dibromomethyl]phenyl)-6-phenylpyridine (146) (0.35 g, .86 mmol) was 
dissolved in dry ethanol (10 cm3) and added dropwise to a solution of sodium ethoxide 
(sodium metal (0.20 g) dissolved in ethanol (20 cm3)). The reaction mixture was 
refluxed for 30 minutes, cooled and the solvent was evaporated in vacuo. The residue 
was dissolved in water and extracted with chloroform. The extract was dried , 
evaporated and the residue was purified by column chromatography (petroleum spirit 
and diethyl ether, 90: 10) to give the acetal (147) (0.46 g, 47%), mp 46-47 °C; IR 
(KBr) v maicm-1 2268, 2161, 1867, 1586, 1566, 1316, 1232, 1184, 1115, 1072, 1040, 
998, 996, 850, 814, 766, 736, 696; IHNMR (360 MHz, CDCI3) 0 1.24 (6H, m, 2 x 
CH3), 3.53- 3.70 (4H, m, 2 x CH2), 5.58 (IH, s, CH), 7.46 (4H, m, 2 x 3- and 5-Ar-
H), 7.59 (1H, m, 4-Ar-H), 7.70 (2H, m, 3- and 5-py-H), 7.81(IH, t, 4-py-H), 8.14 
(4H, m, 2 x 2- and 6-Ar-H); MS, m/z (r.i.) 334 (M++H, 8), 333 (M, 7), 289 (M-
C2H40, 70),288 (M+-OCH2ClIg, 94), 260 (100), 249 (48), 248 (10), 232 (47), 230 
(10), 127 (10), 110 (12), 98 (10), 97 (10),84 (41) (Found: C, 79.17; H, 6.84; N, 4.18. 
C22H23N02 requires: C, 79.27; H, 6.90; N, 4.20%). 
2-(4-Formylpbenyl)-6-pbenylpyridine (148). 
2-(4-[Diethoxymethyl]phenyl)-6-phenylpyridine (147) (0.20 g, 0.77 mmol) was 
hydrolysed with boiling 3M hydrochloric acid (5 cm3) for 2h. The reaction mixture was 
neutralized with aqueous sodium hydroxide and extracted with chloroform. The extract 
was evaporated and the residue purified by column chromatography (chloroform) to 
give the aldehyde (148) (0.03 g, 19%), mp 46-47 °C; IR (KBr) v mdcm-1 1704 (CO), 
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1606, 1564, 1434, 1423, 1323, 1304, 1268, 1210, 1202, 1160, 1096, 1022, 986, 969, 
846,808, 814, 760, 736, 696; IHNMR (360 MHz, CDCI3) 0 7.43 (5H, m, 2 x 3- , 2 
x 5- and 4-Ar-H), 7.62 (2H, m, 3- and 5-py-H), 7.81 (1H, t, 4-py-H), 8.25 (4H, m, 
2 x 2- and 2 x 6-Ar-H), 10.04 (lH, s, CHO); MS, m/z (r.i) 260 (M+, 44%), 259 (M+, 
100),245 (65), 244 (40), 233 (M-CHO, 10),232 (35), 231 (15),230 (37), 230 (37), 
228 (17),198 (9),188 (12),178 (14),169 (13),167 (11),154 (15),114 (7),84 (41), 
54 (9) (Found: C, 83.18; H, 4.92; N, 5.21. C1SH13NO requires: C, 83.30; H, 5.01; N, 
5.40%). 
2-(4-[EthoxymethyJ]pheoyJ)-6-pheoyJpyridioe (149). 
2-([4-Bromomethyl]phenyl)-6-phenylpyridine (145) (0.30 g, 0.92 mmol) was dissolved 
in dry ethanol (10 cm3) and added dropwise to a solution of sodium ethoxide (sodium 
metal (0.2 g) dissolved in ethanol (20 cm3) . The reaction mixture was refluxed for 30 
min., cooled and the solvent evaporated in vacuo. The residue was dissolved in water 
and extracted with chloroform. The extract was dried, evaporated and the residue was 
purified by column chromatography (petroleum spirit and diethyl ether, 90: 10) to give 
the title compound (149) (0.268 g, 93%), mp 41-41.5 °C; IR (KBr) v maJcm-1 2112, 
1897,1650,1544,1499,1320,1280,1144,1092,962,943, 866, 865,832, 776, 745, 
642,632,612,606, 568, 543; IHNMR (360 MHz, CDCI3) 0 1.12 (3H, t , CH3), 3.42 
(2H, q, CHJ, 4.61 (2H, s, Ar-CHJ, 7.47 (5H, m, 2 x 3-,2 x 5- and 4-Ar-H), 7.6 1(2H, 
m, 3- and 5-py-H), 7.82 (lH, t, 4-py -H), 8.10 (4H, m, 2 x 2- and 2 x 6-Ar- H); MS, 
m/z (r.i.) 290 (M++H, 25%), 289 (M+, 88), 260 (M-CH2CH3' 87), 246 (M- OCH2CH3, 
24), 245 (100), 244 (95), 242 (23), 232 (86), 230 (13), 198 (8), 176 (14), 154 (12), 
149 (22),98 (12), 96 (13),88 (6), 86 (12), 56 (6), 54 (12) (Found (FAB;NOBA): M\ 
289.1467 daltons. C2Ji19NO requires M, 289.1461). 
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4-Acetylbenzoic acid (174). 
A mixture of 4-acetylbenzonitrile (166) (0.98 g, 6.8 mmol), methanol (20 cm3) and 
sodium hydroxide solution (3M, 10 cm3) was refluxed for 1.5 h. The solution was 
cooled and acidified to pH 1 by dropwise addition of concentrated hydrochloric acid. 
The precipitate was filtered off, washed with water and dried to give the acid (1.08 
g, 970/0), mp 209-210 °C (lit.,125 mp 208-210°C); IR (KBr) v rna/cm -1 3444, 1684 
(CO), 1500, 1437, 1283, 937, 815, 815, 642; IHNMR (360 MHz, DMSO-d6) a 2.62 
(3H, s, CH3), 8.04 (4H, s, Ar-H), 11.0 (IH, br.s, exchangeable with D20, OH); MS, 
m/z (r.i.) 165 (M++l, 5%), 164 (M+, 49), 150 (33), 149 (M-CH3' 100), 130 (21), 122 
(9), 121 (84), 93 (5), 65 (22), 43 (13). 
Attempted preparation of 2-(4-[ methoxycarbonyIJphenyl)-6-( 4-tolyl)pyridine 
(172). 
Dry hydrogen chloride was passed into an ice-cold solution of 2-( 4-cyanophenyl)-6-( 4-
tolyl)pyridine (168) (0.27 g, 1 mmol) in dry methanol (300 cm3) until the solution was 
saturated. After 1 h the solution was allowed to reach room temperature and ice-cold 
water (300 cm3) was added, the solvent evaporated, and the crude product was 
solidified by adding acetone and petroleum spirit. The solid was filtered off and 
crystallised from methanol to give the unexpected 4(2-[6-{4-tolylJ}benzoic acid (173) 
(0.25 g, 23%), mp 287-287.5 °C; IR (KBr) v ma/cm -1 3055 (OH), 1579, 1560, 1406, 
1234, 1209, 1116, 1098, 1010, 996, 987, 866, 800, 744, 758, 722, 667, 654, 556, 
543; IHNMR (360 MHz, DMSO-d6) a 2.35 (3H, s, CH3), 5.16 (lH, broad signal, 
exchangeable with D20, OH), 7.32 (2H, d, J = 7.8 Hz, 3- and 5-tolyl-H), 7.99 (5H, m, 
3- and 5-Ar-H, 3-, 4- and 5-py-H), 8.15 (2H, d, J = 7.8 Hz, 2- and 6-tolyl-H), 8.20 
(2H, d, J = 7.8 Hz, 2- and 6-Ar-H). 
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2-(4-[3-Aminopropoxymethyl]phenyl)-6-phenylpyridine (150) . 
A mixture of2-([4-bromomethyl]phenyl)-6-phenylpyridine (145) (0.5 g, 1.6 mmol), 
anhydrous potassium carbonate (0.22 g) and 3-aminopropanol (5 cm3) was refluxed 
for 2 h. The reaction mixture was cooled and filtered. The filtrate was concentrated in 
vacuo and the product was purified by column chromatography (chloroform: methanol: 
aq. ammonia (d 0.88), 90:8:2) to give the 2-(4-[3-aminopropoxymethyl]phenyl)-6-
phenylpyridine (150) (0.30 g, 61%), mp 82-83 °C~ IR (KBr) v max /cm-1 3320 (NH2), 
3210 (NH2), 1891, 1756, 1650, 1567, 1543, 1443, 1378, 1323, 1278, 1198, 1144, 
1096, 1056, 969, 963, 866, 632, 543, 522,501~ IHNMR (360 MHz, CDCI3) l> 1.73 
(2H, m, CH2-CH2-CH2-NHJ, 2.42 (2H, br.s, exchangeable with D20, NH2), 2.91 (2H, 
m, CH2-CH2-CH2-NH2), 3.83 (2H, t, J = 5.2 Hz, CH2-CH2-CH2-NH2), 3.86 (2H, s, 
Ar-CHJ, 7.48 (5H, m, 2 x 3-,2 x 5- and 4-Ar-H), 7.67 (2H, m, 3- and 5-py-H), 7.79 
(1H, t, 4-py-H), 8.13 (4H, m, 2 x 2- and 2 x 6-Ar-H)~ MS, m/z(r.i.) 319 (M++H, 29%), 
318 (M+, 41), 273 (15), 260 (M-(CH2)3NH2' 30), 259 (32), 245 (24), 244 (67), 242 
(23),232 (51), 231 (13),212 (9),123 (9), 109 (13), 98 (15), 87 (10), 85 (64), 83 
(100) (Found: (EI): M+, 318.1732 daltons. C21H22N20 requires M, 318.1725). 
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GENERAL METHOD FOR AMINOLYSIS OF 2-(4-[BROMOMETHYL] 
PHENYL )-6-PHENYLPYRIDINE. 
A mixture of the appropriate 2-( 4-[bromomethyl]phenyl)-6-arylpyridine (145) (1.6 
mmol) and anhydrous potassium carbonate (0.22 g) was dissolved in an excess of a 
diamine under a nitrogen atmosphere. The mixture was refluxed for 2 h unless stated 
otherwise. After cooling, the mixture was filtered and the filtrate concentrated in 
vacuo. The resulting oil was distilled to remove the excess of diamine and the crude 
product purified by column chromatography on silica gel using a mixture of 
chloroform and methanol (85: 15) containing conc. aqueous ammonia (3-5 drops) 
unless otherwise stated. 
2-(4-[4-Amino-2-azabutyl] phenyl)-6-phenylpyridine (151). 
2-(4-[Bromomethyl]phenyl)-6-phenylpyridine (145) (0.50 g), anhydrous potassium 
carbonate and ethylene diamine (5 cm3) gave the 2-(4-[4-amino-2-azabutyljphenyl)-6-
phenylpyridine (151) (0.25 g, 53%), mp 69-70 °C; IR (KBr) v max fcrn l 3420 (NH), 
3330 (NH2), 3240 (NH2), 1654, 1616, 1570, 1543, 1448, 1412, 1386, 1323, 1114, 
1098, 1043, 1021,996, 986, 760, 696, 543, 520; lHNMR (360 MHz, CDCI3) () 1.66 
(3H, br.s, exchangeable withD20, NH and NH2), 2.73 (2H, t,}= 5.6 Hz, CH2), 2.83 
(2H, t,} = 5.6 Hz, CHJ, 3.87 (2H, s, Ar-CH2), 7.43 (5H, m, 2 x 3-,2 x 5- and 4-Ar-
H), 7.65 (2H, m, 3- and 5-py-H), 7.80 (IH, t, 4-py-H), 8.12 (4H, m, 2 x 2- and 2 x 
6-Ar-H) ; MS, m1z(r.i.) 304 (M++H, 220/0), 303 (M\ 100),273 (M- CH2NH2, 22), 245 
(42),244 (94), 243 (9),241(6), 122 (5), III (13), 109 (6), 98 (12), 96 (14), 85 (16), 
83 (25), 56 (14) (Found: (EI): M+, 303.1735 daltons. C2Ji2lN3 requires M, 303.1728). 
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2-(4-[5-Amino-2-azapentyl]phenyl)-6-phenylpyridine (152). 
2-( 4-[Bromomethyl]phenyl)-6-phenylpyridine (0.50 g), anhydrous potassium carbonate 
and 1,3 -diaminopropane (5 cm3) yielded the 2-(4-[ 5-amino-2 -azapentyl }phenyl)-6-
phenylpyridine (152) (0.25 g, 52%), mp 69-70 °C; IR (KBr) v max fcrn l 3420 (NH), 
3330 (NH2), 3210 (NH2), 1654, 1570, 1448, 1386, 1234, 1123, 1114, 1098, 1032, 
996,986, 760, 696, 543, 521; lHNMR (360 MHz, CDCI3) () 1.71 (2H, m, CH2), 1.96 
(3H, br.s, exchangeable withD20, NH and NH2), 2.73 (2H, m, 2 x CH2), 3.87 (2H, 
s, Ar-CHJ, 7.43 (5H, m, 2 x 3-,2 x 5-and 4-Ar-H), 7.67 (2H, m, 3- and 5-py-H), 7.80 
(1H, t, 4-py-H), 8.10 (4H, m, 2 x 2- and 2 x 6-Ar-H) ; MS, m/z (r.i.) 318 (M++H, 
18%), 317 (M+, 76), 260 (20), 259 (M-(CH2)3 NH2, 57), 246 (21), 245 (100), 242 
(43), 232 (19), 122 (5), 121 (32), 113 (12), 109 (9), 105 (13), 103 (7), 98 (43), 96 
(12),89 (7),85 (16), 83(25) (Found (EI): M+, 317.1892 daltons. C21H23N3 requires M, 
317.2884). 
2-(4-[8-Amino-2-azaoctyl] phenyl)-6-phenylpyridine (153). 
2-(4-[Bromomethyl]phenyl)-6-phenylpyridine (145) (0.50 g), anhydrous potassium 
carbonate and an excess of 1,6-diaminohexane (5 cm3) afforded the title compound 
(153) (0.23 g, 43%), mp 88-89 °C; IR (KBr) v max fcm- l 3420 (NH), 3330 (NH2), 3220 
(NHJ, 1654, 1570, 1448, 1442, 1386, 1232, 1212, 1114,1098,1043,1021,986,987, 
886, 885, 760, 696; lHNMR (360 MHz, CDCI3) () 1.32 (8H, m, 4 x CH2), 1.56 (3H, 
br.s, exchangeablewithD20, NH and NH2), 2.64 (4H, m, 2 x CH2), 3.84 (2H, s, Ar-
CHJ, 7.49 (5H, m, 2 x 3-,2 x 5- and 4-Ar-H), 7.68 (2H, m, 3- and 5-py-H), 7.80 (1H, 
t,4-py-H), 8.13 (4H, m, 2 x 2- and 2 x 6-Ar-H); MS, m/z (r.i.) 360 (M++1, 17%), 
359 (M+, 55), 240 (17), 329 (10), 273 (M- (CH2)s NH2, 22), 266 (14),259 (44),246 
(20%), 245 (100), 244 (52), 232 (8), 165 (13), 143 (12), 129 (10), 105 (14), 98 (9), 
96 (8), 89 (12), 85 (13), 84 (30) (Found: (EI): M+, 359.2361 daltons. C24H29N3 
requires M, 359.2361). 
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2-( 4-[8-Amino-2-azaoctyl] pbenyl)-6-( 4-metbylpbenyl)pyridine (156) 
2-( 4-[Bromomethyl]phenyl)-6-( 4-methylphenyl)pyridine (154) (0.53 g), anhydrous 
potassium carbonate and an excess of 1,6-diaminohexane (5 cm3) gave 2-(4-[8-
amino-2-azaoctyljphenylj-6-(4-methylphenyl)pyridine (156) (0.27 g, 45%), mp 98-99 
°C; IR (KBr) v DllL'/cm-1 3420 (NH), 3330 (NH:J, 3210 (NH:J, 1876, 1765, 1686, 1654, 
1570,1560,1448,1423,1386,1323,1234,1212,1114, 1098, 1045, 1021,986,886, 
843, 760, 696; IHNMR (360 MHz, CDCI3) {) l.23-l.52 (8H, m, 4 x CH2), l.88 (3H, 
s, exchangeable with DzO, NH and NH z ), 2.42 (3H, S, Ar-CH3), 2.66 (4H, m, 2 x 
CHz), 3.85 (2H, s, Ar-CH:J, 7.29-7.31 (2H, m, 3- and 5-tolyl-H), 7.45 (2H, m, 3- and 
5-Ar-H), 7.67 (2H, d, J= 7.6 Hz, py-H), 7.77 (1H, t, 4-py-H), 8.01-8.18 (4H, m, 2-
and 6-tolyl, 2- and 6-Ar-H) ; MS, m/z(r.i.) 374 (M++ 1, 13%), 373 (M\ 60), 354 (42), 
287 (25), 258 (M- NH(CHZ)6 NHz , 55), 191 (39), 149 (28), 148 (37), 134 (26), 129 
(100), 112 (34), 86 (45) (Found: (EI): M+, 373.2499 daltons. C2sH31N3 requires M, 
373.2508). 
2,6-Bis(4-[8-amino-2-azaoctyl]pbenyl)pyridine (157). 
A mixture of 2,6-bis([4-bromomethyl]phenyl)pyridine (155) (0.66 g), anhydrous 
potassium carbonate and an excess of 1,6-diaminohexane (5 cm3) afforded the crude 
product which was purified by column chromatography (methanol: aq. ammonia, 
85: 15) to give the 2,6-bis(4-[8-amino-2-azaoctyljphenylpyridine (157) (0.20 g, 26%), 
mp 147-148 °C; IR(KBr) vmro!cm1 3420 (NH), 3330 (NH2), 3320 (NH2), 1654, 1570, 
1448, 1386, 1234, 1212, 1114, 1098, 1065, 998, 986, 886, 884, 760, 696, 543; 
IHNMR (360 MHz, CDCI3) {) l.44 (6H, s, exchangeable with ~O, 2 x NH and 2 x 
NH2), 1.34-1.56 (16H, m, 8 x CHz), 2.67 (8H, m, 4 x CH2), 3.91 (4H, s, 2 x Ar-CH2), 
7.44 (4H, m, 2 x 3- and 2 x 5-Ar-H), 7.65 (2H, m, 3- and 5-py-H), 7.81 (1H, t, 4-py-
H), 8.11 (4H, m, 2 x 2- and 2 x 6-Ar-H) (Found: (EI): M+, 488.3746 daltons. C31H4SNs 
requires M, 487.3660). 
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GENERAL METHOD FOR THE PREPARATION OF SULFIDES FROM 2-([4-
BROMOMETHYL]PHENYL)-6-ARYLPYRIDINE. 
Metallic sodium (1.19 g, 52 mmol) was reacted with anhydrous ethanol (100 cm3) and 
resultant solution of sodium ethoxide was treated with 2-( dimethyl amino )ethanethiol 
hydrochloride (3.68 g, 26 mmol). The mixture was stirred for 10 min. at 25°C then 
treated with the appropriate 2-(4-[bromomethyl]phenyl)-6-arylpyridine (24 mmol) and 
stirred for 2 h at reflux. The solid was filtered off and the filtrate evaporated. The 
crude product was purified by chromatography on silica gel with a mixture of 
chloroform and methanol (98:2) unless otherwise stated. 
2-(4-[4-Dimethylamino-2-thiabutyl] phenyl)-6-( 4-methylphenyl)pyridine 
(158). 
The product from 2-( 4-[bromomethyl]phenyl)-6-( 4-tolyl)pyridine (154) (8.0 g) and 2-
(dimethylamino )ethanethiol hydrochloride (3.68 g) gave the colourless title compound 
(158) (7.0 g, 81%), mp 54-55°C; IR (KBr) v max/Cm-l 2234, 1643, 1570, 1560, 1432, 
1414,1343,1245,1209,1167, 1078, 1067,1008,996,994,887,883,796,668,662, 
592, 569; lHNMR (360 MHz, CDCI3) 0 2.21 (6H, s, 2 x CH 3), 2.43 (3H, S, CH 3), 
2.51 (4H, m, 2 x CHJ, 3.74 (2H, s, Ar-CHJ, 7.30 (2H, d, J = 8 Hz, 3- and 5-tolyl-H), 
7.44 (2H, d, J = 8 Hz, 3- and 5-Ar-H), 7.65 (2H, m, 3- and 5-py-H), 7.78 (lH, t, 4-py-
H), 8.04 (2H, d, J = 8 Hz, 2- and 6-tolyl-H), 8.09 (2H, d, J = 8 Hz, 2- and 6-Ar-H); 
MS, m/z(r.i.) 363 (M++ 1, 6%), 362 (M+, 18), 302 (9), 290 (M- (CH3)2, 7), 273 (7), 
260 (20), 259 (100),258 (34),222 (45),122 (5), 123(13), 112 (9), 98 (5), 8795), 85 
(16),83 (25) (Found: (EI): M+, 362.1892 daltons. C23H26N2S requires M, 362.1808). 
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2-(4-[4-Dimethylamino-2-thiabutyl]phenyl)-6-(4_bromophenyl)pyridine 
(163). 
The 2-(4-[bromomethyl]phenyl)-6-(4-bromophenyl)pyridine (162) (9.9 g) and 2-
(dimethyl amino )ethanethiol hydrochloride yielded 2-(4-[ 4-dimethylamino-2-
thiabutyljphenyl)-6-(4-bromophenyl)pyridine (163) (6.6 g, 62%), mp 82.7-83 °C; IR 
(KBr) v max/cm-l 1590, 1560, 1434, 1423, 1368, 1324, 1289, 1267, 1234, 1166, 1070, 
1006,998,968,886,798,745, 723,689,678,662,654,592,543,520,512,518,512; 
IHNMR (360 MHz, CDCI3) a 2.36 (6H, s, 2 x CH 3), 2.40-2.79 (4H, m, 2 x CH 2), 
3.70 (2H, s, Ar-CH2), 7.46 (2H, d, J = 8 Hz, 3- and 5-Ar-H), 7.66 (4H, m, 3- and 5-
py, 3- and 5-Ar-H), 7.81 (IH, t, 4-py-H), 8.07 (4H, m, 2 x 2- and 2 x 6-Ar-H); MS, 
m/z (r.i.) 428 (M+for 81Br, 9%), 426 (M+for 7~r, 9), 368 (M- CH2N(CH3)2, 8), 357 
(16),356 (14), 354 (8), 326 (19), 325 (98), 324 (63),223 (9),212 (13), 112 (14), 109 
(3), 98 (43), 83 (25) (Found: (EI): M+, 426.0765 daltons. C22H23BrN2S requires M, 
426.0809). 
2-(4-[4-Dimethylamino-2-thiabutyl]phenyl)-6-( 4-cyanophenyl)pyridine 
(170). 
The 2-( 4-[bromomethyl]phenyl)-6-( 4-cyanophenyl)pyridine (169) (8.35 g) and 2-
(dimethyl amino)ethanethiol hydrochloride afforded the tertiary amine (170) (4.8 g, 
54%), mp 53-54°C; IR (KBr) v max /cm-1 2362, 2226 (CN), 1558, 1506, 1376, 1270, 
1164,1016,1009,1005,998,987,867,845, 798, 765,669,662,592,547,542,521, 
511; IHNMR (360 MHz, CDCI3) a 2.21 (6H, s, 2 x CH3), 2.48- 2.57 (4H, m, 2 x 
CHJ, 3.79 (2H, s, Ar-CH2), 7.44 (2H, d, J= 8 Hz, 3- and 5-Ar-H), 7.72 (4H, m, 3-
and 5-py, 3- and 5-Ar-H), 7.86 (IH, t, 4-py-H), 8.07 (4H, m, 2 x 2- and 2 x 6-Ar-H); 
MS, m/z (r.i.) 373 (M+' 6%), 328 (6), 313 (7), 271(15), 270 (64), 269 (M-
S(CHJ2N(CH3}b 36), 268 (5), 268 (5), 267 (6), 123 (9), 115 (13), 109 (65), 105 (8), 
104 (9), 98 (7), 87 (15), 71(5), 66 (9), 65 (13), 59 (4), 58 (100) (Found: (EI): M+, 
373.1604 daltons. C23H23N3S requires M, 373.1613). 
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EthyI4-(2-[6-{4-(2-[dimethylamino]ethyl)thiomethyl}phenyl]pyridyl) 
benzoate (180). 
The ethyl 4-(2-[6-{4-bromomethylphenyl} ]pyridyl)benzoate (179) (9.48 g) and 2-
( dimethylamino )ethanethiol hydrochloride gave a product which was purified by 
chromatography (chloroform: methanol, 96:4) afforded ethyI4-(2-[6-{4-(2-[dimethyl 
aminojethyl)thiomethyl}phenyljpyridyl)benzoate (180) (0.25 g, 70%), mp 36-36.5 °C; 
IR (KBr) v max /cm-1 1686, 1555, 1505, 1443, 1414, 1324, 1311, 1270, 1115, 1050, 
998, 976, 945, 879, 866, 798, 665, 663, 598, 573, 565, 530 ; IHNMR (360 l'v1Hz, 
CDCI3) 5 1.43 (3H, t, CH3), 2.24 (6H, s, 2 x CH3), 2.49- 2.58 (4H, m, 2 x CH2), 3.80 
(2H, s, Ar .. CH2), 4.42 (2H, q, CH2), 7.42 (2H, d, J = 6.7 Hz, 3- and 5-Ar-H), 7.73 
(2H, m, 3- and 5-Ar-H), 7.84 (1H, t, 4-py-H), 8.09 (2H, m, 3- and 5-py-H), 8.21 (4H, 
m, 2 x 2- and 2 x 6-Ar-H); MS, m/z (r.i.) 317 (15%)~ 316 (M- S(CH2)2N(CH3)2, 8), 
149 (8), 122 (14), 105 (22), 103 (19), 83 (8), 77 (9), 73 (9), 70 (39), 58 (100), 56 
(33), 45 (49), 42 (32) (Found: (EI): M+ , 421.1951 daltons. C25H2SN202S requires M, 
421.1940). 
2-([Tert-Butoxycarbonylamino]ethyl)amine (176). 
To an ice-cooled solution of 1,2-diaminoethane (5 cm3, 0.075 mol) in dichloromethane 
(40 cm3) was added di-tert-butyldicarbonate (5.45 g, 0.025 mol) in dichloromethane 
(20 cm3) over 20 min. After being stirred at ambient temperature overnight, the 
suspension was filtered and the filtrate concentrated, the residue was connected to a 
vacuum pump to remove the excess amine and to leave 2-(tert-
butoxycarbonylamino]ethylamine (3.84 g, 96%)63 IHNMR (360 MHz, CDCI3) 5 1.24 
(2H, s, NH~, 1.46 (9H, s, Boc), 2.73 (2H, m, CH2) , 3.13 (2H, s, CH2), 5.02 (IH, s, 
NH); MS, m/z (r.i.) 160 (M+, 4%), 143 (M+ - NH3, 17), 115 (M - C(CH)3, 100), 98 
(16). 
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N-(2-[Tert-Butoxycarbonylamino]ethyl)-4-(2-[6-{4-tolyl}pyridyl])benzamide 
(177). 
A mixture of the 4-(2-[6-{4-toly}phenyl]pyridyl)benzoic acid (173) (0.367 g, 1.27 
mmol), 1-[3-( dimethylamino )propyl]-3-ethylcarbodiimide hydrochloride (EDCI) (0.29 
g, 1.52 mmol) and I-hydroxybenzotriazole (HOBT) (0.22 g, 1.65 mmol) in anhydrous 
DMF (10 cm3) was stirred at room temperature for 30 min and to this solution was 
added the protected amine (0.212 g, 1.33 mmol). After the mixture had been stirred 
overnight the solid was filtered off and the filtrate removed in vacuo. The residue was 
treated with ethyl acetate, the suspension was filtered, the filtrate concentrated and the 
product purified by chromatography ( ethyl acetate~ petroleum spirit 60:40 ) to give 
colourless N-(2-[tert-butoxycarbonylamino Jethyl-4-(2-[ 6-{4-tolyl}pyridyl]) benzamide 
(177) (0.370 g, 68%) mp 198-198.5 °C~ IR (KBr) v ma! cm -1 3342 (NH), 1686 (CO), 
1635, 1588, 1534, 1448, 1388, 1366, 1322, 1252, 1166, 970, 860, 802, 770, 630~ 
IHNMR (360 MHz, DMSO-d6) 0 1.34 (9H, s, 3 x CH3), 2.38 (3H, s, Ar-CH3), 3.14-
3.36 (4H, m, 2 x CH2), 6.81 (IH, s, exchangeable with ~O, NH), 7.32 (2H, d, J= 
7.8 Hz, 3- and 5-Ar-H), 7.92 (5H, m, 3-and 5-Ar, 3-, 4- and 5-py-H), 8.24 (2H, d, J 
= 8 Hz, 2- and 6-tolyl-H , 8.28 (2H, d, J = 8 Hz, 2- and 6-Ar-H) , 8.42 (1H, s, 
exchangeable with D20, NH)~ MS, m/z (ri) 316 (9%), 315 (M+- NH(Boc), 7), 314 
(34), 313 (100),312 (49),311 (15), 302 (15), 301 (12), 289 (17), 285 (32), 284 (98), 
273 (12),272 (24), 245 (19), 244 (22), 221 (9), 142 (20) (Found: C, 72.12~ H,6.51; 
N, 9.62. C26H29N303 requires C, 72.38; H, 6.72~ N, 9.74 %). 
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GENERAL METHOD FOR AMINOLYSIS OF ETHYL 4-(2-[6-{4-(2-
[DIMETHYLAMINO]ETHYL)THIOMETHYL}PHENYL]PYRIDYL)BENZO-
ATE (180). 
The ethyl 4-(2-[ 6-{4-(2-[ dimethyl amino ]ethyl)thiomethyl} phenyl]pyridyl)benzoate 
(180) (1.6 mmol), anhydrous potassium carbonate (1.6 mmol) and an excess of amine 
(5 cm3) were refluxed under a nitrogen atmosphere for 8 h. The reaction mixture was 
cooled and filtered. The filtrate was concentrated in vacuo, the excess of amine 
removed by distillation and the crude product was purified by column chromatography 
with a mixture of methanol, chloroform and conc. aqueous ammonia (90: 5: 5) unless 
otherwise stated and then crystallised from methanol. 
N-(2-Aminoethyl)-4-(2-[6-{4-(2-[ dimethylamino ]ethyl)thiomethyl} 
phenylpyridyl)benzamide (181). 
The ethyl 4-(2-[ 6-{4-(2-[ dimethylamino ]ethyl)thiomethyl} phenyl]pyridyl)benzoate 
(180) (0.67 g) and 1,2-diaminoethane afforded a product which was purified by 
column chromatography (methanol: chloroform: aq. ammonia, 92:8:2) to give the title 
compound (181) (0.48 g, 700/0), mp 103-104 DC; IR (KBr) v max fcm- l 3340 (NH), 
3320 (NH2), 3212 (NHJ, 1734, 1718 (CO), 1686, 1628, 1586, 1540, 1320, 1164, 
1014,808, 768, 754, 696, 632, 587, 542, 512; lHNMR (360 MHZ, DMSO-d6) {) 2.11 
(6H, s, 2 x CH3), 2.42-2.54 (4H, m, 2 x CH2), 2.71-3.17 (4H, m, 2 x CH2), 3.29 (2H, 
br.s, exchangeable with D20, NH2), 3.82 (2H, s, Ar-C&), 7.48 (2H, d, J = 8.0 Hz, 
3- and 5-Ar-H), 7.98 (5H, m, 3-and 5-Ar, 3-, 4- and 5-py-H), 8.18 (2H, d, J = 8.0 Hz, 
2- and 6-Ar-H), 8.30 (2H, d, J = 8.0 Hz, 2- and 6-Ar-H ), 8.55 (lH, t, exchangeable 
with D20, NH); MS (FAB;NOBA) (ri) 435 (M++ 1, 53%),413 (75), 391 (39), 301 
(12), 287 (9), 243 (27), 234 (12), 194 (23), 189 (10), 176 (45), 167 (26), 154 (16), 
149 (100), 141 (20), 132 (42), 123 (47), 118 (19), 109 (12), 98 (9), 87 (43) (Found: 
C,69.01; H, 6,41; N, 13.08. C25H30N4S0 requires: C, 69.09; H, 6.95; N, 12.890/0). 
141 
N-(4-Aminobutyl)-4-(2-[6-{4-(2-[dimetbylamino] etbyl)tb iome tbyl}pbenyl] 
pyridyl)benzamide (182). 
The ethyl 4-(2-[ 6-{ 4-(2-[ dimethylamino ]ethyl)thiomethyl }phenyl]pyridyl)benzoate 
(180) and 1,4-diaminobutane afforded a product which was twice triturated with 
diethylether (2 x 10 cm3) to give colourless N-(4-aminobutyl)-4-(2-[6-{4-(2-
[dimethylaminoj ethyl)thiomethyljphenyljpyridyl)benzamide (182) (0.30 g, 41%), 
mp ISS-156°C; IR (KBr) v max/cm-13340 (NH), 3300 (NH2), 3200 (NH2), 2938,1718 
(CO), 1686,1628,1588,1540,1450,1442,1320,1239,1164, 1123,1014,808,768, 
632,589,543,511,510; IHNMR (360 MHz, DMSO-d6) () 1.40-1.62 (4H, m, for 2 x 
CH~, 2.10 (6H, s, 2 x CH3), 2.29-2.40 (4H, m, 2 x CH0, 2.51-3.21 (4H, m, 2 x CH2), 
3.39 (2H, br.s, exchangeable with D20, NH2), 3.82 (2H, s, Ar-CH2), 7.47 (2H, d, J = 
8.2 Hz, 3- and 5-Ar-H), 7.98 (5H, m, 3- and 5-Ar, 3-, 4- and 5-py-H), 8.18 (2H, d, J 
= 8.2 Hz, 2- and 6-Ar-H), 8.31 (2H, d, J = 8.2 Hz, 2- and 6-Ar-H) , 8.65 (IH, t, 
exchangeable with D20, NH); MS (FAB;NOBA) (r.i.) 463 (M++l, 100%),413 (9), 
391 (12),358 (33), 272 (14), 243 (24),212 (9), 149 (32), 144 (12), 123 (25), 107 (45) 
(Found: C, 69.51; H, 7.15; N, 11.92. C2sH3oN40S requires: C, 70.09; H, 7.40; N, 
12.10%). 
N-(6-Aminobexyl)-4-(2-[6-{4-(2-[dimetbylamino]ethyl)thiometbyl} 
pbenyl]pyridyl)benzamide (183). 
The ethyl 4-(2-[ 6-{4-(2-[ dimethylamino ]ethyl)thiomethyl} phenyl]pyridyl)benzoate 
(180) and 1,6-diaminohexane yielded a product which was crystallised from a mixture 
of methanol and diethyl ether to give colourless N-(6-aminohexyl)-4-(2-[6-{4-(2-
[dimethylaminojethyl)thiomethyljphenyljpyridyl)benzamide (183) (0.30 g, 38%), 
mp 143-144 °C; IR (KBr) v max /cm-1 3400 (NH), 3321 (NH2), 3200 (NH2)' 2923, 
1719 (CO), 1696, 1628, 1567, 1540, 1486, 1420, 1220, 1154, 1014,968,867,816, 
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789,768,632, 580, 565; IHNMR (360 MHz, DMSO-d6) () 1.32-1.54 (8H, m, for 2 x 
CH;J, 2.10 (6H, s, 2 x CH3), 2.39-2.50 (4H, m, 2 x CH2), 2.90-3.28 (4H, m, 2 x CH2), 
3.29 (2H, br.s, exchangeable with D20, NH2), 3.82 (2H, s, Ar-CH2), 7.48 (2H, d, J = 
8.1 Hz, 3- and 5-Ar-H), 7.98 (5H, m, 3- and 5-Ar, 3-,4- and 5-py-H), 8.19 (2H, d, J 
= 8.1 Hz, 2- and 6-Ar-H), 8.30 (2H, d, J = 8. Hz, 2- and 6-Ar-H), 8.57 (lH, t, 
exchangeable with D20, NH); MS (FAB;NOBA) (r.i.) 491 (M++1, 100%),419 (5), 
387 (24), 315 (16), 272 (15), 243 (17),212 (9), 183 (7), 176 (12), 161 (14), 149 (15), 
132 (15), 123 (47), 117 (93), 107 (21), 98 (7), 88 (12) (Found: C, 70.53; H, 7.47; N, 
10.86. C2Jf38N4S0 requires: C, 70.98; H, 7.80; N, 11.41%). 
GENERAL METHOD FOR ACETYLATION OF THE AMINES. 
Acetic anhydride (0.012 g, 1 mmol) was added to a mixture of the appropriate amine 
(1 mmol) in glacial acetic acid at room temperature and then the reaction mixture was 
retluxed for 1 h. The solvent was evaporated in vacuo and the crude product was 
purified by chromatography using methanol as eluent. The acetamide was crystallised 
from a mixture of methanol and diethyl ether. 
N-(2- [Acetamido] ethyl)-4-(2-[6-{4-(2-[dimethylamino ]ethyl)thiomethyl} 
phenyl]pyridyl)benzamide (184). 
The N-(2-aminoethyl)-4-(2-[ 6-{4-(2-[ dimethylamino ]ethyl)thiomethyl} phenyl]pyridyl) 
benzamide (181) (0.434 g) , glacial acetic acid and acetic anhydride yielded pale 
yellow N-(2-[ acetamino }ethyl)-4-(2-[ 6-{ 4-(2-[ dimethylamino }ethyl)thiomethyl} 
phenyl} pyridyl)benzamide (184) (0.406 g, 85%), mp 192-193 °C; IR (KBr) v max 
/cm-1 3282 (NH), 2923, 1675 (amide CO), 1628, 1560, 1540, 1408, 1323, 1290, 
1129, 1016,968, 886, 768, 632, 589, 540, 521; IHMvfR (360 MHz, DMSO-d6) () 1.82 
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(3H, s, CH3), 2.10 (6H, s, 2 x Cl\), 2.48-2.50 (4H, m, 2 x CHJ, 3.29-3.39 (4H, m, 
2 x CH2), 3.82 (2H, s, Ar-CH2), 7.48 (2H, d, J = 7.8 Hz, 3- and 5-Ar-H), 7.98 (5H, 
m, 3- and 5-Ar, 3-, 4- and 5-py-H), 8.10 (1H, t, exchangeable with D20, NH), 8.17 
(2H, d,J= 7.8 Hz, 2- and 6-Ar-H), 8.31 (2H, d, J= 7.8 Hz, 2 and 6-Ar-H), 8.71 (1H, 
t, exchangeable with D20, NH); MS (FAB;NOBA) (r.i.) 477 (M++1, 100%),461 (12), 
413 (18),391 (22),373 (29),349 (10), 273 (12),259 (17), 243 (20),192 (10),149 
(30), 132 (9), 123 (35), 122 (12), 107 (54) (Found: C, 68.36; H, 6.48 ; N, 11.24 
C27H32N402S requires: C, 68.06; H, 6.72; N, 11.76%). 
N-(2-[Acetamido] butyl)-4-(2-[6-{4-(2-[ dimethylamino ]ethyl)thiomethyl} 
phenyl]pyridyl)benzamide (185). 
The N-( 6-aminobutyl)-4-(2-[ 6-{4-(2-[ dimethylamino ]ethyl)thiomethyl } phenyl]pyridyl) 
benzamide (182) (0.462 g), glacial acetic acid and acetic anhydride gave the title 
compound(185) (0.25 g, 50%), mp 178.9-179 °C; IR(KBr) v max/cm-1 3290 (NH), 
2923, 1632 (amide CO), 1558, 1540, 1450, 1372, 1330, 1288, 1230, 1164, 1128, 
1044, 1016, 926,862,810, 756, 745, 696, 606, 520; IHNMR (360 MHz, DMSO-d6) 
o 1.47-1.56 (4H, m, for 2 x CH~, 1.81 (3H, s, CH3), 2.11 (6H, s, 2 x CH3), 2.34-2.51 
(4H, m, 2 x CH2), 3.07-3.32 (4H, m, 2 x CH2), 3.82 (2H, s, Ar-CH2), 7.48 (2H, d, J 
= 8.0 Hz, 3- and 5-Ar-H), 7.81 (1H, t, exchangeable with D20, NH), 7.98 (5H, m, 3-
and 5-Ar, 3-, 4- and 5-py-H), 8.18 (2H, d, J = 8.0 Hz, 2- and 6-Ar-H), 8.30 (2H, d, 
J = 8.0 Hz, 2- and 6-Ar-H), 8.61 (lH, t, exchangeable with D20, NH); MS 
(FAB;NOBA) (r.i.) 505 (M++l, 85%),490 (6), 413 (22),400 (15),391 (32),273 (16), 
259 (18), 243 (15), 191 (14), 166 (32), 149 (56), 140 (22), 128 (20), 123 (68), 107 
(100) (Found: C, 69.29; H, 7.10; N, 11.31 C2Ji36N402S requires:C, 69.04; H, 6.86; 
N, 11.11%). 
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N-(2-[Acetamido]hexyl)-4-(2-[6-{4-(2-[dimethylamino]ethyl)thiomethyl} 
phenyl]pyridyl)benzamide (186). 
The N-( 6-aminohexyl)-4-(2-[ 6-{4-(2-[ dimethyl amino ]ethyl)thiomethyl } phenyl ]pyridyl) 
benzamide (183) (0.49 g), glacial acetic acid and acetic anhydride gave N-(2-
[acetamindojhexyl)-4-(2-[6-{4-(2-[dimethylaminojethyl)thiomethyl}phenylj 
pyridyl)benzamide (186) (0.29 g, 55%), mp 150-150.5 °C; IR (KBr) v max /cm-1 3290 
(NH), 2923, 1660 (amide CO), 1550, 1540, 1480, 1320, 1260, 1150, 1124, 1041, 
1081,928, 850, 756, 745, 696, 606, 568, 520; IHNMR (360 MHz, DMSO-d6) () 1.32-
1.55 (8H, m, 4 x CH2), 1.84 (3H, s, ClIg), 2.15 (6H, s, 2 x Cflg), 2.38-2.51 (4H, m, 
2 x CHJ, 3.01-3.30 (4H, m, 2 x CHJ, 3.82 (2H, s, Ar-CH2), 7.48 (2H, d, J = 8.1 Hz, 
3- and 5-Ar-H), 7.83 (1H, t, exchangeable with D20, NH), 7.98 (5H, m, 3- and 5-Ar, 
3-,4- and 5-py-H), 8.19 (2H, d, J = 8.1 Hz, 2- and 6-Ar-H), 8.29 (2H, d, J = 8.1 Hz, 
2- and 6-Ar-H), 8.60 (lH, t, exchangeable with D20, NH); MS (FAB;NOBA) (r.i.) 
533 (M++ 1, 100%),429 (16), 413 (15),391 (16),259 (11), 243 (14),201 (14), 149 
(25), 120 (23), 107 (42) (Found: C, 69.61; H, 7.22 ; N, 9.86 C31H40N402S requires: 
C, 69.92; H, 7.51; N, 10.52%). 
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Physico-Chemical Measurement 
DNA Binding constant. 
The interaction of drugs with nucleic acid can be measured by the loss of the ethidium 
fluorophore, which occurs upon binding of the compounds. Ethidium binds with 
nucleic acid through intercalation and this causes a large fluorescence enhancement 
( ~ 25 fold) due to the immersion of the ethidium in the hydrophobic region of the 
nucleic acid and the isolation of the fluorophore from water. 126,127 
Ifanother drug which binds with DNA is added to a solution of DNA saturated with 
ethidium and if this drug binds more strongly to DNA than ethidium, then displacment 
of some ethidium from DNA occurs and the fluorescence decreases. 
The DNA binding constant of the drugs can be estimated by the decrease in 
fluorescence of ethidium as a function of the concentration of the added drug. The 
drug concentration which produces 50% inhibition of fluorescence is approximately 
inversely proportional to the binding constant which was determined in this work from 
a plot of percentage fluorescence against drug concentration measured at pH 7.5. 
The binding constant of ethidium is 107 M-1 when the concentration of ethidium is 
8 /lm. Therefore the binding constant can be calculated by dividing the product of 
ethidium bromide concentration and ethidium bromide binding constant by the 
concentration producing 50% loss in fluorescence. The measured fluorescence was 
corrected in all cases by subtracting the blank value, which is the fluororescence of 
ethidium bromide alone in buffer. The fluorescence of 100% was then the value for 
DNA saturated with ethidium bromide. The calculated binding constants are shown in 
Table 1. 
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DNA Binding Drugs Concentration of Drugs DNA Binding Constant 
at pH 7. 5 1M-I 
181 
182 
183 
184 
185 
186 
XI 11M 
23.82575 
25.75277 
17.65464 4.5 X 106 
233.6548 
187.9639 
75.18557 
Table 1: Binding constants of the novel compounds. 
(181) n = 2, R = H 
(182)n=4,R=H 
(183) n = 6, R = H 
(184) n = 2,R = COCH3 
(185) n = 4,R = COCH3 
(186) n = 6,R = COCH3 
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4.3 X 105 
It has been reported 86 that tricyclic unfused polyaromatic systems with a cationic side 
chain are better amplifiers (binding constant, K=13 X 106 M-1) than classical inter-
calators (107_105 M-1) at low concentration. 
The electrostatic interaction of these cationic groups with the anionic DNA chain 
enhances groove binding or intercalation of the aromatic portion of the molecule. This 
is due to the stability of the molecule-DNA complex. 128 Several other unfused 
compounds with alkylthio or alkylamino linkages and with cationic side chains were 
tested. The thio substituted derivatives were found to bind more strongly than the 
amino analogue. 129 
In the present work, the novel amines (181-183) were found to bind to DNA and the 
different cationic side chains produced only a very small difference in the binding 
strengths (Table 1). The compounds having the longest cationic side chain and 
including a sulfur atom bind more strongly than the other DNA binders. The lower the 
values of the drug concentration, the greater the interaction with DNA. These 
compounds have been coupled through an amide link with analogues of the metal-
binding part of the bleomycin structure, it was therefore of interest to study the DNA 
binding of the compounds after they had been converted from amines to amides and 
the acetyl derivatives (184-186) were studied. An order of magnitude decrease in the 
binding constant in going from the amine to the amide occurred, except in the case of 
(183) and (186) where the difference was less. 
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Experimental 
All the experiments were carried out using 10 mM TES (N-tris(hydroxymethyl)methyl-
2-aminoethanenesulfonic acid) and 0.5 mM EDTA (ethylenediaminetetraacetic acid) 
at pH 7.5 containing 9.92 /lM DNA. 
The fluorescence measurement was carried out on a Perkin-Elmer LS50B 
luminescence spectrometer at excitation and emmision wave lengths of 525 and 600 
nm respectively. The effect of the drug in quenching the ethidium-DNA fluorescence 
was then measured by the addition of consecutive amounts (3 /lLs) of a solution of the 
drug (concentration within the range O. 1 /lM to 100 /lM), leaving 5 min intervals 
between the addition of the drug and the measurement of the new fluorescence. 
Increasing amounts of the drug were added until the fluorescence was quenched by 
over 50 %. All fluorescence readings were corrected by subtraction of the blank value 
(that fluorescence recorded for ethidium bromide in buffer alone). 
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CONCLUSION 
The study of certain hexaazapentacenes has shown that these compounds can be 
obtained from 1 ,4-dithia[2,3-b: 5,6-b ]diquinoxalines and bis(2-chloroquinoxalin-3-
yl)sulfides by using different reaction conditions. The 3-amino-5,6-dimethoxy-1 ,2,4-
benzotriazine-l-oxide resisted attempts to cause further N-oxidation, probably due to 
steric hindrance. 
Several routes for the synthesis of2,6-diphenylpyridines carrying different substituents 
at the 4 and 4' positions of the phenyl nuclei have been investigated. A successful 
method for the preparation of 2,6-diphenylpyridines carrying a dimethyl amino alkyl 
group on one phenyl nucleus and a primary alkylamine substituent on the other phenyl 
ring has been developed. The binding of these compounds and the acetyl derivatives 
of the amines with DNA was studied. 
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APPENDIX 
List of Novel Compounds 
2,3 -Dimethoxy-1, 4-diazaanthracene-9, 10-dione (55) 
Bis(2-chloroquinoxalin-3-yl)sulfide (57) 
6, 13-Dibutyl-5,6, 7,12,13, 14-hexaazapentacene (58) 
13-Butyl-6, 13-dihydro-6-thia-5, 7,12,13, 14-pentaazapentacene (59) 
6, 13-Dibenzyl-5,6, 7,12,13, 14-hexaazapentacene (60) 
13 -(2-Aminoethyl )-6, 13 -dihydro-6-thia-5, 7, 12, 13, 14-pentaazapentacene (61) 
6, 13 -Dihydro-6-thia-5, 7, 12, 13, 14-pentaazapentacene (62) 
1-Hydroxy-4,7-dimethoxy-1,2,3-benzotriazole (65) 
2,5-Dimethoxy-6-nitroaniline (66) 
2,5-Dimethoxy-4-nitroaniline (67) 
N-(2,5-dimethoxy-6-nitrophenyl)guanidine (68) 
3-Amino-5,6-dimethoxy-1,2,4-benzotriazine-1-oxide (69) 
4,7-Dimethoxy-1,2,3-benzotriazole (70) 
1-(4-Methylphenyl)-3-( dimethyl amino )propane-1-one hydrochloride (141) 
1-( 4-Cyanophenyl)-3 -( dimethyl amino )propane-1-one hydrochloride (167) 
4-(3-dimethylaminopropanoyl)benzoic acid hydrochloride (175) 
1-(4-Methylphenacyl)pyridinium bromide (138) 
Phenacylpyridinium bromide (143) 
1-(4-Bromophenacyl)pyridinium bromide (160) 
2-Phenyl-6-( 4-tolyl )pyridine (144) 
2-( 4-Bromophenyl)-6-( 4-tolyl)pyridine (161) 
2-( 4-Cyanophenyl)-6-( 4-tolyl)pyridine (168) 
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4-(2-[6-{ 4-Tolyl}pyridylDbenzoic acid (173) 
Ethyl 4-(2-[6-{4-tolyl}pyridyIDbenzoate (178) 
2-( 4-[Bromomethyl ]phenyl)-6-phenylpyridine (145) 
2-( 4-[Bromomethyl]phenyl)-6-( 4-tolyl)pyridine (154) 
2-( 4-[Bromomethyl]phenyl)-6-( 4-bromophenyl)pyridine (162) 
2-( 4-[Bromomethyl ]phenyl)-6-( 4-cyanophenyl )pyridine (169) 
Ethyl 4-(2-[6-{ 4-bromomethylphenyl} ]pyridyl)benzoate (179) 
2-( 4-[DibromomethylphenyID-6-phenylpyridine (146) 
2-( 4-[Diethoxymethyl]phenyl)-6-phenylpyridine (147) 
2-( 4-F ormylphenyl)-6-phenylpyridine (148) 
2-( 4-[Ethoxymethyl]phenyl)-6-phenylpyridine (149) 
2-( 4-[3-Aminopropoxymethyl]phenyl)-6-phenylpyridine (150) 
2-(4-[ 4-Amino-2-azabutyl]phenyl)-6-phenylpyridine (151) 
2-(4-[5-Amino-2-azapentyl]phenyl)-6-phenylpyridine (152) 
2-(4-[8-Amino-2-azaoctyl]phenyl)-6-phenylpyridine (153) 
2-(4-[8-Amino-2-azaoctyl ]phenyl)-6-( 4-methylphenyl)pyridine (156) 
2,6-Bis( 4-[8-amino-2-azaoctyl ]phenyl )pyridine (157) 
2-( 4-[ 4-Dimethylamino-2-thiabutyl ] phenyl )-6-( 4-methylphenyl )pyridine 
(158) 
2-( 4-[ 4-Dimethylamino-2-thiabutyl ] phenyl )-6-( 4-bromophenyl )pyridine 
(163) 
2-(4-[ 4-Dimethylamino-2-thiabutyl]phenyl)-6-( 4-cyanophenyl)pyridine 
(170) 
Ethyl 4-(2-[ 6-{ 4-(2-[ dimethyl amino ]ethyl)thiomethyl} phenyl]pyridyl) 
benzoate (180) 
N -(2-[Tert-Butoxycarbonylamino ]ethyl)-4-(2-[ 6-{ 4-tolyl} pyridylD 
benzamide (177) 
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N -( 2-Amino ethyl )-4-( 2-[ 6-{ 4-(2-[ dimethylamino ] ethyl )thiomethyl } phenyl] 
pyridyl)benzamide (181) 
N-(4-Aminobutyl)-4-(2-[6-{4-(2-[dimethylamino]ethyl)thiomethyl}phenyl] 
pyridyl)benzamide (182) 
N -( 6-Aminohexyl)-4-(2-[ 6-{ 4-(2-[ dimethyl amino ] ethyl )thiomethyl } phenyl] 
pyridyl)benzamide (183) 
N -(2-[ Acetamido ]ethyl)-4-(2-[ 6-{ 4-(2-[ dimethyl amino ]ethyl)thiomethyl} 
phenyl ] pyridyl)benzamide (184) 
N -( 2-[ Acetamido ]buty I )-4-( 2-[ 6-{ 4-(2-[ dimethylamino ] ethyl )thiomethyl } 
phenyl]pyridyl)benzamide (185) 
N -( 2-[ Acetamido ]hexyl )-4-( 2-[ 6-{ 4-( 2-[ dimethyl amino ] ethyl )thiomethyl } 
phenyl]pyridyl)benzamide (186) 
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